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ABSTRACT
The dynamic, co-ordinated remodelling of the actin cytoskeleton is attributed to the 
interaction of actin with a wide variety of actin regulating proteins. The remodelling of 
actin is central to many cellular processes including endocytic uptake, polarisation of 
growth, cell motility, and is important for the ability of cells to respond to many 
intracellular and extracellular signals. Therefore, the study of individual actin regulating 
proteins enables a greater understanding of the complex overall control of the actin 
network and many cellular processes.
Slalp is an endocytic adaptor protein with several known roles in the cytoplasm, 
which include linking proteins involved in the early stages of endocytic uptake with those 
required for the actin polymerisation at endocytic sites. The data presented in this thesis 
however details the nuclear localisation of Slalp. In addition to this initial observation, 
further analysis has allowed the proposal of a mechanism for the nuclear translocation of 
Slalp. This was achieved by analysis of potential nuclear transport signals in wild-type and 
slal mutants, consideration of phosphorylatory mechanisms, and by detailed studies of 
nuclear transport receptor mutants. Finally, results of microarray analysis undertaken 
between wild-type and slal mutant strains were used to elucidate potential roles of nuclear 
Slalp. These studies suggest that Slalp localises both to the cytoplasm and the nueleus in 
S. cerevisiae and that its activity and cellular localisation may be regulated primarily 
through phosphorylation.
The key to the dynamic remodelling of the actin cytoskeleton is the coordinated 
control of filament nucléation, polymerisation and disassembly. Data presented in this 
thesis demonstrates the association of the cortical patch protein Ysc84p with actin 
filaments, and the ability of Ysc84p to both sever and cap these filaments in vitro. A 
possible regulatory mechanism for the protein is also considered. Additionally, a Ysc84p 
homologue is localised to dynamic actin structures in mammalian cells and studies suggest 
that this protein may have a similar actin regulatory mechanism. These studies therefore 
suggest an exciting role for the cortical patch protein Ysc84p in the regulated control of 
branched actin filaments in S. cerevisiae.
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1 INTRODUCTION
1.1 General introduction
The ability of cells to grow and replicate is fundamental to the development of 
organic life. Remodelling of the cytoskeleton is central to both cellullar growth and 
replication, enabling both the polarised transport of organelles and vesicles to specific 
sites, cellular remodelling and division.
Cytoskeletal networks are also of interest in the study of disease. The lack of 
regulated cellular growth and division displayed in tumour cell lines enables such cells 
to proliferate in an unrestrained manner, and consequently involves cytoskeletal 
components, which regulate cellular polarisation and remodelling. Understanding the 
control of cytoskeletal networks will therefore enable greater insight into cellular 
dysregulation, while also providing important information on the growth, motility, 
polarity and development of cells.
Actin is an important component of the cytoskeletal network. This introductory 
chapter provides an initial overview of the composition of the cytoskeletal network and 
integral actin filaments. The focus then turns to the actin molecule, polymerisation of 
actin and the control of polymerising actin structures by additional proteins. I will then 
introduce the various cellular structures formed by filamentous actin, concentrating 
finally on the control of actin in the budding yeast Saccharyomyces cerevisiae and the 
reasons for choosing to study cytoskeletal networks in this model organism.
1.2 Actin
Central to our understanding of cell polarisation and growth is an appreciation of 
the control of cytoskeletal networks. Actin is a highly conserved and ubiquitously 
expressed protein in eukaryotic cells and is an important component of such cytoskeletal 
networks. The conservation of the actin protein throughout eukaryotes reflects the 
importance of this molecule in cellular function. Actin is involved in many diverse roles 
including intracellular organisation, organelle movement and inheritance, cell structure, 
endocytosis, transcription, cell division and polarisation. Composing approximately 
10% of total cellular protein in the highly motile amoeba Dictyostelium (Hug et al, 
1995), actin is regarded as a crucial cellular cytoskeletal protein, with roles in a wide 
variety of general and cell-specific processes. In motile cells, actin is an essential 
component of the machinery required for cell contractility and motility. While in the 
non-motile budding yeast S. cerevisiae however, actin is involved in events including
bud site selection and bud emergence. Actin is present therefore in all cells and has roles 
both in conserved cellular processes and also in cell specific activities.
Cytoskeletal actin exists in two basic forms, as monomeric G-actin and 
polymeric, filamentous F-actin. Actin monomers polymerise to form actin filaments 
which are then organised into higher order cellular structures. The diversity of actins’ 
cellular roles is primarily dependent on the association of a wide variety of proteins with 
both G- and F-actin which control and generate intricate, highly regulated filamentous 
actin networks. These actin binding proteins regulate nucléation, polymerisation and 
organisation of filamentous actin at specific sites, allowing the actin structures and the 
force generated by actin polymerisation to be hainessed and utilised in the cell.
The cytoskeleton is composed of an array of protein filaments which not only 
maintain cellular structure but which also enable changes in cell shape and intracellular 
reorganisation and remodelling. In S, cerevisiae, the cytoskeleton is composed of only 
two types of protein filament, actin filaments and microtubules. Microtubules are 
similar to F-actin in that polymerisation occurs from monomeric proteins; alpha and 
beta tubulin. Microtubules are however hollow cylindrical filaments, whereas actin 
filaments polymerise in helical pairs and form thin filaments. Cytoskeletal networks in 
most species generally however contain intermediate filaments, in addition to 
microtubules and actin filaments. The components of intermediate filaments are diverse 
and cell specific but are known to including keratins in epithelial cells, vimentins, 
nuclear lamins which are involved in the stabilisation of the nuclear envelope and 
neurofilaments.
1.3 Structure of G-actin
An actin monomer is composed of 375 amino acid residues. Analysis of the 
crystal structure of actin has revealed that actin monomers are organised into two major 
domains (Kabsch et al, 1990). Each domain is then composed of a further two smaller 
sub-domains (figure 1-1). Actin monomers contain a divalent cation and nucleotide 
binding site in the deep cleft between the two large domains. Comparison of ADP- 
bound and ATP-bound actin structures has demonstrated conformational changes 
between sub-domains 2 and 3 (Otterbein et al, 2001; Graceffa and Dominguez, 2003). 
These rotational changes are thought to increase the stability of actin monomer 
incorporation in filaments when in the ATP-bound form. Hydrolysis of ATP bound to 
actin monomers promotes monomer release from a filament.
The preference of actin monomers to polymerise at high concentrations rather 
than form crystals, slowed the study of the structure of actin. The crystal structure of 
actin was therefore initially determined from crystallised 1:1 complexes of actin with 
profilin (Schutt et al, 1993), DNase 1 (Kabsch et al, 1990) and a fragment of gelsolin 
(McLaughlin, 1993; Robinson, 1999). Both profilin and DNase 1 are relatively small 
proteins which inhibit the polymerisation of actin. Recent studies have however enabled 
the crystallisation of ADP-bound G-actin monomers alone, using the fluorescent probe 
tetramethylrhodamine-male imide (TMR) to inhibit polymerisation by interaction with 
the Cys^ "^^  residue of the actin molecule (Otterbein et al, 2001) (figure 1-1). Interference 
with the Cys^^  ^residue renders the actin monomer polymerisation deficient. The debate 
is ongoing however with regard to whether the binding of this molecule prevents 
movement of the actin monomer into its true ADP-bound state. Attachment of the TMR 
molecule partially blocks the hydrophobic cleft between sub-domains 1 and 3 of the 
actin monomer. This hydrophobic cleft has recently been demonstrated to be important 
for binding of several ABPs (for review see Dominguez, 2004).
1.4 Structure of F-actin
The hydrophobic cleft between sub-domains 1 and 3 of actin is proposed to 
mediate binding to other actin monomers, enabling the generation of actin filaments. 
The DNase 1 binding loop (figure 1-1), encompassing the His'^ -^Gly'^® residues of 
subunit 2, is proposed to bind in this hydrophobic cleft. This binding is demonstrated in 
the filament model shown in figure 1-2, proposed by Holmes and colleagues (Holmes et 
al, 1990; Lorenz et al, 1993). This loop region has been shown to interact with DNase 1 
in an Actin:DNasel complex and in the TMR-bound crystallised monomer assumes an 
alpha-helical structure (Otterbein et al, 2001).
Crystallisation studies of filamentous actin in combination with myosins or F- 
actin binding proteins have not so far been achieved. The crystallisation of G-actin 
alone however paves the way for these studies. F-actin has been studied in combination 
with several F-actin binding proteins by electron microscopy. These binding proteins 
include utrophin (Moores et al, 2000), tropomyosin (Xu et al, 1999), and myosin 
(Volkmann et al, 2000). These studies have however provided limited resolution.
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Figure 1-1. The structure of an actin monomer in a TMR bound state.
ADP binds in the centre of the actin monomer, in the deep cleft formed. Sub-domain 1 is 
shown in purple, sub-domain 2 in green, 3 in yellow, and sub-domain 4 in red. The DNase 1 
binding loop in sub-domain 2 is known to form an alpha-helix in this ADP bound state. 
Potential cations binding sites identified in these crystals are shown as spheres. The binding 
site o f Tetramethylrhodamine-5-maleimide (TMR) is also shown. Figure adapted from 
Otterbein and colleagues, 2001.
Figure 1-2. The Holmes filament model.
The proposed regions of interaction between two actin monomers in an actin filament are 
shown. Sub-domains 1-4 on each actin monomer are numbered. The alpha-helical DNase 1- 
binding loop in sub-domain 2 is shown in red and is proposed to interact with the hydrophobic 
cleft found between sub-domains 1 and 3 on an adjacent actin monomer. ADP and a spherical 
cation are also shown bound in the centre o f each monomer. Figure adapted from Dominguez, 
2004.
The helical nature of actin filaments (F-actin) was determined by X-ray 
crystallography and electron microscopy studies (Holmes et al, 1990; Milligan et al, 
1990 respectively). Filaments are known to consist of two proto-filaments attached by 
lateral contacts and which wind around each other to form a helix. A full helical twist in 
the actin filament is formed every 37 nm (figure 1-3).
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Figure 1-3. The structu re  of an actin filament
Actin filaments are composed of two proto-filaments of polymerised actin monomers, held 
together by lateral contacts. Each proto-filament lies in the same orientation and the two rotate 
around each other to form a helix. One helical turn is occurs every 37 nm. The barbed (plus) and 
pointed (minus) ends of the filament are shown. Figure adapted from Alberts ef at, 2002.
1.5 Polymerisation of actin
Actin filaments are formed by the polymerisation of actin monomers, a process 
which requires ATP, monovalent (K' )^ and divalent (Ca^ "^ , Mg^^) cations. Polymerisation 
occurs when ATP bound G-actin monomers incorporate into an existing actin filament. 
Hydrolysis of ATP and the release of inorganic phosphate (Pi) follow monomer 
incorporation. ATP hydrolysis induces a conformational change in the newly 
incorporated actin monomer and this is thought to play a critical role in actin dynamics 
due to the preference of specific actin binding proteins for ATP or ADP bound actin. 
Hydrolysis of ATP is also known to reduce the binding affinity of the monomer for the 
adjacent actin monomers, promoting eventual dissociation of monomers from the 
filament (Alberts et al, 2002).
Nucléation describes the formation of a new actin filament from free actin 
monomers and is a two step process. The initial step, formation of an actin dimer is 
energetically unfavourable and dimers are therefore unstable. In vivo, additional factors 
are involved in overcoming this kinetic barrier. The second step towards nucléation is 
formation of an actin trimer or ‘nucleus’ from which polymerisation proceeds by 
sequential addition of actin monomers to both ends of the new filament. The time 
course of polymerisation in vitro is shown in figure 1-4. Following addition of ATP, 
monovalent and divalent cations to a solution of monomeric actin, polymerisation is 
seen to progress in three stages. During lag phase the slow process of filament 
nucléation occurs. This is followed by a period of rapid filament growth as monomers 
incorporate at both ends of the filaments, termed the elongation phase. Finally an 
equilibrium or ‘steady state’ is achieved when the filament remains at a constant length 
due to monomer incorporation occumng at the same rate as monomer loss.
Actin filaments are highly dynamic due to the rapid loss and addition of actin 
monomers from both filament ends. While both filament ends are able to incorporate or 
dissociate monomers, filaments are however polarised due to the orientation of 
monomers in each proto-filament. The barbed (fast growing) end favours addition of 
monomers over the pointed end, leading to a ‘treadmilling’ effect with actin monomers 
moving through the filament as polymerisation occurs preferentially at the filament 
barbed end. This treadmilling effect is seen during the equilibrium stage of 
polymerisation. During this stage, filaments remain at a constant length while still 
experiencing a net flux of actin subunits through the filament (figure 1-5). The 
equilibrium phase occurs when the concentration of free monomers in solution is above 
the critical concentration for the barbed end of the filament but below that of the pointed 
end. The critical concentration at each filament end differs as it takes into account the 
number of monomers added to the filament per second; dependent on the concentration 
of free monomers in solution, and loss of monomers from the filament end, which is not 
dependent on the concentration of free monomers. Thus as the filament lengthens, the 
number of free monomers decreases until the addition of monomers slows to the same 
rate as that lost from the filament end, due to a lack of free monomers available for 
incorporation. At this point the concentration of free actin monomers is constant and 
this is termed the critical concentration. When this occurs, monomers are added to the 
barbed end of the filament and lost from the pointed end at the same rate, allowing the 
filament to stay at a constant length while still experiencing a net flux of monomers.
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Figure 1-4. The time course of actin polymerisation in vitro. Polymerisation is 
initiated by increasing the salt concentration in a monomeric actin solution. The 
formation of trimer complexes from actin monomers is termed nucléation. The formation 
o f this nucleus is relativelyslow, producing the lag phase of polymerisation. Growth 
phase occurs as monomers are added to elongating filaments, while the equilibrium 
phase is reached when growth o f the polymer is balanced by monomer loss. (Figure 
adapted from Alberts et al, 2002).
Nucléation forms a 
stable trimeric complex 
(nucleus) Filament growth 
(polymerisation at both ends)
/Free pool of actin monomers Hydrolysis of older protomers 
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Figure 1-5. Filament generation and treadmilling. ATP-bound G-actin monomers 
(blue) initially form trimeric nucléation complexes onto which actin filaments are 
assembled. Assembly occurs by incorporation of additional ATP-G-actin monomers at 
both ends o f the filament. Following incorporation into the filament ATP bound 
‘protomers'1 hydrolyse releasing inorganic phosphate and generating ADP-bound 
protomers (yellow). These protomers will eventually be released from the filament and 
they will be free to cycle back into actin filaments followin exchange into the ATP 
bound form. Due to the preferential addition o f ATP-G-actin to the barbed (+) end of a 
filament and the preferential dissociation o f hydrolysed protomers from the pointed (-) 
end and a difference in critical concentration, a treadmilling effect is seen.
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1.6 Regulation of actin
Polymerisation and organisation of actin filaments is regulated in vivo by a large 
number of actin binding proteins (ABPs) (Engel et al, 1977). Filament dynamics are 
controlled by these proteins in a vaiiety of ways. Specific ABPs cap, uncap and sever 
filaments, while yet others affect the rates of integration or dissociation of actin 
monomers or promote nucléation of actin filaments. Additionally, filament stabilising, 
bundling and cross-linking proteins promote incorporation of actin filaments into higher 
order structures. Many actin regulating proteins bind directly to actin in its monomeric 
or filamentous form. These proteins have been classified into several general groups 
depending on their mechanism of actin regulation (figure 1-6). Most actin regulating 
proteins however regulate actin in a number of ways and classification of ABPs into 
groups is therefore further complicated. Additionally, actin regulating abilities 
determined in vitro in many cases differ from activities seen in an in vivo. For this 
reason the precise functions of many actin binding proteins in a cellular environment are 
not fully defined.
1.6.1 Monomer binding proteins
Monomer binding proteins regulate actin polymerisation by binding directly to 
actin monomers and affecting their availability for incorporation into filaments. As the 
rate of filament elongation is directly proportional to the concentration of actin 
monomers available in solution (Pollard, 1986), these proteins exert significant control 
over actin polymerisation and remodelling in the cell. The small actin binding protein 
profilin has been shown to inhibit actin filament growth in vitro by monomer binding 
and sequestration (Carlsson et al, 1977). In vivo however, the preference of profilin to 
bind to ATP-actin monomers is thought to promote filament polymerisation by 
maintaining a pool of free actin monomers, ready for incorporation into a filament. 
Additionally, profilin is also known to bind to ADP-actin monomers, promoting the 
exchange of ADP for ATP, and thereby increasing polymerisation rates by increasing 
the number of actin monomers available in a ‘polymerisation ready’ state. Members of 
the ADF/cofilin family also regulate actin monomers directly. These proteins accelerate 
dissociation of actin monomers from filaments using two mechanisms. 
Depolymerisation is promoted by monomer sequestration with preferential binding to 
ADP-actin (Aizawa et al, 1995, Carlier et al,
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Figure 1-6. Overview of actin regulating proteins. Previous studies have enabled the 
classification of actin binding proteins into functional groups, each with specific effects 
on actin polymerisation or organisation. Proteins specific to S. cerevisiae are underlined.
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1997), while filament severing increases the number of filament ends, thereby 
promoting monomer exchange from these sites. Proteins of this family were first 
recognised for their ability to rapidly depolymerise actin and are found at the leading 
edge of motile cells and in ruffling membranes (Aizawa et al, 1995). Cofilin and 
profilin therefore act together in the control of available G-actin monomers.
1.6.2 Filament stabilising proteins
Several groups of actin binding proteins regulate actin by stabilising filamentous 
structures. Many achieve this by preventing further incorporation or loss of monomers 
from filaments, while others promote the incorporation of filaments into bundles or 
intricate networks of filaments. Filament side-binding proteins stabilise actin by binding 
along the length of actin filaments and making contact with multiple subunits, as in the 
case of tropomyosins. Additionally, some filament side-binding proteins, including 
tropomyosin, decrease the rate of subunit loss from filament ends by filament binding. 
Tropomyosins in yeast associate with actin cables and are encoded by TPMl and TPM2.
1.6.3 Capping proteins
Capping proteins stabilise actin filaments by ‘capping’ filament ends and 
preventing monomer exchange at these sites. Studies have shown that most actin 
filament barbed ends are not freely accessible in the cell (Hug et al, 1995), and most 
filament barbed ends are therefore thought to be capped. A model proposing selective 
uncapping of specific sites has been proposed by Carlier and Pantaloni (Carlier and 
Pantaloni, 1997). Selective uncapping of filaments to promote localised actin 
polymerisation at specific sites is a very attractive model. By selective uncapping, 
polymerisation would be restricted and confined to areas containing uncapped 
filaments, a process termed ‘funnelling’ of polymerisation. Uncapping of filament 
barbed ends by dissociation of capping protein (CP) has been shown to be an activity of 
the polyphosphoinositides, PIP2 and PIP in vitro (Schafer et al, 1996). CP is 
ubiquitously expressed in all eukaryotes and co-localises with filamentous actin. In S. 
cerevisiae CP is a heterodimeric protein encoded by CAPl and CAP2.
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1.6.4 Bundling and cross-linking proteins
Actin bundling proteins stabilise filaments by dual filament binding. These 
proteins bring actin filaments into close proximity and generate thick bundles of actin 
filaments, termed actin cables. Actin cross-linking proteins however promote the 
incorporation of actin filaments into intricate networks. Fimbrin, villin and a-actinin are 
examples of actin bundling proteins. Fimbrin contains two pairs of calponin homology 
(CH) domains (deArruda et al, 1990) which mediate actin binding. Sac6p (yeast 
fimbrin) is required for normal actin organisation, endocytosis and cell polarisation in 
yeast. Deletion of SAC6 destabilises actin cables (Karpova et al, 1995). The calponin 
homology domain has been identified in many actin-associating proteins such as, 
spectrin, filamin and plectin. Pairs of CH domains have well-documented actin binding 
capabilities, however it is still unclear as to whether a single CH domain alone can bind 
to actin. Recently, another actin bundling protein, Sep Ip has been identified in yeast. 
Scplp is the yeast homologue of transgelin and contains a single CH domain and 
calponin-like repeat (CLR). Scplp has been shown to bundle actin filaments in vitro and 
is found to localise primarily to cortical actin patches in yeast, suggesting the protein 
may have additional roles in the regulation of actin, as actin filaments do not bundle at 
this location (Goodman et al, 2003; Winder et al, 2003).
1.6.5 Severing proteins
Actin severing proteins cleave actin filaments and promoting both filament 
disassembly and filament polymerisation by the generation of free filament ends. The 
generation of free filament ends promotes filament breakdown or filament 
polymerisation depending on the availability of actin monomers and the action of actin 
regulating proteins at these sites. Gelsolin, villin, fragmin and adseverin are well-studied 
calcium regulated, actin severing proteins. All require high levels of calcium for actin 
severing. Intriguingly, the structure of yeast cofilin suggests the protein may have 
severing activity (Maciver, 1998), although this activity has yet to be shown in vitro and 
is debatable. Cofilin localises to cortical actin structures in S. cerevisiae (Moon et al, 
1993). Additionally, many actin severing proteins also cap actin filaments, as in the case 
of gelsolin. Gelsolin activity is regulated by pH and phosphotidylinositol 4,5- 
biphosphate (PIP2), in addition to calcium. To date no gelsolin family members have 
however been identified in yeast or plant cells.
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1.6.6 Nucleating proteins
Actin nucleating proteins promote the formation of actin dimers and trimers 
which act as the starting blocks for polymerisation. The Arp2/3 complex nucleates new 
actin filaments and promotes branching of existing filaments, and is a highly conserved 
key regulator of actin (for review see Higgs and Pollard, 2001). This seven subunit 
complex contains two protein subunits which are structurally similar to actin and which 
are thought to mimic an actin dimer. The relatively weak intrinsic nucleating activity of 
the Arp2/3 complex is dramatically increased in conjunction with a number of 
nucléation promoting factors (NPFs) (Winter et al, 1999a; Goode et al, 2001). 
Overexpression of the NPFs: WASP and N-WASP and the yeast WASP homologue 
Lasl7p/Beelp generate large actin aggregates in the cell, presumably due to an increase 
in the nucleating activity of Arp2/3 (Madania et al, 1999; Symons et al, 1996, Miki et 
al, 1998).
The Arp2/3 complex is not the only factor able to mediate actin nucléation. 
Recently, formin proteins have also been shown to have nucleating ability (Evangelista 
et al, 2002; Sagot et al, 2002b). Filaments nucleated by formins are proposed to 
generate the unbranched actin filaments which collectively form actin cables in yeast. 
Arp2/3 complex nucleated filaments are however thought to form the branched 
filaments specifically found in actin patches at the cell cortex (Lew, 2002, Sagot et al, 
2002a). These proposals are supported by cellular studies, in which the loss of the yeast 
formins Bnilp and BniTp result in a rapid, reversible loss of actin cables, while cortical 
actin patches remain unaffected (Evangelista et al, 2002, Sagot et al, 2002a). Formins 
are Rho-GTPase effectors that communicate Rho-GTPase signals to the cell 
cytoskeleton. These proteins are multi-domained and are defined by the presence of a 
conserved FH2 (formin homology 2) domain. The FH2 domain alone is able to mediate 
actin filament nucléation in vitro (Pruyne et al, 2002, Sagot et al, 2002b), although this 
domain is usually flanked by a FHl domain which binds profilin, SH3 domains or WW 
domains. Diaphanous related formins contain both a DAD (Diaphanous Autoregulatory 
Domain) and a GBD (GTPase binding domain) domain which associate to inhibit the 
activity of the protein. Rho-GTPase binding to the GBD domain inhibits this regulatory 
interaction and promotes an active conformation (Alberts et al, 2001, Evangelista et al, 
2002). The mechanism of actin nucléation mediated by formin proteins is under 
investigation. Yeast Bnilp however nucleates filaments at the bud tip in S. cerevisiae, 
while Bnrlp localises to the bud neck during bud development. Each of these formins is
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thought to nucleate filaments which emanate from these specific sites and form the 
polarised actin cables seen during bud development (Evangelista et al, 2002; Pruyne et 
al, 2004). Filament nucléation by formins is known to occur in a profilin dependent 
manner with the formation of actin cables from these filaments involving tropomyosin 
(Evangelista et al, 2002)
1.6.7 The Arp2/3 complex in more detail
The Arp2/3 complex mediates nucléation and actin filament branching. The 
complex was first isolated from Acanthamoeba castellanii (Machesky et al, 1994) and 
studies have shown the complex to be a central component of the actin regulatory 
network. Arp2/3 has since been identified in a variety of other species including 
Xenopus (Ma et al, 1998), S, cerevisiae (Winter et al, 1997) and human cell lines 
(Welch et al, 1997). The structure of this seven subunit complex is highly conserved 
throughout eukaryotes and includes two actin related protein subunits, Arp2p and 
Arp3p. Ai'p2/3 is able to nucleate actin filaments while also mediating branching of 
existing filaments. Filament branching generates Y-branched filaments from existing 
filaments, by nucléation of a new filament at a 70° angle as shown in figure 1-8. The 
ability of Arp2/3 to nucleate actin filaments is thought to dependent on the Aip2p and 
Arp3p actin related protein subunits of Arp2/3. These actin related subunits mimic an 
actin dimer, thereby forming a template for actin nucléation and bypassing the 
energetically unfavourable formation of an actin dimer from actin monomers (Robinson 
et al, 2001, Volkmann et al, 2001). The nucleating ability of the Arp2/3 complex is 
stimulated from a low basal level by a variety of NPFs proteins (for review see Higgs 
and Pollard, 2001). Known NPFs in yeast include the yeast WASP homologue 
Lasl7p/Beelp (Li, 1997; Winter et al, 1999a; Madania et al, 1999), Abplp (Goode et 
al, 2001), Panlp (Duncan et al, 2001), Myo3p and Myo5p (Evangelista et al, 2000) ail 
of which localise to actin structures at the cell cortex with Arp2/3. Mammalian NPFs 
include WASP (Wiskott Aldrich Syndrome protein) and N-WASP. NPFs contain a CA 
(connector and acidic) region; a short stretch of basic and acidic residues which can 
induce a conformational change in the Arp2/3 complex. Additionally, NPFs also contain 
an F-actin (Class II NPFs) or G-actin (Class I NPFs) binding site adjacent to the CA 
region.
Immunogold labelling experiments have confirmed that the Arp2/3 complex 
remains at the ‘Y’ junctions following branching (Svitkina and Borisy, 1999). The
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mechanism by which Arp2/3 forms ‘Y’ branched filaments is however disputed. Two 
mechanisms have been proposed. The ‘dendritic nucléation’ model (Pollard et al, 2000) 
proposes binding of the activated form of Arp2/3 to the side of an existing filament and 
nucléation of a new filament branch. In addition, a ‘barbed end branching’ model 
(Pantaloni et al, 2000) has been proposed, suggesting integration of the actin related 
subunits directly into an existing filament at the barbed end during polymerisation. 
Subsequent electron cryomicroscopy studies have supported the dendritic nucléation 
model; 2-dimensional reconstructions of Acanthamoeba Arp2/3 with F-actin 
demonstrated that the existing filament is unperturbed following filament branching 
(Volkmann et al, 2001). Investigation into the mechanism of filament branching is 
however ongoing, with the study of branch polymerisation kinetics providing further 
support for the filament side binding model (Carlsson et al, 2004).
Deletion of Arp2/3 subunits in yeast generated severe growth defects or 
lethality, suggesting the importance of this complex in the yeast cell (Winter et al, 
1999b). Studies of the motile bacterial pathogen Listeria monocytogenes have also 
implicated the Aip2/3 complex in the generation of cellular motility and intracellular 
movement. Following invasion of the bacterial cell, an actin ‘comet tail’ was seen to 
develop on the surface of the pathogenic cell, and appeared to drive movement of the 
pathogen both within the host cell and from one host cell to the next. These comet tails 
were shown to consist of various actin binding proteins (Loisel et al, 1999; Theriot et al, 
1994; Carlier et al, 1997; Rosenblatt et al, 1997) and actin filaments orientated with 
their barbed ends towards the bacterial surface (Tilney et al, 1990; Gouin et al, 1999). 
These studies suggested that polymerisation of actin was either occurring on or close to 
the surface of the bacterial cells, and that polymerisation was the driving force for 
motility. Additionally, studies in Listeria have shown that the Act A surface protein (an 
NPF) recruits and activates the Arp2/3 complex (Welch et al, 1997) at the bacterial 
surface; driving motility by actin assembly and the formation of an actin comet tail.
1.7 Chemical tools used to study actin
1.7.1 Phalloidin
Filamentous actin can be visualised using rhodamine labelled phalloidin. This 
fluorochrome-labelled phallotoxin binds to actin filaments, preventing their 
depolymerisation and enabling direct visualisation of actin filaments in permeabilised 
cells by fluorescence microscopy (Adams and Pringle, 1991). Phalloidin was originally
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obtained from the fungus Amanita phalloides. Binding is specific for filamentous actin
and occurs at the junction between two subunits, stabilising the association of actin
monomers (Barden et al, 1987).
1.7.2 Cytochalasin D
Cytochalasin D is a cell permeant fungal alkaloid which promotes filament 
depolymerisation by binding to the barbed end of an actin filament. This action blocks 
further addition or loss of actin monomers at this site (Cooper et al, 1987). Cytochalasin 
D is obtained from the fungus Zygosporium mansonii.
1.7.3 Latrunculin-A
Latrunculin-A is used to disrupt the actin cytoskeleton and has similai’ effects to 
cytochalasin, although the toxins are unrelated (Ayscough et al, 1997). Latrunculin-A 
inhibits actin polymerisation by binding to actin monomers preventing their 
incorporation into actin filaments (Morton et al, 2000). This membrane permeable 
macrolide toxin is obtained from the sea-sponge Latrunculia magnifica, .
1.7.4 Jasplakinolide
Jasplakinolide is the most commonly used actin stabilising drug. This toxin is 
cell permeant and stabilises the association of actin monomers in filaments in a manner 
similar to phalloidin. Jasplakinolide is obtained from the marine sponge Jaspis 
johnstoni.
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1.8 Actin in eukaryotic cells
Control of actin nucléation, polymerisation and disassembly is required for 
cytoskeletal remodelling, polarisation of growth and many cell-specific processes. 
Studies have demonstrated a large intracellular pool of actin monomers in many motile 
cells, suggesting actin could be directly involved in and central to cell motility. A large 
pool of freely available actin monomers would enable actin polymerisation and turnover 
to occur at higher rates than in cells with limited amounts of freely available actin. The 
highly motile amoeba Dictyostelium discoideum is known to share many physiological 
functions with mammalian cells and is widely used as a model organism. Dictyostelium 
cells have been shown to contain approximately 100 times more actin than S', cerevisiae 
cells (Hug et al, 1995). Actin in S. cerevisiae composes 0.1% of the total protein. 
Additionally approximately 50% of this actin in Dictyostelium cells exists as free or 
buffered monomers compared to 0.3% found in the monomeric form yeast cells 
(Karpova et al, 1995). This reduction in monomer availability in yeast is thought to 
reflect the lack of cellular motility, and thus the need for rapid filament assembly as 
seen at the leading edge of motile cells. Actin filament assembly is thought to enable 
intracellular movement and cell motility by generating a pushing force that is harnessed 
by the cell at specific sites. Motile cells require a highly dynamic cytoskeletal network, 
with actin polymerisation focusing at the leading edge; potentially generating the force 
required to push the leading edge of the cell forward.
Cell motility can be broken down into specific processes, which include the 
forward movement produced by initial protrusion of the leading edge, cellular 
attachment to a surface, and retraction of the rear of the cell. The leading edge of motile 
fibroblasts does not proceed forward uniformly; instead showing shows cycles of 
protrusion followed by retraction. In protrusions at the leading edge, actin filaments are 
polarised with the barbed end of the filament orientated towar d the edge of the cell. This 
polarisation orientates the fast growing (barbed) filament ends in the direction of growth 
and subsequently orientates the branching of filaments. Two forms of actin containing 
structures co-exist at the leading edge of motile cells, lamellipodia and filopodia (see 
figure 1-7). Lamellipodia are persistent protrusions, such as would be required for the 
forward movement of the leading edge of a cell. Lamellipodia appear as flat, sheet-like 
continuous protrusions punctuated with filopodia. Filopodia are individual protrusions 
which are thought to form sensory and exploratory tasks in the surrounding extracellular 
environment. Filopodia are composed of densely packed pai'allel bundles of actin
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filaments (figure 1-7), while in contrast, several studies of lamellipodia have shown 
actin to assume a densely packed, branched structure (Svitkina and Borisy, 1999; 
Abraham et al, 1999). Branching of actin filaments at the leading edge is thought to 
strengthen the filamentous network, allowing it to sustain a pushing force on the plasma 
membrane without the filaments flexing substantially (Svitkina and Borisy, 1999). 
Filament branching is known to be an activity of the Arp2/3 complex as previously 
discussed.
Figure 1-7. Actin structures in lamellipodia and filopodia.
A) Actin filaments are found in a branched form in lamellipodia. Branching of actin filaments is 
thought to strengthen filament structures, allowing the force of actin polymerisation to be 
transmitted to the edge of the cell to push the membrane forward, without significant flexing of 
filaments. B) Proposed mechanism of actin bundling in filopodia. Inhibition of filament capping 
would enable filaments to lengthen and merge to produce filopodial protrusions. Figure adapted 
from a paper by Vignjevic and colleagues, (Vignjevic et al, 2003).
Branched actin structures in lamellipodia, and bundled actin filaments specific to 
filopodia are generated by the action of many actin regulating proteins. The generation 
of branched actin filaments in lamellipodia requires both the branching activity of the 
Arp2/3 complex and the action of capping proteins to regulate filament length. 
Elongated actin filaments in filopodia are however thought to be generated by the 
inhibition of filament capping and branching at such sites. Arp2/3 has been localised to 
the leading edge of motile cells in studies by Welch and colleagues (Welch et al, 1997) 
and has been shown to be rapidly recruited to the leading edges of fibroblasts following 
chemoattractant stimulation (Bailly et al, 1999). In addition, capping proteins such as 
gelsolin have also been shown to localise to the leading edge of such cells and are 
thought to act both by filament capping which ensures short filaments, and by
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promoting polymerisation by filament severing and the generation of new barbed ends 
(for review see Borisy et al, 2000; Carlier et al, 1998). The Arp2/3 complex has been 
shown to be excluded from filopodia (Svitkina and Borisy, 1999).
The ‘dendritic nucléation’ model of Arp2/3 filament branching has been 
extended to propose a model for the regulation of dynamic actin structures at the leading 
edge of a motile cell (for review see Pollard and Borisy, 2003) (figure 1-8). The initial 
stage of filament nucléation proceeds with the action of nucléation promoting factors 
(NPFs) which promote actin filament nucléation by Arp2/3. Following initial 
polymerisation, filament branching occurs by attachment of the Arp2/3 complex to the 
side of an existing actin filament, and subsequent nucléation of a new filament branch at 
a 70° angle to the existing ‘mother’ filament. Growth of both the mother and daughter 
filaments is thought to generate the force required to push the cellular membrane 
forward. Filament polymerisation at the leading edge is also thought to require the actin 
binding protein profilin, which binds to free ADP-actin monomers and promotes 
exchange of ADP for ATP. Profilin thereby presents recycled actin monomers for 
subsequent reincorporation into filaments in the ATP-bound form. Polymerisation is 
thought to proceed until capping proteins binds to the barbed end of the actin filaments, 
preventing further attachment or dissociation of monomers at these sites. Filament 
recycled also occurs, as actin monomers dissociate from the uncapped, pointed end of 
the filament, an action which is promoted by members of the ADF/cofilin family, 
thereby releasing ADP-actin monomers back into the available pool to be recycled back 
into newly growing filaments. ADF/Cofilin is also known to sever filaments, an action 
which may be useful both in the breakdown of filaments and for promoting further 
polymerisation, as severing generates free filament ends.
The ‘convergent elongation’ model has been proposed to explain the formation 
of the unbranched actin bundles seen in filopodia. In this model filopodia are generated 
from the lamellipodial actin network by the action of a tip complex which remains 
tightly associated with the barbed ends of actin filaments, preventing filament capping. 
Regulation of polymerisation at the barbed end of actin filaments is therefore central to 
both models. The importance of baited end capping at the leading edge has recently 
been demonstrated in studies by Mejillano and colleagues (Mejillano et al, 2004) in 
which RNA interference was used to study the effects of capping protein depletion; 
which generated a striking phenotype of overproduction of filopodial protrusions and 
inhibition of lamellipodial components such as the Arp2/3 complex at the leading edge.
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Figure 1-8 Model of dendritic nucléation for protrusion of the leading edge. The
polymerisation of actin filaments at the leading edge o f motile cells is thought to generate 
the mechanical force required to push the cell membrane forward. Activated Arp2/3 
nucleates new filaments and promotes filament branching at these sites. Profilin promotes 
polymerisation by catalysing the exchange o f ADP for ATP on actin monomers and 
presenting ‘polymerisation ready’ monomers at sites of polymerisation. Polymerisation and 
filament length is controlled by the action of capping proteins, which terminate filament 
elongation. Recycling of filaments and filament breakdown is promoted by the action of 
ADF/cofilin which severs and preferentially depolymerises ADP-actin filaments. Figure 
adapted from Pollard and Borisy, 2003
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Actin structures are not however limited to the leading edge of motile cells. 
Actin polymerisation at the cell cortex has recently been shown to be intimately linked 
to the endocytic uptake in S. cerevisiae, and actin is also seen to associate with 
endocytic structures in higher cells. Actin polymerisation is at these sites is proposed to 
generate the force required for vesicle fission and movement into the cell during 
endocytosis. Actin is also known to be central to the polarisation of cellular growth, 
providing a structural basis for polarisation throughout the cell. Additionally, actin is 
seen to associate with the nuclear' matrix in Xenopus oocytes (Kiseleva et al, 2004) and 
chromatin remodelling complexes (for review see Olave et al, 2002), and as such is 
proposed to play a structural role in the nucleus. Diverse cellular actin structures are 
however linked by the filamentous nature of actin, the polymerisation and organisation 
of which is tightly controlled by the plethora of actin regulating proteins which act 
together to control the generation and disassembly of actin structures in response to both 
intracellular and extracellular cues.
1.9 Yeast as a model organism
The expression of actin is ubiquitous throughout eukaryotes, suggesting the 
importance of this structural protein. The study of proteins and cellular processes is 
undertaken in model organisms such as the budding yeast S. cerevisiae due to the ease 
with which classical genetic and molecular genetic manipulations can be performed. 
The knowledge gained in these systems can additionally, in many cases, be extrapolated 
to higher organisms, through the conservation of proteins, signalling pathways and 
cellular mechanisms. The identification of yeast counterparts of many mammalian actin 
regulatory proteins indicates a high degree of conservation in cytoskeletal networks 
across these species, and confirms that S. cerevisiae is an excellent model organism in 
which to study cytoskeletal components.
1.10 Polarisation of growth in S. cerevisiae
The budding yeast S. cerevisiae is commonly used for genetic analysis and the 
study of protein to protein interactions. S, cerevisiae cells grow well in culture and are 
stable in both haploid and diploid states. Conversion between these states occurs by the 
mating and sporulation of yeast cells. Both haploid and diploid cells polarise their 
growth during specific growth phases, enabling the development of buds and the 
formation of the mating projection (figure 1-9). Polarisation of growth to specific sites
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involves the asymmetric delivery of components required for cellular growth and 
involves the polarisation of cytoskeletal structures including actin. Remodelling of the 
actin network is involved in the development of asymmetric growth, by directing 
localised vesicle fusion and cell wall synthesis to specific sites (for review see Pruyne 
and Bretscher, 2000b). Polarisation of the actin cytoskeleton towards sites of cell 
growth has been demonstrated by the localisation of GFP-tagged Actlp in living cells 
(figure 1-10) (Doyle and Botstein, 1996). Punctate actin patches were seen to 
accumulate at sites of bud development during the G1 growth phase, and remained 
polarised towards the bud tip during the early stages of bud growth. Thin cellular actin 
cables were also seen to polarise along the mother-bud axis during budding. During the 
later stages of bud development, a switch from apical to isotropic growth occurs within 
the bud, following the isotropic redistribution of actin. Finally, synthesis of new cell 
wall occurs at the bud neck during cytokinesis, allowing cellular fission to occur. Actin 
is seen to repolarise towards this site at the onset of cytokinesis.
1.11 Actin structures iu S. cerevisiae
Yeast actin is the product of a single gene, ACTl, which encodes the globular 
protein G-actin. Yeast actin is 88% identical at the amino acid level to rabbit muscle 
actin and has been shown to have similar biochemical properties (Nefsky and Bretscher, 
1992; Gallwitz and Sures, 1980).Yeast actin polymerises to form filaments with a 7 nm 
diameter and which show a high degree of similarity to purified, polymerised rabbit 
muscle actin (Greer and Schekman, 1982). Due to a decrease in the time taken for 
nucléation to occur however, yeast actin has been shown to polymerise more rapidly 
than muscle actin. Additionally, polymerisation is inhibited in the presence of the 
barbed end capping protein gelsolin; which is known to increase the rate of 
polymerisation of muscle actin due to its nucleating ability (Buzan and Frieden, 1996). 
While yeast actin retains a high degree of conservation with muscle actin therefore, 
differences are however apparent.
Tight regulation is required to control the assembly and organisation of actin 
filaments into the three types of filament-based actin structure seen in the yeast cell. F- 
actin structures can be visualised using rhodamine phalloidin, and such studies highlight 
distinct actin structures termed actin cables, cortical actin patches and the cytokinetic 
ring (Adams and Pringle, 1991).
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Figure 1-9. The life cycle of S. cerevisiae. Haploid and diploid cells are 
generated by sporulation and mating respectively. Polarisation of growth is 
required for the formation of the mating projection and growth of new buds.
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Figure 1-10. Polarisation of the actin cytoskeleton in S. cerevisiae. Polarisation of 
actin throughout the cell cycle A) The location o f proteins known to direct cell 
polarisation are shown in blue These proteins signal to the cytoskeletal network and 
direct the polarisation o f actin filaments (red) and cortical patches (red spots) 
throughout the cell cycle Arrows on the inner circle demonstrate the direction of 
growth during polarisation. Polarised growth is thought to be dependent on the 
transport of secretory vesicles along polarised actin cables. The cell cycle stages. 
M=mitosis, G=growth phase, S=synthesis phase are also shown. Figure adapted from 
Pruyne and Bretscher, 2000b. B) Actin containing structures visualised throughout 
the cell cycle. Image obtained from David Amberg
1.11.1 Actin cables
Actin cables are bundles of actin filaments which appear as thin filaments in the 
unbudded yeast cell, and which align along the mother-bud axis during budding (figure 
1-10) (Karpova et al, 1998; Pruyne and Bretscher, 2000a). Actin cables are known to 
act as ‘tracks’ for the movement of secretory vesicles to sites of cellular growth. Sac6p 
(yeast fimbrin) and Scplp are both known to be able to bundle actin in vitro in S. 
cerevisiae (Adams et al, 1989; Winder et al, 2003). Sac6p has been shown to co- 
localise with all actin structures in yeast, while Scplp localises to punctate patches at 
the cell cortex, suggesting Scplp may have additional actin regulatory roles (Winder et 
al, 2003). Cm Ip, the yeast homology of coronin also bundles actin filaments in vitro 
and regulates the filament nucleating activity of the Arp2/3 complex (Goode et al, 1999; 
Humphries et al, 2002). Coronin localises to sites of dynamic actin assembly and Crnlp 
localises to cortical actin patches. Actin cables can be difficult to visualise in yeast, 
therefore the localisation of actin bundling proteins to these sites is sometimes difficult 
to visualise directly.
1.11.2 Cortical actin patches
Cortical actin patches are F-actin rich structures which appear as 0.1-0.2 pm 
diameter punctuate spots at the cell cortex. Patches are composed of branched actin 
filaments (Young et al, 2004) and over thirty additional proteins (Pruyne and Bretscher, 
2000b). Actin patches associate with plasma membrane invaginations (Mulholland et al, 
1994) and their localisation is seen to polarise to sites of cell growth throughout the cell- 
cycle. In unbudded cells, actin patches localise randomly at the cell cortex. Following 
the onset of bud development, patches then accumulate at the predetermined bud site in 
early G1 (see figure 1-10) and localise to the bud tip during the early stages of bud 
growth. Following substantial bud growth, patch localisation remains polarised towards 
the bud, however patches appear evenly around the cell cortex after the onset of 
isotropic growth. Completion of bud growth sees the redistribution of actin patches 
randomly throughout the mother and bud cell, with patch accumulation at the bud neck 
during cytokinesis. Actin patches therefore accumulate at all sites of cell growth 
throughout the cell cycle (Adams and Pringle, 1984). This correlation between the 
localisation of actin patches to sites of cell growth and recent studies which have linked 
patch generation to endocytic uptake, demonstrate the role of actin patches in membrane
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turnover and endocytosis during cellular development. The polarised distribution of 
cortical actin patches is not strictly required for bud development however, as 
demonstrated in mutants which show depolarised cortical actin patches but which are 
still able to bud normally (Gourlay et al, 2003). Such studies therefore indicate the 
importance of actin cables rather than actin patches in maintaining cell polarisation and 
enabling polarised cell growth (Evangelista et al, 2002; Sagot et al, 2002a).
Initial studies suggested that actin patches were independent motile entities, with 
studies of the GFP-tagged actin patch protein Cap2p, reporting that patch movement 
occurred at an average rate of 0.31 pm/s (Waddle et at, 1996), although both highly 
motile phases and relatively stationary phases were seen (Doyle and Botstein, 1996; 
Waddle et al, 1996). Original proposals also included the suggestion that patch 
movement occurred along tracks or filaments such as actin cables or microtubules, this 
was however disproved following studies which demonstrated that patches moved 
independently of each other and that movement was unaffected by the mutation of 
known myosins (Carlsson et al, 2002; Waddle et al, 1996). Subsequent studies have 
now demonstrated the dynamically changing composition of cortical actin patches, their 
rapid assembly and disassembly, and an association with endocytic structures. 
Assembly and disassembly of cortical actin patches was initially studied by Smith and 
colleagues (Smith et al, 2001). By following the GFP-labelled cortical actin patch 
proteins Abplp and Sac6p, actin patches were shown to persist for on average only 4 
seconds, suggesting the rapid assembly and disassembly of actin patches at specific 
sites, as oppose to pre-formed, motile patches.
Mutation of the Arp2/3 complex has been shown to block movement of actin 
patches and to block endocytic uptake (Winter et al, 1997), implicating actin regulation 
bu Arp2/3 and cortical patches in the progression of endocytic uptake. Proteins 
including Slalp and Sla2p have also been shown to link the regulation of actin at the 
cell cortex with endocytic components (W anen et al, 2002; Gourlay et al, 2003). 
Additionally, recent studies using tagged endocytic components have demonstrated the 
recruitment of actin and actin regulating proteins to endocytic sites (Kaksonen et al, 
2003). Actin patches are now therefore regarded as integral components of the 
endocytic machinery.
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1.11.3 The cytokinetic ring
The cytokinetic ring forms at the bud neck following completion of bud growth 
and contracts to enable mother and bud cell separation. The cytokinetic ring contains 
both actin and myosin IÏ, but while the formation of branched actin filaments at cortical 
patches has been attributed to the activity of the Arp2/3 complex, and the formation 
actin cables to the yeast formins BmTp and Bnilp, the mechanism of actin filament 
generation at the cytoplasmic ring is less clear. Latrunculin-A studies have 
demonstrated the dynamic nature of actin in the cytokinetic ring, suggesting that actin 
filaments are directly generated at this site (Tolliday et al, 2002). Additionally, the 
cytokinetic ring has been shown to form independently of the Arp2/3 complex (Winter 
et al, 1999b). Ring formation was however affected in tropomyosin mutants and a 
temperature sensitive profilin mutant, suggesting that the yeast formins may mediate 
nucléation of actin filament at this site (Tolliday et al, 2002). The rescue of actin ring 
defects in a rhol-2 mutant by an activated Bnilp encoding plasmid construct suggests 
that Bnilp may mediate actin assembly at the cytokinetic ring, in addition to filament 
generation at the bud tip (Tolliday et al, 2002)
1.12 Polarisation of actin in S. cerevisiae
Cell polarisation is central to cellular development. Polarisation of the yeast 
actin cytoskeleton during bud development is maintained by a variety of proteins at the 
bud tip; including Cdc42p. Cdc42p is a member of the Rho family of guanosine 
triphosphatase (GTPase) proteins. These proteins participate in signalling events by 
cycling between an active (GTP-bound) and inactive (GDP-bound) form. Cdc42p is 
essential for the maintenance of cell polarisation and activités several signalling 
cascades, which signal directly to the actin cytoskeleton. S, cerevisiae has five Rho- 
related GTPases, Cdc42p, Rho Ip, Rho2p, Rho3p, and Rho4p that enable the 
coordinated reorganisation of the cytoskeleton and control cell surface growth. 
Additional proteins localised to the bud tip are also known to be involved in the 
nucléation and anchoring of actin cytoskeletal filaments, providing a direct link between 
the cell cycle and actin remodelling. In addition to that seen during cell cycle 
progression, polarisation and remodelling of the actin cytoskeleton occurs in response to 
various intracellular and extracellular signals. In S. cerevisiae, haploid cells remodel in 
response to mating pheromones, generating a characteristic ‘shmoo’ phenotype by the 
development of a mating projection and polarisation of cell growth. Pseudohyphal
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growth in response to nutrient deprivation also involves polarisation of cell growth. This 
response enables the exploration of the surrounding extracellular environment in an 
attempt to find a nutrient source. Cdc42p is again central to the polarisation of growth 
during this polarised growth phase (for review see Gancedo, 2001).
1.13 Cortical patch proteins
Cortical actin patches are composed of a network of branched actin filaments 
(Young et al, 2004) and many associated proteins (Pruyne and Bretscher 2000b). Many 
of these proteins have been studied individually and have defined roles in the regulation 
of actin, while the precise function of others remains unknown. Known cortical patch 
proteins are summarised in table 1-1. The function of proteins in vivo is often difficult to 
determine. This is in part due to the use of in vitro studies which may demonstrate 
protein activities that are unseen in a cellular environment. Additionally, upon gene 
deletion many mutants lack specific phenotypic defects due to partial redundancy with 
other proteins. Therefore, understanding the function of cytoskeletal proteins in vivo is 
often a significant challenge, requiring the analysis of regulatory and biochemical 
interactions in addition to in vitro studies.
Cortical patch proteins include the Arp2/3 complex activators Lasl7p, Abplp, 
and Panlp and the Arp2/3 complex itself. Many patch proteins are known to play direct 
or indirect roles in the regulation of the actin (for review see Pruyne and Bretscher, 
2000b). The rapid assembly and disassembly of cortical patches is thought to be 
achieved by the co-ordinated action of these proteins.
Protein Known
activities
M am m alian
orthologue/
Homologue
Known interactions with 
actin cytoskeletal 
components
Selected References
A bplp Activates the 
Arp2/3 complex. 
Binds actin
mABPl Arp2/3, A ctlp Ark2p, 
Prklp, Rvsl67p, Srv2p
Goode et al, 2001 
Lila et al,1991
Actlp G-actin
monomer, forms 
F-actin
Actin Coflp, Lasl7p, Pfylp, 
Rvsl67p, Srv2p
Amberg et al, 1995 
Adams and Pringle, 
1984
Ark Ip/ 
Prklp
Phosphorylates 
actin regulating 
proteins
AAKl/GAK Abplp, Sla2p, Panlp Zeng et al, 2001 
Smythe and Ayscough, 
2003
Arp2p Nucleates actin 
filaments
Arp2/3 subunit Lasl7p, Abplp, Panlp, 
Crnlp, Bnilp, Myo3/5
Moreau etal, 1996
Arp3p Arp2/3 subunit Winter et al, 1997
Arcl5p Arp2/3 subunit Winter etal, 1999b
ArclSp Arp2/3 subunit
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Arcl9p Arp2/3 subunit
Arc35p Arp2/3 subunit Schaerer-Brodbeck and 
Reizman, 2000
Arc40 Arp2/3 subunit
Cap 1/2 Caps filament 
barbed ends
Capping
proteins
Bzzlp Amatruda et al, 1992
Cm dlp May complex 
with Arp2/3
Calmodulin Arp2/3 Schaerer-Brodbeck and 
Reizman, 2003
Coflp Severs and 
disassembles F- 
actin
Cofilin Actlp, Cmdlp, Aiplp, 
Applp, Srv2p, Crnlp
Rodal et al, 1999
Crnlp Inhibits Arp2/3 Coronin Arp2/3 Humphries et al, 2002
End3p Inhibits Panlp 
phosphorylation
Eps 15 
homology
Panlp, Slalp Tang et al, 2000 
Tang etal, 1997
Entl-4p Endocytic
component
Epsins Panlp Aguilar et al, 2003
Lasl7p Binds activates 
Arp2/3
WASP Aip2/3, Vrplp, Slalp, 
Myo3/5p, Rvsl67p
Madania et al, 1999
Lsb3p Unknown Lasl7p Gavin et al, 2002
Myo3/5 Actin filament 
motor
Myosin 1 Actlp, Arp2/3, Vrplp, 
Lasl7p, Cmdlp
Panlp Activates Arp2/3 Eps 15 End3p, Slalp Tang and Cai, 1996
Pfylp Sequesters actin 
monomers
Profilin Actlp, Bnilp, Bnrlp, 
Srv2p
Sagot et al, 2002b
Rvsl61p/
Rvsl67p
Régulât 
es endocytosis
Amphiphysins Abplp, Actlp, Lasl7p, 
Slalp, Sla2p, Srv2p
Lila and Drubin, 1997 
Colwill et al, 1999
Sac6p Actin bundling Fimbrin Actlp Karpova et al, 1995
Slalp Endocytic 
component, 
adaptor protein
Cin85
homology
Lasl7p, Ysc84p, 
Rvsl67p, Srv2p, End3p, 
Panlp, Sla2p
Stamenova et al, 2004 
Tang et al, 2000
Sla2p Binds actin 
monomers
HiplR Slalp, Actlp, Rvsl67p, 
Ark Ip
Wesp etal, 1997 
Gourlay et al, 2003
Srv2p Binds actin 
monomers
CAP Abplp, Actlp, Aiplp, 
Pfylp, Rvsl67p, Slalp
Tw flp Caps filament 
barbed ends
Actlp Goode et al, 1998
Vrplp WIP homologue, WIP Lasl7p, Actlp, Myo3/5p Evangelista et al, 2000
Ysc84p SH3yl-l Slalp, Lasl7p Madania et al, 1999
Table 1-1 Known cortical patch proteins 
1.14 Actin and endocytosis
Endocytosis describes the internalisation of membrane components and 
extracellular material by invagination of the plasma membrane and formation of 
intracellular vesicles. These membranous vesicular compartments form the early and 
late endosomes which are trafficked to the vacuole for degradation (for review see Shaw
31
et al, 2001). Only a proportion of internalised molecules are however targeted for 
degradation in the vacuole; many escape this fate and are recycled due to the presence 
of a recycling/retention signal. Endocytic uptake has been classified into three distinct 
types, depending on the type of molecules internalised. Fluid-phase endocytosis 
describes the internalisation of particles which do not require direct binding, receptor- 
mediated endocytosis describes the uptake of plasma membrane receptor bound ligands 
(for review see Munn, 2000; Wendland et al, 1998), while phagocytosis describes the 
uptake and degradation of large particles. The study of endocytosis in S. cerevisiae was 
initially hindered by the presence of the yeast cell wall, which blocked the uptake of 
labelling molecules used successfully in other systems to study the process. The 
fluorescent dye lucifer yellow carbohydrazide (LY) was however shown to undergo 
internalisation and is now used widely as a marker for fluid-phase endocytosis, due to 
the inability of the dye to permeate the cell membrane (Reizman, 1985). LY therefore 
accumulates in the vacuole in wild-type yeast cells. The fluorescent dye FM4-64 is also 
used to study endocytosis as the dye labels the endocytosed plasma membrane (Vida 
and Emr, 1995).
Although the individual components of cortical patches have in most cases been 
well studied, the function of the cortical patch was unclear until recently. Localisation 
of cortical patches at the cell cortex and their association with plasma membrane 
invaginations (Mulholland et al, 1994) had previously suggested participation in 
endocytic events. Additionally, studies demonstrated actin defects in many endocytic 
mutants and vice versa (Munn et al, 1995; Moreau et al, 1997; Raths et al, 1993; Tang 
et al, 1997), while the Arp2/3 complex was associated with motile endosomal vesicles 
(Kaksonen et al, 2000), suggesting a link between the two processes. Endocytosis was 
also shown to require functional actin patches and not actin cables during a study of 
tropomyosin mutants. Yeast tropomyosins (Tpmlp and Tpm2p) bind along the length of 
actin filaments and stabilise filamentous structures. The major isoform of yeast 
tropomyosin, Tpmlp is a component of actin cables but does not co-localise with 
cortical actin patches (Lui and Bretscher, 1989). Deletion of tpml generated cells which 
lacked detectable actin cables but in which endocytosis was not affected. This study 
suggested that actin patches alone played a crucial role in maintaining endocytic 
function.
A number of potential roles for the actin cytoskeleton in endocytic uptake have 
been suggested (figure 1-11). Endocytosis can be divided into early events, which 
include invagination of the plasma membrane and the formation of vesicles, and later
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events such as vesicle fission and vesicle movement into the cell. Actin has been 
proposed to have roles both early and late endocytic events. Potential roles include the 
recruitment or retention of components of the endocytic machinery at endocytic sites, 
and generation of the force required for membrane invagination by actin polymerisation. 
Actin has also been proposed to act as a barrier which prevents endocytic events and 
which is absent at specific endocytic sites. The polymerisation of actin has also been 
suggested to generate the force required for pinching off of vesicles and/or movement of 
vesicles into the cell (for review see Qualmann et al, 2000). Data demonstrating that the 
region around clathrin-coated pits lacks actin filaments (Fujimoto et al, 2000) provided 
evidence for a potential barrier effect of actin. Data also suggests that ENTH domain 
containing proteins such as epsin may effect membrane curvature during endocytosis 
(for reviews see Hurley and Wendland, 2002; Nossal and Zimmerberg, 2002), implying 
that actin involvement as a driving force for invagination of cell membrane may not be 
required. The epsin homologues in yeast, Entlp and Ent2p contain ENTH domains and 
are required for endocytic uptake, suggesting the involvement of these proteins in 
plasma membrane invagination. Actin therefore is known to have an important, but 
poorly understood role in endocytosis.
Recent data has provided strong experimental evidence to link the function of 
actin at the cell cortex with endocytic uptake. A study by Kaksonen and colleagues 
(Kaksonen et al, 2003) has been significant in the study of endocytic uptake and cortical 
actin patch components. In this study, real time cell imaging was used to enable the 
movement of fluorescently tagged cortical patch and endocytic components to be 
followed. The proteins studied were Lasl7p, Slalp, Sla2p, Panlp, Abplp and ArclSp; a 
component of the Arp2/3 complex. Strikingly, this study demonstrated the late 
recruitment of actin to endocytic sites, following recruitment of the cortical patch 
proteins Lasl7p, Slalp, Sla2p and Panlp to pre-existing endocytic sites. This report 
therefore suggested that actin does not recruit endocytic machinery to specific sites. 
This study also determined the pattern of sequential
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3) Dissolution of a cortical 
actin barrier
4) Force generation during 
vesicle fission
5) Vesicle movement into 
the cytoplasmO
1) Recruitment of endocytic 
machinery to specific sites
2) Invagination of the plasma 
membrane
Figure 1-11. Proposed roles for the actin cytoskeleton in endocytosis
Many possible roles for actin during endocytosis have been proposed. 1) The actin cytoskeletal 
may direct movement of endocytic machinery to specific sites or may retain endocytic 
machinery at these locations. 2) Actin polymerisation may generate a force required for 
invagination of the cell membrane. 3) The actin cytoskeleton may perform an inhibitory role 
preventing invagination of the membrane, except at endocytic sites. 4) Actin polymerisation may 
generate a force required to enable the ‘pinching o ff  of vesicles. 5) Actin polymerization may 
promote vesicle movement into the cytoplasm by forming actin ‘comet tails’ (figure adapted 
from Qualmann et al, 2000).
recruitment of cortical patch and endocytic proteins to endocytic sites (figure 1- 
12). Accumulation of actin regulating proteins before the recruitment of actin to 
endocytic sites implies additional roles for these proteins. During the initial stages of 
endocytosis, the Arp2/3 activating protein LaslVp is seen at endocytic sites. The delay 
in the recruitment of the Arp2/3 complex, which arrives along with actin, however 
suggests LaslVp has additional roles during the early stages of endocytosis. As LaslVp 
interacts with Slalp (Li, 199V), but co-localisation of LaslVp with cortical actin patches 
is not dependent on Slalp (Ayscough et al, 1999), a proposed role for LaslVp at 
endocytic sites therefore is the recruitment of proteins including Slalp. Following
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LaslVp recruitment, endocytic development continues with recruitment of Slalp, Sla2p 
and Panlp. Sla2p is known to localise to the cell cortex independently of actin and 
potentially via interactions mediated by its ENTH domain. Sla2p interacts with Slalp 
(Gourlay et al, 2003), and as such may interact with the trimeric, endocytic 
Slalp/Panlp/End3p complex. The Arp2/3 complex, actin and Abplp were the last 
proteins in the study by Kaksonen and colleagues to be recruited to endocytic sites. 
Recruitment of these proteins coincides with endocytic complexes moving away from 
the plasma membrane towards the interior of the cell. The ability of Panlp to bind to 
and activate Arp2/3, suggests that Panlp may recruit Arp2/3 to these sites (Duncan et 
al, 2001). Interestingly, by studying the sequential recruitment of proteins to endocytic 
sites, it has been shown that changes in patch motility correlate with changes in patch 
composition; with the appearance of actin at these sites coinciding with an increased in 
motility. Additionally, Sla2p has been shown to be crucial in linking endocytic 
components with actin polymerisation. Deletion of sla2 is known to block endocytosis 
in yeast, and this study demonstrates the mechanism by which this is achieved. Deletion 
of sla2 is shown to uncouple the association of actin with the endocytic machinery, an 
effect first seen in a study by Ayscough and colleagues (Gourlay et al, 2003). In a Asla2 
strain, actin polymerisation is not associated with components of the endocytic 
machinery; a block in endocytic uptake occurs and actin ‘tails’ are seen to form at the 
cell cortex. These studies propose a detailed early endocytic model in which actin, 
Arp2/3 and Abplp accumulate at pre-determined endocytic sites and promote endocytic 
uptake through the polymerisation of actin.
Inhibition of endocytosis occurs in both in yeast and mammalian systems when 
cells are exposed to drugs which inhibit actin polymerisation, such as latrunculin-A and 
jasplakinolide (Ayscough et al, 199V; Ayscough, 2000). Evidence linking the actin 
cytoskeleton with endocytosis in higher eukaryotes is not as strong as in yeast (for 
review see Engqvist-Goldstein and Drubin, 2003). In mammalian cells, endocytic 
uptake shows an increased complexity due the existence of several endocytic pathways 
including: the clathrin-dependent pathway, a caveolar pathway, a clathrin and caveolar- 
independent pathway, phagocytosis and micropinocytosis. A direct role for actin 
polymerisation in all types of endocytic internalisation is however suggested by studies 
such as that by Merrifield and colleagues, which demonstrates the association of actin 
with clathrin coated vesicles and macropinosomes (Merrifield et al, 1999; Merrifield et 
al, 2002)
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Figure 1-12. Current model demonstrating the proposed role of actin in endocytosis
A study by Kaksonen and colleagues has determined the pattern of sequential recruitment of 
cortical patch and endocytic proteins to sites o f endocytosis. During early stages of 
developments Las 17, Slal, Sla2 and Panlp are seen at sites o f endocytosis. Later stages are 
defined by the recruitment of aetin, Abpl and the Arp2/3 complex to sites and coincide with 
movement of specific component away from the plasma membrane and into the cell. 
Following vesicle fission, disassembly o f endocytic complexes is thought to be mediated by 
action of actin regulating kinases, Arkl/Prkl (Zeng et al 2001), while actin polymerisation 
continues to mediate vesicle movement. Time taken for patch development is shown in 
seconds. Figure adapted from Kaksonen et al, 2004.
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The importance of the Panlp/End3p/Slalp trimeric complex in actin and 
endocytic regulation in yeast is well established (Tang et al, 2000). Panlp localises to 
cortical actin patches and is required for normal polarisation of the actin cytoskeleton, 
fluid phase and receptor mediated endocytosis, and is known to be required for the 
internalisation step of endocytosis (Tang and Cai, 1996; Tang et al, 1997). End3p is also 
required for endocytosis, with end3 mutation causing depolarisation of the cortical actin 
network and the appearance of abnormal clumps of F-actin in the cytoskeleton 
(Benedetti et al, 1994). The epsin homology (EH) domain containing proteins Panlp 
and End3p are therefore involved in both the regulation of actin and endocytosis. Panlp, 
End3p and Slalp have been shown to form a ternary complex, which may potentially 
include other factors. The actin regulating kinases, Prklp and Ark Ip are known to 
regulate this complex and other actin regulatory components in yeast by 
phosphorylation (Cope et al, 1999; Zeng and Cai, 1999). Arklp and Prklp localise to 
cortical actin patches and their activities partially overlap (Cope et al, 1999; Zeng and 
Cai, 1999). These kinases are proposed to promote actin patch disassembly by 
phosphorylation of specific cortical patch proteins, as suggested by the accumulation of 
large actin clumps in an àarklAprkî double mutant (Cope et al, 1999). Prklp 
negatively regulate interactions in the Slalp/End3p/Panlp trimeric complex by 
phosphorylation of both Panlp and Slalp (Zeng and Cai, 1999; Zeng et al, 2001).
Essentially, recent data demonstrates that cortical patches generation occurs as 
an integral part of endocytic uptake. Actin is therefore an integral component of the 
endocytic machinery, while studies suggest that its polymerisation promotes the 
movement of endocytic vesicles into the cell.
1.15 The endocytic adaptor protein Slalp
Slalp was identified during analysis of the first protein shown to bind to actin in 
S. cerevisiae, actin binding protein-1 (Abplp). Abplp was shown to interact with actin 
by affinity chromatography using an actin column (Drubin et al, 1988). Abplp co­
localised with cortical actin patches in yeast, suggesting a role in actin regulation, while 
overexpression of Abplp produced severe depolarisation of the actin cytoskeleton. 
Deletion of abpl however produced no obvious cellular phenotypes, suggesting a 
functional overlap with other yeast proteins. In order to identify functionally 
overlapping proteins, a synthetic lethal screen was performed to allow the identification 
of genomic mutations that caused cells to become dependent the expression of Abplp
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(Holtzman et al, 1993). Three genes were identified in this screen as being essential in 
strains lacking Abplp, These genes were SLAl (synthetic lethal with abpl-1), SLA2 
(synthetic lethal with abpl-2) and SAC6 (yeast fimbrin).
The amino-terminus of Slalp contains three SH3 (Src homology-3) domains 
(figure 1-13). These domains are highly conserved protein to protein binding domains 
of approximately 60 amino acids in length. SH3 domains interact with proline-rich 
motifs including PxxP, and aie found in a variety of proteins including the cytoskeletal 
proteins, Abplp and myosin I, and many proteins involved in signal transduction (for 
review see McPherson, 1999; Macias et al, 2002). The central region of Slalp contains 
two regions with high homology to the Slalp homologues in other fungal species. These 
regions are termed homology domains 1 and 2 (SHDl and SHD2) and show 58% and 
60% identity respectively between S. cerevisiae and S. pombe. The carboxy-terminal 
region of Slalp contains 26 repeats rich in proline, glutamine, glycine and threonine 
with the consensus sequence LxxQxTGGxxxPQ (Holtzman et al, 1993; Ayscough et al, 
1999). This C-terminal repeat region contains many potential Prklp phosphorylation 
motifs (Zeng et al, 2001). This carboxy-terminal repeat region has In addition been 
shown by immunoprécipitation to interact with the N-terminal EH domain of End3p and 
the LR2 domain of Pan Ip. Slalp therefore forms a trimeric endocytic complex with 
End3p and Panlp (Tang et al, 2000).
A recent study by Stamenova and colleagues (Stamenova et al, 2004) has 
proposed the mammalian protein CIN85/CD2AP/CMS (Cbl-interacting protein of 85 
kDa; CD2 associated protein; Cas ligand with multiple SH3 domains) as a functional 
homologue of Slalp. The CIN85/CD2AP/CMS protein is significantly smaller than 
Slalp and shows 34% similarity across the corresponding amino-terminal region of 
Slalp. The structure of CÏN85/CD2AP/CMS is similar to the amino-terminus of Slalp; 
containing three amino-terminal SH3 domains with similar spacing to that found in 
Slalp, CIN85/CD2AP/CMS is not however a direct homologue of Slalp, but the protein 
does show comparable interactions and has been shown to be involved in endocytosis in 
mammalian cells (Kowanetz et al, 2003; Kowanetz et al, 2004).
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SH3 domains C-terminal repeat region 
SHD1 SHD2 1244
Slalp
Figure 1-13. Schematic representation of domains present in Slalp. Slalp contains 
three amino-terminal SH3 domains (red), two regions of high homology to Slalp 
homologues, SHDl and SHD2 (grey) and a carboxy terminal repeat region containing 26 
repeats o f consensus sequence LxxQxTGGxxxPQ (blue).
1
S. cerevisiae 
Ysc84p
S. cerevisiae 
LsbSp
S. pombe 
Ysc84p
Mouse
SH3yl-1
Human
SH3yl-1
Ysc84 N-terminal 
homology domain 184
SH3
domain 468
451
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43% identity 46% identity
Figure 1-14. Schematic representation of domains present inYsc84p and its 
homologues. Selected Ysc84p homologues are shown. Ysc84p in S. cerevisiae contains 
an amino terminal region (blue) highly conserved amongst its homologues (43% identity) 
but which shows no similarity to known motifs. In addition a highly conserved (46% 
identity) carboxy-terminal SH3 domain (red) is present in Ysc84p and its homologues.
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1.15.1 Phenotypes of Isslal cells
Cells lacking SLAl display an aberrant cortical actin phenotype, with fewer but 
enlarged cortical actin patches. This strain also shows a temperature dependent growth 
defect when grown at 2TC, and a dependence on ABPl expression. (Holtzman et al, 
1993). Additionally, a Aslal strain shows an increased resistance to the actin-disrupting 
drug latrunculiii-A, suggesting a less dynamic actin cytoskeleton (Ayscough et al, 
1997). Studies of slal mutants have demonstrated the importance of the Gapl and third 
SH3 domain for the regulation of the actin cytoskeleton. Deletion of the Gapl+SH3#3 
region (residues 118-551) of Slalp generated cells with actin cytoskeletal defects but 
which were not Abplp dependent (Ayscough et al, 1999). Deletion of the C-terminal 
region of Slalp {slalACt expression) does not generate actin defects but these cells are 
Abplp dependent. In addition, growth of this mutant at 37°C demonstrates that slalACt 
is partially functional (Warren et al, 2002). These studies demonstrate the importance of 
the Gapl and third SH3 domain of Slalp for normal actin organisation, while 
determining that the region required for the rescue of Abplp dependence lies in the C- 
terminal repeat region of Slalp.
Studies show that deletion of SLAl caused mislocalisation of Sla2p and Rholp 
(Ayscough et al, 1999), and that Slalp is required for the localisation of Sla2p to 
cortical actin patches (Gourlay et al, 2003; Kaksonen et al, 2003). Sla2p is required for 
normal actin organisation and endocytic uptake, while Rholp is a component of the g- 
glucan synthase enzyme, p-glucan synthase is involved in the synthesis of the cell wall 
material and consequently, cells lacking SLAl demonstrate an abnormal deposition of 
cell wall material (Ayscough et al, 1999). The combination of Asia I and Asla2 deletion 
has also been reported to generate an interesting actin phenotype. Deletion of both genes 
causes accumulation of cortical actin patches primarily at the distal end of the mother 
cell, far removed sites of cell growth (Gourlay et al, 2003). Budding appears to progress 
normally in these enlarged cells and additional cortical patch components have also 
been localised to the aberrant patch sites. The mechanism for this localisation is not 
clear; however this study does demonstrate that polarised cell growth continues 
following the loss of actin patch accumulation at sites of cell growth.
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1.15.2 Interactions of Slalp
Characterisation of Slalp has determined that the protein acts as a 
multifunctional adaptor, required for both the organisation of the cortical actin 
cytoskeleton and endocytic uptake. Slalp interacts with a plethora of actin regulating, 
endocytic proteins and several additional factors, including the Arp2/3 activating 
proteins Lasl7p/Beelp (Li, 1997) and Abplp. Slalp is thought to regulate actin 
dynamics through Lasl7p and Abplp (Warren et al, 2002), which localise to cortical 
actin patches in S. cerevisiae. Additionally, Slalp has also been shown to interact with 
the cortical patch protein Ysc84p (Uetz et al, 2000; Drees et al, 2001; Dewar et al,
2002). The interaction between Slalp and several cortical patch proteins, and the partial 
co-localisation of Slalp to cortical patches suggested a strong link between Slalp and 
the regulation of actin.
Slalp forms a trimeric complex with the endocytic proteins End3p and Panlp 
(Tang et al, 2000). This complex is important for actin organisation, endocytosis and 
cell wall morphogenesis (Benedetti et al, 1994; Tang and Cai, 1996; Tang et al, 1997; 
Ayscough et al, 1999). Slalp binds to the LRl (Long Repeat 1) region of Panlp and the 
N-terminus of End3p (Tang et al, 2000). The C-terminal region of End3p also binds to 
the LR2 region of Panlp (Tang et al, 1997). Prklp, an actin regulating kinase 
phosphorylates Panlp (Zeng and Cai, 1999) and is proposed to phosphorylate motifs in 
the carboxy-terminal repeat region of Slalp (Tang et al, 2000). Protein interactions in 
this complex appear to be regulated primarily by phosphorylation, with binding of the 
C-terminal repeat region of Slalp to the LRl domain of Panlp inhibited by Prklp 
phosphorylation (Zeng et al, 2001). Both regions contain multiple Prklp 
phosphorylation motifs, Mislocalisation of Slalp in an end3-l mutant, suggests End3p 
is required for the localisation of Slalp to the cell cortex (Warren et al, 2002).
The Slalp protein has been shown to associate with Sla2p (Gourlay et al, 2003). 
The minimal interacting regions of these proteins, as determined by 2-hybrid analysis 
are residues 118-361 of Slalp, and the central region of Sla2p from residues 310-768. 
Sla2p is the yeast homologue of the mammalian protein HIPIR (Huntingtin interacting 
protein-1), a protein involved in endocytic function in mammalian cells (Engqvist- 
Goldstein et al, 1999). A C-terminal region of Sla2p shows homology to the 
mammalian actin binding protein, talin (Hemmings et al, 1996), while an N-terminal 
ENTH domain has been shown to bind to membrane inositol phospholipids and to 
mediate localisation of Sla2p to the cell cortex. The talin homology domain of Sla2p
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binds F-actin in vitro (McCann and Craig, 1997). Expression of this C-terminal region 
of Sla2p in yeast also localises the fragment to cortical actin patches (Yang et al, 1999). 
Full-length Sla2p however localises only to subset of cortical patches (Yang et al, 
1999), which only partially co-localise with actin but which co-localise to a large extent 
with Slalp (Yang et al, 1999; Gourlay et al, 2003). Slalp is required for the localisation 
of Sla2p to cortical actin patches. In the absence of Slalp, Sla2p localises to patch like 
structures at the cell cortex rather than the aberrant actin in ‘chunks’ seen in this mutant 
(Ayscough et al, 1999).
Recent work has demonstrated binding of Slalp to the ubiquitin ligase Rsp5p 
through the central domain of Slalp (residues 420-720) (Stamenova et al, 2004). Rsp5p 
mediates mono-ubiquitination of many plasma membrane components including 
permeases, transporters and receptors, specifying internalisation of these proteins 
(Galan et al, 1996; Dunn and Hicke, 2001). Ubiquitin mediated endocytosis is emerging 
as an important pathway for the removal of plasma membrane components. Rsp5p is 
also required for fluid phase endocytosis and as such is proposed to have multiple 
functions in the regulation of endocytosis (Dunn and Hicke, 2001). GFP-tagging has 
localised Rsp5p to membrane invaginations and peri-vacuolar structures (Wang et al, 
2001a). The vacuolar localisation of Rsp5p is dependent on its catalytic activity and 
Sla2p, suggesting Rsp5p may be transported to this location via endocytic uptake. The 
interaction of Rsp5p with Slalp also raised the possibility that Slalp recruits Rsp5p to 
proteins requiring ubiquitination, or in some way facilitates the process of 
ubiquitination. This however appears unlikely as ubiquitination and endocytosis of the 
Ste2p receptor occurs normally in Aslal cells (Stamenova et al, 2004). In addition to 
interacting with Rsp5p, Slalp interacts with Rvsl67p, which in turn interacts with 
Rsp5p (Stamenova et al, 2004). A Aslal strain has previously been shown to be 
synthetically lethal with Rvsl67p (Tong et al, 2004), and work by Stamenova and 
colleagues confirmed a direct interaction between the two proteins. Rvsl67p forms a 
dimer with Rvsl61p in an analogous manner to mammalian amphiphysins, 
Amphiphysins are endocytic and actin regulatory proteins of which Rvsl67p is 
proposed to be an orthologue, Rvsl67p is known to bind to the Aip2/3 complex NPF, 
Lasl7p (Colwill et al, 1999; Madania et al, 1999). The interaction of Slalp with End3p, 
Panlp, Sla2p and Rsp5p therefore demonstrate links between Slalp and endocytosis.
Recent data from our lab has also demonstrated the interaction of Slalp with 
Lsb5p and subsequently, an interaction between Lsb5p and Arf3p (Dewar et al, 2002; 
Costa et al, 2005). Lsb5p shows similarity to the GGA family of membrane trafficking
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proteins which are known to bind ADP-ribosylating factor (Arf) proteins both in 
manunalian and yeast systems (Zhdankina et al, 2001; for review see Boman, 2001). 
Similarity was determined by the identification of an N-terminal Vps27p, Hrs, Stam 
(VHS) domain and an Arf-interacting GGA and Toml (GAT) domain in the LsbSp 
sequence. Arf binding by GGA proteins is known to be mediated by GAT domains 
(Zhdankina et al, 2001). In mammalian cells, activated Arf proteins with the exception 
of Arf6, recruit specific coat proteins and GGAs to sites of vesicle development at the 
trans-golgi network (TGN) (Puertollano et al, 2001; Takatsu et al, 2002). The yeast 
homologue of mammalian Arf6, Arf3p, additionally localises predominately to the 
plasma membrane (Huang et al, 2003), while yeast Arflp and Arf2p are Golgi localised. 
Arf3p is linked to endocytosis at the plasma membrane by interaction with Lsb5p. In 
additional to a potential role as a membrane trafficking protein, Lsb5p has been 
implicated in endocytic regulation through a genetic interaction with the gene encoding 
Ysc84p (Dewar et al, 2002). Lsb5p localises to the cell cortex in punctuate spots, a 
localisation which is affected by slal deletion (Dewar et al, 2002) and interacts with 
Lasl7p by 2-hybrid (Madania et al, 1999). Slalp may therefore interact indirectly with 
Arf3p, which is plasma membrane associated in its GTP bound form (Huang et al,
2003), through Lsb5p. Additionally, Slalp is proposed to recognise and mediate the 
uptake of plasma membrane proteins containing NPFX(i,2)D motifs. These motifs are 
found in proteins including Ste2p, Ste3p and Kex3p (Howard et al, 2002),
1.16 The cortical patch protein Ysc84p
Ysc84p is a 468 amino acid protein which localises to cortical actin patches in S. 
cerevisiae (Dewar et al, 2002). Ysc84p has a conserved amino terminal domain and a 
conserved SH3 (Src homology 3) domain in the carboxy-terminal region of the protein 
(figure 1-14). SH3 domains are known to mediate protein to protein interactions with 
proline rich regions including containing PxxP motifs (for reviews see McPherson, 
1999; Macias et al, 2002). The amino-terminal domain of Ysc84p does not show 
homology to known motifs or domains, but is highly conserved between Ysc84p 
homologues. This N-terminal domain encompasses amino acids 1-184 of the protein 
and is conserved with 43% identity across the species. The mouse homologue of 
Ysc84p was identified by Aoki and colleagues (Aoki et al, 2000) and shows 53% 
identity across the amino terminal region, and 50% identity across the carboxy terminal 
SH3 domain. Ysc84p also has a homologue in S. cerevisiae which shows 59% identity
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at the protein level. This S. cerevisiae homologue, LsbSp is also known to co-localise 
with cortical actin patches (Dewar et al, 2002). Additionally, studies have demonstrated 
phosphorylation of Ysc84p on serine residue 301 by phosphoproteome analysis (Ficaro 
et al, 2002).
1.16.1 Phenotypes of Aysc84 cells
Deletion of YSC84 generates no obvious cellular phenotype (Dewar et al, 2002). 
The association of phenotypes with single mutations or deletions can indicate the 
importance of a gene in cellular function. In conjunction with deletion of LSB5 
however, which also shows no distinct phenotypes upon single deletion, depolarisation 
of actin, endocytic defects and growth defects at high temperature however become 
apparent (Dewar et al, 2002). Severe phenotypic defects upon deletion of both YSC84 
and LSB5 suggest that the encoded proteins may act in functionally redundant pathways. 
Lsb5p localises to the cell cortex in punctate patches, a localisation which is partially 
dependent on Slalp (Dewar et al, 2002). Lsb5p is implicated in vesicle trafficking due 
to similarity to yeast GGA proteins and the presence of an NPFXD motif, which are 
known to bind to epsin homology (EH) domains present in the endocytic proteins Panlp 
and End3p (deBeer et al, 2000). Additionally, Lsb5p has been shown to interact with 
Arf3p at the plasma membrane (Costa et al, 2005) and the Aip2/3 regulating factor 
LaslVp (Madania et al, 1999). The ADP-ribosylation factors (Arfs) are a family of 
small ubiquitously expressed Ras-like GTPases that are central to many vesicular 
transport processes.
1.16.2 Interactions of Ysc84p
The function of Ysc84p at cortical patches sites has so far remained unstudied. 
Localisation of Ysc84p to cortical actin patches however suggests a role in the 
regulation of actin, as many patch proteins regulate actin directly (see table 1-1). 
Ysc84p localisation is dependent on actin, with Latrunculin-A treatment causing rapid 
mislocalisation of GFP-Ysc84p (Dewar et al, 2002). Lack of a conserved actin binding 
motif in the Ysc84p sequence however suggested that co-localisation with actin was 
mediated by additional cortical patch proteins. In addition, the localisation of Ysc84p to 
cortical actin patches was shown to be dependent on Abplp and to a lesser extent on 
Lasl7p/Beel, the yeast WASP homologue (Dewar et al, 2002), suggesting potential
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mechanisms for Ysc84p recruitment and localisation to cortical patches. Furthermore, 
Ysc84p has been shown to interact with LaslVp by 2-hybrid (Madania et al, 1999) and 
to immunoprecipitate in a complex containing Abplp (Ho et al, 2002). As previously 
discussed, genomic wide yeast 2-hybrid screens initially reported an interaction between 
Ysc84p and Slalp (Uetz et al, 2000; Drees et al, 2001). Domains mediating this 
interaction were subsequently localised to residues within amino acids 118-511 of Slalp 
and the C-terminal region of Ysc84p from residues 229-468. Interaction between Slalp 
and Ysc84p has also been confirmed biochemically (Dewar et al, 2002).
1.17 Aims of this project
The dynamic nature of the actin cytoskeleton is attributed to the interaction of 
actin monomers and filaments with a plethora of actin regulating proteins. Regulation of 
individual actin filaments and their co-ordinated organisation into higher order 
structures allows the participation of actin in a wide variety of dynamic cell processes. 
Actin is involved in structural roles, in the polarisation of growth and development, in 
endocytic uptake, and in generating cellular and intracellular movement; enabled by 
harnessing the force generated by actin polymerisation. Previous studies have enabled 
the classification of actin regulating proteins into generalised functional groupings and 
overall actin regulatory mechanisms to be investigated. The study of individual actin 
regulatory proteins therefore contributes to the overall understanding of the regulation 
of actin, allowing regulatory pathways and complexes to be examined.
The aim of this project was to further investigate two proteins implicated in the 
regulation of the actin cytoskeleton in yeast. The cortical adaptor protein Slalp had been 
the focus of many studies and was known to have several roles at the cell cortex. In 
addition however, we had observed this protein in the yeast nucleus (Kathryn 
Ayscough, unpublished observations). As Slalp was already known to be a multi­
functional protein, an addition role for nuclear Slalp was an interesting possibility. In 
order to further investigate and characterise nuclear Slalp, a variety of cellular and 
proteomic techniques were used. In addition, this project aimed to investigate the 
cortical patch protein Ysc84p. Previous studies had provided little insight into the 
function of the Ysc84p protein, having not defined either a specific role for Ysc84p, or a 
mechanism for its localisation to cortical patches. In order to gain further insight into 
the function of Ysc84p, extensive biochemical and cellular analysis were carried out. 
Studies were also extended to include analysis of the Ysc84p homologue, hSH3yl-l.
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Ill chapter 3 of this thesis, I describe the advances that I have made in the study 
of nuclear Slalp, which include examining the nucleocytoplasmic trafficking of Slalp 
and investigating potential nuclear roles, I will additionally demonstrate that nuclear 
Slalp is not affected by cytoplasmic actin remodelling and will propose a mechanism 
for the nuclear translocation of Slalp. Localisation of Slalp to the nucleus has not been 
described prior to this work.
In chapter 4 ,1 detail my investigation of the yeast protein Ysc84p and its human 
homologue, hSH3yl-l. My studies suggest a direct role for both proteins in the 
regulation of actin, and detail the biochemical analysis of Ysc84p, which has identified 
the actin binding, severing and capping abilities of this protein. My studies identify 
specific activities of Ysc84p in vitro which promote interesting possibilities for the role 
of the protein at cortical patch sites.
In chapter 5, I describe my study of Gtslp in S. cerevisiae. Previous 2-hybrid 
analysis had suggested that G tslp may interact both with Ysc84p and Slalp in vivo. My 
work confirms these 2 -hybrid studies and further defines the domains mediating this 
interaction. I additionally demonstrate that localisation of Gtslp to the cell cortex occurs 
independently of Slalp and actin, and provide evidence for a role for Gtslp in the 
regulation of both actin and endocytosis.
In chapter 6 , I provide a summary of my thesis and propose additional 
experiments which would provide additional insight into the roles of Ysc84p, Gtslp and 
nuclear Slalp.
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2 MATERIALS AND METHODS
47
2.1 Materials
All chemicals and media used in this study were obtained from Merck or Sigma 
unless otherwise stated. Enzymes used in this study were obtained from New England 
Biolabs unless otherwise stated.
2.2 Yeast Strains, Plasmids and Oligonucleotides
All plasmids, oligonucleotides, yeast strains and antibodies generated and used 
during the course of this study are listed in tables 2-1, 2-2, 2-3 and 2-4 respectively.
Plasmid Description Origin
pCR®4-T0P0 TOPO cloning Invitrogen
pGAD-C2 (pKA163) 2-hybrid Gal4 empty activation domain (James et al, 1996)
pGBDU-Cl 2-hybrid Gal4 empty binding domain (James et al, 1996)
pFA6-3xHA-
HIS3MX6
For C-teriTiinal 3xHA tagging (H1S3 marked) (Longtine et al, 1998)
pFA6-13xmyc-TRP 1 For C-terminal IBxmyc tagging (TRPl 
marked)
(Longtine et al, 1998)
pFA6-HIS3Mx6 For HIS3 marked gene deletions (Longtine et al, 1998)
pTrcHis For N-terminal 6x histidine tagging Invitrogen
pWZV86 (pKA119) For TRPl marked gene deletions K. Nasmyth (IMP, Vienna)
pWZV87 (pKA159) For C-terminal myc tagging {TRPl marked, 
pFA6-13xmyc)
K. Nasmyth (IMP, Vienna)
pWZV89 For C-terminal 3xHA tagging {TRPl marked) K. Nasmyth (IMP, Vienna)
pKA32 Slal-AI18-511 plasmid generated from 
pKA53
(Ayscough et al, 1999)
pKA53 pRS313 + slal AGI ^ SH3#3 (Ayscough et al, 1999)
pKA55 pRS313 + slal BamHI fragment (Ayscough et al, 1999)
pKA142 pGEX4Tl Pharmacia
PKA143 pGEX4T2 Pharmacia
pKA151 For C-terminal myc tagging {HIS marked, 
pFA6-13xmyc)
pKA241 Gal4-AD-Ysc84-229-468 {LEU marked) This study
pKA242 Gal4-AD-Ysc84-181-468 {LEU marked) This study
pKA243 Gal4-AD-Ysc84-143-468 {LEU marked) This study
pKA251 Gal4-AD-Ysc84-(-SH3) pKA241 minus SH3 
domain (LEU marked)
This study
pKA252 pME18S-FL + hSH3yl-l cDNA Dr Hata (University of Tokyo)
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pKA256 p416MET25 methionine inducible CEN URA (Mumberg et al, 1994) 
(pMET25)
pKA259 pCR®4-TOPO + YSC84 This study
pKA275 pCR® 4-T0P0 + hSH3YL-l This study
pKA276 pCR® 4-T0P0 + ysc84 (1-654) This study
pKA277 pCR® 4-T0P0 + ysc84 (1-552) This study
pKA278 pGEX4Tl + ysc84 (1-654) This study
pKA279 pGEX4Tl + YSC84 This study
pKA328 Gal4-AD-Slal-SH3#l-3 (LEU marked) This study
pKA388 Gal4-BD-Gtsl (TRP marked) This study
pKA392 pK416MET25 + hSH3YL-l 
(pM E n5-hSH 3yl-l)
This study
pKA394 pGEX4T2 + (259-552) This study
Table 2-1 Plasmids used in this study
oKA Sequence Description
2 TGCTGCTCCGGTTTCATCTGCTCCGGTTTC
ATCTGCTCCCGCTCCATTGGATCCATTCAA
TCCGGTTCTGCTGCTAG
Tagging and deleting C- terminal repeats 
0ÎSLA1 (5’)
3 GTAATCATTGGCATCATCACAAAGCCAGTA
GATAAGGGTAAGATATTGTTGCCACCGGTT
CCTCGAGGCCAGAAGAC
Tagging and deleting C-terminal repeats of 
SLAl (3’)
7 CCTCAACAATCAAGGCAAGCCAACATATTCAA
TGCTACTGCATCAAATCCGTTTGGATTCTCCGG
TTCTGCTGCTAG
SLAl N-terminal 3’ tagging
8 ACGAAACTATTTCATATAGCTTGTTTTAGTTAT
TATCCTATAAAATCTTAAAATACATTAATCGG
AGCTCCGGTCTTCTG
SLAl N-terminal 5’ tagging
13 CATTATTGGGACTGAGAACG SLAl-tag C-terminal check (5’)
14 CCATTGGATCCATTCAAAACC SLA 1-tag C-terminal check (3’)
124 GCATGGCCTTTGCAGGGC pGEX cloning checking oligo, forward
132 ACGAAACTATTTCATATAACGTGTTTTAGTTAT
TATCCTATAAAATCTTAAAATACATTAATCGA
ATTCGAGCTCGTTTAAAC
(3*) amplification of 9x Myc tag for SLAl
133 CTCAACAATCAAGGCAAGCCAACATATTCAAT
GCTACTGCATCAAATCCGTTTGGATTCGCTGCA
GCCGCTGCAGCTGCACGGATCCCCGGGTTAAT
TAA
(5*) amplification of 9x Myc tag for SLAl
153 ATACCACTACAATGGATGATG pGAD (5’) sequencing
154 AGATGGGCATTAATTCTAGTC pGAD (3’) sequencing
182 ACATCATCATCGGAAGAGAG pGBD (5') sequencing
183 AATGAAAGAAATTGAGATGG pGBD (3’) sequencing
231 GACCGGATCCATGAATAACCCTATACCTTCC hSH3YL-l(2') amplification
232 GAGCGGATCCAGTATACGCTTTAATTCATGG hSH3YL-l (5’) amplification
236 GATCGGATCCATGGGTATCAATAATCCAATTC YSC84 (5’) amplification
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237 GATCGGATCCACCAATCATTTTGAGAATCTGA YSC84 (3’) amplification
239 GATCGGATCCTTAAAAGTTGAACGCTCTTGA YSC84 (3’) amplification from bp 654
251 GATCGAATTCTTAGTAAAACTTTCGATTAGC YSC84 (3’) amplification from bp 552
349 GATCGGATTCATGTCCCATCCGCACTCACAT GGA2 (5’) amplification
350 GATCGGATCCTTATACATTAGGTAACGTAAA GGA2 (3’) amplification
351 GATCGGATTCATGGACCCACATAATCCAATT ARP2 (5’) amplification
352 GATCGGATCCCTATCTTGGACCAAATTTAGT ARP2 (3’) amplification
353 GATCGGATTCATGTATTCTTGGAAGTCAAAG YPKl (5’) amplification
354 GATCGGATCCCTATCTAATGCTTCTACCTTG YPKl (3’) amplification
355 GATCGGATTCAATGTCTGATGCGGCTCCTTCA STE2 (5’) amplification
356 GATCGGATCCGTCATAAATTATTATTATCTTC STE2 (3’) amplification
357 GATCGGATTCAATGCAGACGTCAATGGTGAGC WSC4 (5’) amplification
358 GATCGGATCCGTTATTCGTTCATTAGCCGCAG WSC4 (3’) amplification
364 GATCGAATTCATGAGAGAAGTTATTAGTATT TUB! (5’) amplification
365 GATCGGATCCTTAAAATTCCTCTTCCTCAGC TUBl (3’) amplification
366 GATCGGATCCATGGCAGGTGCTGGTGCAGGT YSC84 (5’) amplification from bp 259
377 GATCGAATTCATGGCTGATAAGATAGATGAGG SLT2 (5’) amplification
378 GCGCGGATTCCTAAAAATATTTTCTATC SLT2 (3’) amplification
410 TACAGACAAGCTGTGACC pGEX cloning checking oligo, reverse
Table 2-2 Oligonucleotides used in this study
Strain Genotype Origin/Reference
pJ69-2a MATa trp-901, leu2-3,112, um3-52, his3-A200, gal4A, 
galSOA, GAL2::ADE2, GAL1::HIS3
Clontech
pJ69-4a MATa trp-901, leu2-3,112, ura3-52, his3-A200, gal4A, 
galSOA, LYS2::GAL2[j/[s-GALlfj\f/{-HIS3, GAL2u^s' 
GAL2 tata~ADE2
Peter Piper (University of 
Sheffield), (James et al, 
1996)
pJ69-4a MATa trp-901, leu2-3,112, ura3-52, his3-A200, gal4A, 
gal80A, LYS2.'.'GAL2ijas'"GAL1j-ata~PI33, GAL2uas~
G A L2 TATA DE2
Peter Piper (University of 
Sheffield), (James et al, 
1996)
KAY300 MATa trpl-1 leu2-3,112 his3-A200 ura3-52 
Aslal ::URA3
(Ayscough et al, 1999)
KAY301 M ATa trpl-1 leu2-3,112 his3~A200 ura3-52 Aslal::URA3 (Ayscough er a/, 1999)
KAY302 MATa, trpl-1, leu2-3,112, lys2-801, his3-A200, ura3-52 (Ayscough et al, 1999)
KAY303 KAY302 + integrated SLAl-9\myc\\TRP (Ayscough et al, 1999)
KAY367 MATa, trpl-1, his3-A20, leu2-3,112, ura3-52 
Aslal ::LEU2, slal A l 18-511 -9xmyc::TRP
(Gourlay et al, 2003)
KAY382 MATa his3-A200, ura3-52, leu2-3,112, trpl-1 
Aslal::URA3 SLA1AG2::H1S3
Kathryn Ayscough 
(University of Sheffield)
KAY387 M ATa, trpl-1, his3-A20, leu2-3,112, ura3-52 
Aslal: :LEU2, slal A G2-9xmyc: : TRP
(Gourlay et al, 2003)
KAY389 MATa, trpl-1, leu2-3,112, lys2-801, his3-A200, ura3-52 (Ayscough et al, 1999)
KAY429 MATa leu2A, his3A, trpl-1, ura3A A crm l/xpol::KamMX + M. Rashbash
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pDC-crm7 (LEU2 CEN)
KAY430 MATa leu2A, his3A, trpl-1, ura3A Acrm l/xpol : : KanMX 
+ pDC-crm7T539C (LEU2 CEN)
M. Rashbash
KAY443 KAY429 + SLAl-9xmyc::TRP This study
KAY444 KAY430 + SlAl-9xmyc::TRP This study
KAY446 MATa hisAl, leu2A, uraSA, met ISA (also BY4741) Research Genetics
KAY447 MATa hisAl, leu2A, ura3A, met ISA (also BY4742) Research Genetics
KAY480 MATa/a, his3Al/his3Al, leu2Al/ leu2Al, ura3A/ura3A, 
MetlS/M ETlS, LYS2/LYS2A
Research Genetics
KAYS 10 M ATa his3-A200, ura3-52, leu2-3,112, trpl-1, lys2-801 
Aysc84::HIS
(Dewar et al, 2002)
KAY516 MATa his3A, leu2A, ura3A, lys2A, AlsbS::KanMX, 
Aysc84::HIS3
(Dewar et al, 2002)
KAY554 MATa his3A, leu2A, uraSA, trpl-1, lys2-801 Aysc84::HIS 
AlsbS ::URA3
(Dewar et al, 2002)
KAY606 MATa, rnal-1, ura3-52, trplA63, leu2Al (Koepp et al, 1996)
KAY607 MATa, srpl~31, leu2-3, 112, ura3~52, his3, ade2, trpl Paul Ko Ferrigno 
(University of Cambridge)
KAY608 MATa, kapl23A::HIS3, ura3-52, his3A200, leu2Al (Seedorf et al, 1997)
KAY609 MATa, lph2A:;HIS3, ura3-52, leu2Al, his3A200 Paul Ko Ferrigno 
(University of Cambridge)
KAY610 MATa, rsll-4, ura3-52, leu2Al, trplA63 Paul Ko Ferrigno 
(University of Cambridge)
KAY612 MATa, xpolA/crml::LEU2, pKW440 (XPOl/CRMl, HIS3) Karsten Weis (University 
of California)
KAY613 MATa, mtrlO-1, ura3-52, lys2-301 Alan Tartakoff
KAY614 MATa, msnSA::HIS3, ura3-52, his3A200, leu2Al Paul Ko Ferrigno 
(University of Cambridge)
KAY615 MATa, losl-1, SUP4, ade2-l, canl-100, lysl-1, trp5-48, 
ura3-l, his5-2
Anita Hopper 
(Pennsylvania State 
University)
KAY616 MATa, xpolA/crml::LEU2 pKW440 (xpol-l/crm l-1, 
HIS3)
Karsten Weis (University 
of California)
KAY617 MATa, ura3-52, his3A200, leu2-3,112, trp lA l, lys2-801 GUnter Blobel (Rockefeller 
University, New York)
KAY619 MATa, nmd5A::HlS3 Paul Ko Ferrigno 
(University of Cambridge)
KAY620 MATa, sxmlA::HlS3, leu2Al, his3A200, trplA63, ura3-52 Paul Ko Ferrigno 
(University of Cambridge)
KAY621 M ATa, psel-1, ura3-52, leu2Al, trplA63, (Seedorf et al, 1997)
KAY622 MPYÏa,prp20-l, ura3-52, leu2Al, trplA63 (Seedorf et al, 1997)
KAY709 MATa/a his3A/his3A, leu2Aâeu2A, uraSA/uraSA, 
MetlS/M ETlS, LYS2/lys2A Agtsl::KanMX/Agtsl::KanMX
Invitrogen
KAY710 MATa hisSA, leu2A, uraSA, Met 15 Agtsl::KanMX Invitrogen
KAY725 MATa hisSA, leu2A, uraSA, Met 15 GFP-Gtslp Research Genetics
KAY750 pJ694a + Gal4AD-Slal Invitrogen
KAY751 pJ694a + Gal4AD-Ysc84 Invitrogen
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KAY752 MATa his3A, leu2A, ura3A, Met 15, Aslal ::URA3 GFP- 
G tslp
This study
KAY767 MATa his3A, leu2A, ura3A, lys2A, AlsbS::KanMX, 
Aysc84::HIS3 + pMET25-SH3yl-l
This study
KAY768 MATa his3A, leu2A, ura3A, lys2A, Alsb5::KanMX, 
Aysc84::HIS3 + pMET25
This study
Table 2-3 Yeast s trains used in this study
Application Antibody Dilution Factor S ource/Reference
Anti-Ysc84p Primary antibody: rabbit anti- 
Ysc84p
1:2000 This study
Secondary antibody: anti-rabbit- 
HRP
1:10000 Vector Labs
Anti-myc
immunostaining
Primary antibody: rabbit anti-myc 
(A14)
1:100 Santa Cruz 
Biotechnology Inc.
Secondary antibody: goat anti-rabbit 
FITC
1:100
Vector Labs
Secondary antibody: anti-rabbit-AP 1:10000 Vector Labs
Table 2-4 Antibodies used in this study
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2.3 Molecular Biology Techniques
Bacterial Media
2xYT 1% yeast extract (Difco Laboratories)
0.5% NaCl (Sigma)
1.6% tryptone (Difco Laboratories)
For solid media, 2xYT was supplement with 2% bacteriological agar (Oxoid 
Ltd). Ampicillin resistance was identified by addition of ampicillin at 100 pg/ml 
(Melford Laboratories).
2.3.1 Restriction enzyme digestion of DMA
Restriction enzyme digests were carried out according to the manufacturer’s 
instructions using the buffers supplied. Double digests were performed as required and 
where similar digestion conditions allowed, and as recommended by the manufacturer. 
Reactions were typically performed in a final volume of 20 pi using 3-4 U of enzyme 
per reaction. All digests were carried out at 37 °C for 2 hours unless otherwise 
recommended by the manufacturer.
2.3.2 Electrophoresis of DMA using agarose gels
DMA fragments were separated and visualised using agarose gel electrophoresis.
A 0,8% agarose gel was prepared using 0.8% powdered agarose (Melford Laboratories)
in 100 ml of a 1 X TAB (10 mM Tris-HCl pH 7.5, 5 mM Acetic acid, 1 mM EDTA
pH7.5) solution. Typically 0.4 g of powdered agarose was added to 50ml of 1 x TAB.
The agarose/TAE solution was melted and allowed to cool to approximately 50°C. 2 pi
of a 1 0  mg/ml stock of ethidium bromide was then added to the solution and the
solution poured into a gel casting tray and sample wells inserted. Following complete
cooling and solidification of the gel, 6  x gel loading buffer (0.25% Bromophenol Blue,
0.25% Xylene Cyanol FF, 30% glycerol (Merck) in water) was added to the DMA
samples to a final Ix concentration. The agarose gel was then immersed in
electrophoresis buffer (1 x TAB) in a suitable tank and the DMA samples loaded into the
wells of the gel. Samples were electrophoresed at 100 Volts for 50 minutes. The DMA
was then visualised by illuminating the gel with a uv light source.
53
2.3.3 Removal of terminal 5’ phosphate groups using calf intestinal 
alkaline phosphatase (C.I.P.)
0.5 U of C.I.P. and a quantity of lOX C.I.P. buffer (New England Biolabs) 
which gave a final Ix concentration, was added to appropriate amounts of DNA 
requiring dephosphorylation. Samples were then incubated at 37°C for 30 minutes, 
electrophoresed on an agarose gel and the DNA purified as described in section 2.3.4.
2.3.4 Extraction of DNA from an agarose gel slice using the QIAquick Gel 
Extraction Kit '^^
DNA extraction from an agarose gel was performed using the QIAquick Gel 
Extraction Kit™ (Qiagen). DNA samples were first electrophoresed on an agarose gel 
(as described in section 2.2.6). The DNA to be extracted could be visualised by 
illuminating the gel with a UV source, enabling the DNA band to be identified and cut 
from the gel. The gel slice was then placed in a 1.5 ml microfuge tube, weighed, and 3 
volumes of Buffer QG added. The tube was then incubated at 50°C for 10 minutes to 
solubilise the agarose and one volume of absolute ethanol added to the tube, if the DNA 
fragment to be extracted was larger than 500 bp but smaller than 4 Kb. This tube was 
then inverted 3 times and the sample applied to a spin column held in a 2 ml collection 
tube. The column was then centrifuged at top speed in a benchtop centrifuge for 1 
minute. After discarding the flow-through, 750 pi of wash buffer was also added to the 
column and the centrifugation repeated. This was step was again repeated using a 
further 250 pi of wash buffer and centrifugation for 2 minutes to allow drying of the 
membrane. The collection tube was then discarded, the column placed in a 1.5 ml 
microfuge tube and 35 pi of sterile water applied directly to the column membrane. 
Plasmid DNA was then eluted into the 35 pi of water by centrifuging the membrane at 
top speed for 1 minute.
2.3.5 Amplification of DNA using the polymerase chain reaction
Specific sequences of DNA were amplified using the polymerase chain reaction 
(PGR). Specific oligonucleotide primers complementary in sequence to regions 
flanking the sequence of interest were first generated using a commercial service at 
MWG Biotech. A plasmid containing the region to be amplified was then obtained, and 
was termed the template DNA. The PGR method described here is a general method
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used to amplify both fragments of genes for cloning, and sequences from plasmids 
designed to allow deletion or tagging of genes within the yeast genome. All PCR 
reactions were performed using Bioline reagents.
For each PCR reaction, 0.5 pmols primer 1, 0.5 pmols primer 2, 200 nM 
dNTP’s, 1 X NH4 reaction buffer (Bioline), 1.5 mM MgCU (Bioline), 1 pi template 
DNA and sterile water to a total volume of 99.5 pi was added to a 0.2 ml thin walled 
PCR tube held on ice. The components were mixed gently and centrifuged briefly to 
concentrate the liquid in the base of the tube. The tube was then transferred to a pre­
heated PCR machine (Biometra TGradient Thermocycler) at 94‘^ C, to which 5 U of 
BioTaq DNA polymerase enzyme (Bioline) was added after 60 seconds. The PCR was 
performed using 30 cycles of amplification. Each cycle contained an initial denaturing 
step of 94°C for 1 minute, followed by a variable annealing temperature of 
approximately 55°C for 1 minute, and finally an extension step at 72°C for 1 minute per 
Kb of DNA to be amplified. The temperature of annealing was varied in order to 
optimise annealing of the oligonucleotide primers used. A final step of 72"C for 5 
minutes was used at the end of the amplification cycles. The PCR product was then 
visualised by electrophoresis on an agarose gel to check for amplification of a product 
of the correct size.
2.3.6 Ligation of DNA fragments
DNA ligation was performed using T4 DNA Ligase (New England Biolabs). 
Fragments to be ligated were incubated at ratios varying between 1:1 -  1:3 of vector to 
insert DNA, in order to optimise ligation, whilst ensuring that the insert DNA was in 
excess. The total amount of DNA in the reaction did not exceeding 1 pM. DNA was 
added to a 1.5ml microfuge tube containing Ipl of lOx T4 DNA ligase reaction buffer 
(New England Biolabs), 0.5 pi (200 U) of T4 DNA Ligase (New England Biolabs) and 
sterile water to produce a total reaction volume of lOpl. The contents of the tube were 
then mixed gently and incubated overnight at 4°C. 2  pi of the ligation mix was then 
transformed into bacterial cells (section 2.3.9).
2.3.7 Integration of DNA fragments into the pTrcHis-TOPO® vector
The pTrcHis-TOPO®TA Expression Kit (Invitrogen) uses the single 
deoxyadenosine (A) overhangs generated on the 3’ ends of DNA fragments amplified 
by PCR to enable direct recombination of fragments into the pTrcHis-TOPO® vector.
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Cloning of fragments into this vector enabled a 6x His tag to be fused onto the encoded 
protein of interest. Expression of recombinant proteins in this vector is regulated by the 
Trc promoter. 1 pi of a fresh PCR amplified fragment was mixed with 3pl of sterile 
water and 1 pi of pTrcHis-TOPO® vector in a 0.5ml microfuge tube. The contents were 
mixed gently and left to incubate for 5 minutes at room temperature. 2 pi of the reaction 
was then transformed into calcium competent DH5a cells.
2.3.8 Preparation of calcium competent DH5a cells
A 0.5 ml overnight culture of DH5a cells was used to inoculate a further 100 ml 
of 2x YT liquid media which was grown for approximately 2 hours until the optical 
density was between OD6oo=0.5~0.6. The culture was then divided into two 50 ml 
Falcon tubes and placed on ice for 10 minutes. Cells were then harvested by 
centrifugation at lOOOg for 5 minutes at 4°C. The cell pellets were then resuspended in 
50 ml of ice cold 100 mM CaCli and the tubes placed on ice for 30 minutes. Cells were 
again centrifuged at lOOOg for 5 minutes at 4°C and the cell pellet resuspended in 5 ml 
CaCH containing 15% glycerol. From this suspension, 100 pi aliquots were snap frozen 
in liquid nitrogen and stored at -SO'^C.
2.3.9 Transformation of calcium competent DH5a cells
A 100 pi aliquot of calcium competent cells for each transformation to be 
performed, was removed from the -8 0 “C freezer and allowed to thaw on ice for 5 
minutes. To this cell suspension, Ipl of transforming DNA was added, the cells gently 
mixed and the tubes incubated on ice for 10 minutes. A pre-heated water-bath was then 
used to heat shock the cells at 42“C for 35 seconds and the tubes placed back onto ice 
for 2 minutes. 200 pi of 2x YT was then added to tubes and the culture incubated with 
shaking at 37°C for 1 hour. Cells were then spread onto plates containing bacterial 
media and a selective antibiotic at a working concentration, and incubated overnight at 
37“C.
2.3.10 Plasmid DNA purification using the QIAprep Spin Miniprep Kit^ *^
Plasmid DNA was purified using the QIAprep Spin Miniprep Kit^^ (Qiagen).
1.5 ml of cells from a 2 ml overnight bacterial culture was harvested by centrifugation
for 2 minutes at top speed in bench top microfuge. The cell pellet was then resuspended
in 250 pi of Buffer PI, following which 250 pi of Buffer P2 was also added to the tube.
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Samples were mixed by inversion 6 times and incubated at room temperature for 5 
minutes. 350 pi of Buffer N3 was then added and the tubes again inverted 6 times. 
Samples were then centrifuged at top speed in a bench top microfuge for 10 minutes 
after which a white precipitate was visible. The supernatants were then transferred into 
a QIAprep Spin Column^^ held in a 2 ml collection tube and the tubes spun at top speed 
for 1 minute. After discarding the flow through, spin columns were washed with 750 pi 
of Buffer PE and centrifuged at top speed in a bench top microfuge for 1 minute. The 
flow through was again discarded and tubes centrifuged for an additional 1 minute to 
remove residual wash buffer. The QIAprep Columns™ were then placed in a fresh 1,5 
ml microfuge tube and DNA eluted from the columns by adding 35 pi of sterile water to 
the membrane, incubating at room temperature for 1 minute and centrifuging at top 
speed for 1 minute.
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2.4 Yeast Methods
Yeast media
YPAD 1 % yeast extract (Merck)
2% Bacto-peptone (Merck)
40 pg/ml adenine (Sigma)
2% glucose (Merck)
For solid media supplement with 2% agar (Oxoid Ltd)
Synthetic 0.67% nitrogen base without amino acids (Sigma)
drop-out 0.2% drop-out mix (lacking variable amino acids) (Qbiogene Inc)
2% glucose (Merck)
For solid media supplement with 2% agar (Oxoid Ltd)
Sporulation 1% potassium acetate
2% agar (Oxoid Ltd)
5-FOA 0.67% nitrogen base (Difco Laboratories)
0.2% drop-out uracil mix (Difco Laboratories)
2% glucose (Merck)
0.1% 5-FOA (Melford Laboratories)
2% agar (Oxoid Ltd)
2.4.1 Mating yeast strains
Two strains of opposite mating type were grown overnight on YPAD plates. A 
small amount of cells taken from these plates were patched on top of the other on a 
fresh YPAD plate and the plate incubated at 30°C for 5 hours. Cells were then 
transferred onto selective media that would allow only the growth of diploids.
2.4.2 Sporulation and tetrad analysis
Following growth of a diploid strain on YPAD plates overnight at 30°C, cells
from this plate were patched onto a plate containing sporulation media and incubated at
30“C for three to five days. During this time cells were exposed daily to microscopic
analysis to monitor the development of four spored asci. Cells were then removed from
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the plate, resuspended in 100 p\ filter sterilised 0.1 M potassium phosphate buffer + 0.5 
mg/ml lOOT zymolyase and incubated for 10 minutes at room temperature. Digested 
spores were then struck onto YPAD plates and the four spores separated using a 
micromanipulator (Singer) which allowed the precise positioning of the spores using a 
grid system to enable simple placing of each set of four. At least 10 tetrads from each 
diploid were separated due to genetic variability. The plates were then was incubated at 
30°C to allow growth of the spores. The number of viable spores was noted and spores 
were then patched onto YPAD and selective media to test for the presence of genetic 
markers.
2.4.3 Yeast transformations
A 10 ml culture of cells were grown to mid log phase ODeoo = 0.5 for each 
transformation to be performed. Cells were harvested in 15 ml falcon tubes at 3000 rpm 
for 2 minutes, washed once in 5ml of 0.1 M TE (10 mM TRIS~HC1 pH7.5, 1 mM 
EDTA) and once in 5 ml of 0.1 M Lithium acetate/TE. Cells were then resuspended in 
100 jLtl 0.1 M Lithium acetate/TE and transferred to a 1.5 ml microfuge tube. 15 /d of 10 
mg/ml of herring sperm DNA previously boiled for 15 minutes, was added to the tube 
in addition to 0.1-1 pg of transforming DNA. Cells were then gently swirled and 700 p\ 
40 % PEG-4000 (Polyethylene Glycol - Merck) in 0.1 M lithium acetate/TE added, 
followed by gentle mixing of the cells by pipetting. Cells were incubated at room 
temperature for at least one hour on a vertical rotator, followed by incubation at 42°C 
for 15 minutes in a water-bath. Following harvesting by centrifugation at 5000 rpm for 
2 minutes, cells were resuspended in 100 pi of sterile water and plated onto selective 
media.
2.4.4 ‘Knock in’ strategy of generating integrated gene deletions or tagged 
strains
Plasmids previously generated (Longtine et al, 1998) were used to allow the 
tagging or deletion of specific genes within the yeast genome by the use of a simple 
strategy. PCR (section 2.3.5) was used to amplify specific tags or deletion cassettes 
from these plasmids using oligonucleotides designed with homology to the regions 
flanking a specific site in the yeast genome, and homology to the tagging/deletion 
cassette. PCR products generated were then transformed into yeast cells and were thus 
incorporated into a specific site in the yeast genome by homologous recombination. The
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transformed cells were then plated onto selective media which enabled only the growth 
of cells which contain the transformed DNA. Integration of the deletion/tagging DNA at 
the correct site was confirmed by colony PCR as described in Section 2.4.7.
2.4.5 Screening for integrated tags or gene deletions by colony PCR
Following growth of yeast transformants for approximately three days at 30°C 
on selective media, colonies were struck out onto YPAD plates and incubated overnight 
at 30°C. Several single colonies were selected using a toothpick, and were resuspended 
in 20 p\ of SPZ Buffer (1.2 M sorbitol, 0.1 M Potassium Phosphate buffer pH7.5 and
2.5 mg/ml zymolyase) in a 0.2 ml thin walled PCR tube. Cell suspensions were then 
incubated at 37°C for 30 minutes in a PCR machine followed by incubation at 95°C for 
5 minutes. This cell preparation formed the DNA template used for standard PCR 
reactions (section 2.3.5), using oligonucleotides homologous to regions flanking the 
inserted DNA. PCR reactions either produced a DNA fragment of the size of the wild 
type region of genomic DNA, or a fragment corresponding to the size of the integrated 
tag or inserted DNA. PCR products were visualised by agarose gel electrophoresis 
(section 2.3.2).
2.4.6 Testing for temperature sensitivity
Cells to be tested for temperature sensitivity were struck onto YPAD plates and 
incubated at both 30°C and 37°C for 1-2 days to assess if growth was affected at the 
higher temperature.
2.4.7 Overexpression of hSh3yI-l in a Aysc84Alsb5 strain
KAY516 cells were transformed with plasmid pKA392 which encoded hSH3yl- 
1, expression of which was under the control of a methionine inducible promoter. The 
same strain was also transformed with empty yeast expression vector, pKA256. Cells 
from both transformations were grown overnight in 2 ml of YPAD at 30°C and 0.2 ml 
of the cultures used to inoculate 2 ml of YPAD which was then grown for 4 hours at 
30°C. Cells were harvested by centrifugation at 3000 rpm for 5 minutes, and the cell 
pellet resuspended in liquid synthetic media lacking methionine. For overexpression 
studies on plates, cells from both transformations were also struck onto YPAD plates 
and grown overnight at 30°C. A small amount of these cells was then stmck onto
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synthetic media lacking methionine and the cells examined for phenotypic defects 
following 4 hours of growth at 30°C.
2.4.8 Induction of the mating response
A haploid MATa strain expressing Slal-myc (KAY303) was incubated with a 
strain of the opposite mating type to induce the mating response (KAY389). Strains 
were initially grown individually on YPAD plates at 29°C overnight. A small amount of 
each strain was then patched on top of the other on a fresh YPAD plate. The plate was 
then place in the 29°C incubator for 2 hours. Cells were then removed from the plate 
and resuspended in 1 ml of liquid YPAD media. This culture was then processed for 
immunofluorescence as described in section 2.7.1. Cells which formed mating 
projections were identified by microscopy, by identification of the characteristic, 
elongated ‘shmoo’ phenotype.
2.4.9 Glycerol stocks
Stocks of specific yeast strains were generated by the addition of 25% sterile
glycerol to log phase cultures. Stocks were then frozen at -80°C in plastic cryovials.
2.5 Yeast 2-hybrid analysis
2.5.1 Yeast 2-hybrid cloning and transformation
A plasmid containing the GTSl coding sequence fused N-terminally to a 
sequence encoding the Gal4-binding do main (pKA388) was transformed into the 2- 
hybrid MATa strain pJ69-4a. Positive transformants were selected by growth of the 
transformed cells on drop-out tryptophan plates. 2-hybrid strains of the opposite mating 
type, pJ69-4a, transformed with plasmids encoding protein and protein fragments of 
interest fused N-terminally to Gal4-activation domains, were either obtained 
commercially or the plasmids transformed individually into the pJ69-4a strain. Positive 
transformants were selected by growth of the transformed cells on drop-out leucine 
plates
2.5.2 Yeast 2-hybrid analysis
Mating of the 2-hybrid pJ69-4a strain containing the G7157-N-terminal Gal4- 
binding domain encoding plasmid, with cells from the opposite mating type strain pJ69-
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4a which contained plasmids encoding proteins of interest fused N-terminally to Gal4- 
activation domains, was performed. Diploids were selected by growth of the resulting 
cells on drop-out leucine and tryptophan plates. These strains were then tested for 
activation of the Gal4 protein by plating onto drop-out histidine, leucine and tryptophan 
synthetic drop-out media.
2.5.3 p-galactosidase assay
5 ml of cells were grown overnight at 30°C in synthetic media to ensure the 
retention of both 2-hybrid plasmids in the diploid strain. The optical density of this 
culture was noted (ODeoo) and 2 ml of cells harvested by centrifugation. Cells were then 
resuspended in 0.5 ml of Z Buffer (60mM Na2HP0 4 , 40mM NaH2P04, lOmM KCl, 
ImM MgS0 4 , 50mM P-Mercaptoethanol, pH7) to which 3 drops of chloroform and 2 
drops of 1% SDS was added. The suspension was vortexed for 10 seconds, incubated at 
28°C for 5 minutes, and 0.2 ml of ONPG added (Melford)(4mg/ml in Z Buffer) to start 
the reaction. The reaction was stopped by addition of 0.5ml IM Na2C0 3  after the 
solution showed a colour change to pale yellow. The time from the start of the reaction 
until addition of Na2C0 3  was recorded. Samples were then centrifuged for 10 minutes at 
5000 rpm and the O D 420 of the supernatant recorded. Assay results were calculated in P- 
galactosidase units and plotted, using the equation shown below. Assays were 
performed in triplicate.
P-galactosidase units = OP49n_________
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2.6 Protein Methods
2.6.1 Whole cell yeast extracts
Cells were grown in liquid YPAD media (section 2.4.1) overnight in a shaking 
incubator at 29°C. 1.5 mis of this culture was harvested by centrifugation in a bench top 
microfuge at 5000 rpm for two minutes and the supernatant discarded. 100 /xls of acid 
washed glass beads were then added to the cell pellet in addition to 50 juls of 2 x SDS 
sample buffer (62.5 mM Tris-HCl (pH 6.8), 20 % glycerol, 2 % SDS, 0.0025 % 
bromophenol blue). Cell suspensions were boiled for three minutes and vortexed for one 
minute. An additional 100 /tls of 2 x SDS sample buffer (20% glycerol, 100 mM TRIS 
pH 6.8, 4% SDS, 0.2 % Bromophenol Blue, 2 % (3-mercaptoethanol) was then added 
and the sample vortexed again briefly. Before loading the protein containing 
supernatants onto SDS-page gels, samples were boiled for an additional five minutes.
2.6.2 Preparation of protein preps by grinding in liquid nitrogen
100 ml of cells were cultured until the optical density was approximately OD600 
= 0.5. Cells were harvested by centrifugation at 3500 rpm for 5 minutes at 4°C and the 
pellet resuspended in 2 ml of UBT buffer (50 mM KHEPES, pH 7.5, 100 mM KCl, 3 
mM MgC12, 1 mM EOT A, 0.5% Triton X-100) to which protease inhibitors (0.5 mg/ml 
leupeptin, aprotinin, chymostatin, pepstatin A) and 1 mM of PMSF 
(phenylmethylsulfonyl fluoride) had been added. The cells were then slowly dripped 
into a 50 ml falcon tube previously pre-frozen in, and containing, approximately 20 ml 
of liquid nitrogen. Excess liquid nitrogen was then poured from the falcon tube and the 
frozen cells transferred to a pestle and mortar for grinding. To ensure the cells were kept 
frozen throughout grinding a small amount of liquid nitrogen was repeatedly poured 
onto the cells. The cells were ground to a fine powder which was then either transferred 
to microfuge tubes and stored in the -80°C freezer for use later, or transferred to a fresh 
50ml falcon tube and the powder allowed to thaw at 4°C. Once thawed, the solution was 
centrifuged at 45,000rpm for 20 minutes at 4°C and the supernatant retained for use.
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2.6.3 SDS-PAGE electrophoresis
The appropriate percentage of acrylamide gel was poured according to the 
recipes below.
Separating gel:
7.5% 10% 12%
Sterile water 4.10 ml 3.44 ml 2.69 ml
30 % acrylamide (BioRad),
0.8 % bisacrylamide (37.5:1) (BioRad)
2,25 ml 3.00 ml 3.75 ml
Resolving Buffer (1.5 M Tris-HCl (pH 8.8), 0.4 % SDS) 2.25ml 2.25 ml 2.25 ml
10 % ammonium persulfate 31 gl 31 fil 31 gl
TEMED (N,N,N',N' -  tetramethylethylene-diamine) 5 ixl 5 III 5 gl
5 % Stacking gel:
Sterile water 1.71 ml
30 % acrylamide (BioRad),
0.8 % bisacrylamide (37.5:1) (BioRad)
0.50 ml
Stacking buffer (0.5 M Tris-HCl (pH 6.8), 0.4 % SDS) 0.75 ml
10 % ammonium persulfate 35 gl
TEMED (N,N,N',N' -  tetramethylethylene-diamine) 3.5 gl
Following loading of protein samples held in Ix sample buffer (10% glycerol, 
50 mM TRIS pH 6,8, 2% SDS, 0.1 % Bromophenol Blue, 1 % p-mercaptoethanol), gels 
were run in 1 x Running buffer (0.025 M Tris, 0.192 M Glycine, 0.1 % SDS, pH 8.6) at 
90 Volts for 30 minutes, and then 120 Volts for approximately 1 hour, until the dye 
front had run off the bottom of the gel.
Pre-cast NuPAGE® gradient gels (Invitrogen) were also used. These were 
obtained as 4-12% NuPAGE® Bis-Tris gradient gels and 3-8% NuPAGE® Novex Tris- 
Acetate gels. Gels were run in Ix NuPAGE® MOPS buffer SDS Running Buffer 
(Invitrogen) and Ix NuPAGE® Tris-Acetate SDS Running Buffer (Invitrogen) at 200 
Volts for 50 minutes, and 150 Volts for 1 hour respectively.
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2.6.4 Western blotting
Semi-dry blotting was performed as described. Proteins were separated by SDS- 
PAGE gel electrophoresis, the gel removed from the apparatus and immersed in Ix 
NuPAGE® transfer buffer (Invitrogen) containing 10% methanol. PVDF 
(Polyvinylidene Difluoride) membrane (Schleicher and Schuell) and 4 layers of 3 mm 
filter paper were cut to the approximate size of the gel to be transfeiTed and the 
membrane immersed directly in methanol. The filter paper was then soaked in Ix 
NuPAGE® transfer buffer (Invitrogen) containing 10% methanol. The blot sandwich 
was quickly assembled with the exclusion of air bubbles between the gel and PVDF 
which would prevent transfer. The sandwich was then placed into the semi-dry blotter 
(Biorad) and a limiting voltage of 25 Volts applied for 50 minutes. The membrane was 
removed and immersed in TBS-T (10 mM Tris-HCl pH8, 150 mM NaCl, 0.2% Tween- 
20).
Wet blotting was performed as described. Proteins were sepaiated by SDS- 
PAGE gel electrophoresis, the gel removed from the apparatus and immersed in Ix 
CAPS buffer (10 mM CAPS p H ll, 10% methanol). PVDF (Polyvinylidene Difluoride) 
membrane was cut to the approximate size of the gel to be transfeiTed and the 
membrane immersed directly in methanol. Four foam pads were then soaked in Ix 
CAPS buffer. The blot sandwich was quickly assembled with the exclusion of air 
bubbles between the gel and PVDF which would prevent transfer. The sandwich was 
then placed into a wet blotting tank (BioRad), the tank filled Ix CAPS buffer and a 
limiting voltage of 400 mAmps applied for 60 minutes. The membrane was then 
removed and immersed in TBS-T (10 mM Tris-HCl pH8, 150 mM NaCl, 0.2% Tween- 
20).
2.6.5 Western blot detection using Enhanced Chemi-Luminescence (ECL)
Proteins were blotted as described (section 2.6.4) and the PVDF membrane 
immersed in Ix TBS-T (10 mM Tris-HCl pH8, 150 mM NaCl, 0.2% Tween-20) 
containing 5% milk for 1 hour on a rocker. The membrane was removed from this 
blocking solution, immersed in 1 x TBS-T for 5 minutes on a rocker and sealed in 
polythene, to ensure contact with 5 mis of Ix TBS-T containing 1% milk and the 
primary antibody (usually at lOOOx dilution). The membrane was then left to incubate in 
this solution overnight at 4°C on a rotor, enabling slow rotation. The blot was then 
removed and washed three times in 50 ml of 1 x TBS-T for 15 minutes at room
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temperature on a rocker. The membrane was then placed sealed in polythene for a 
second time with 5 mis Ix TBS-T containing 1% milk and a horseradish peroxidase 
(HRP) conjugated secondary antibody (usually 5000 x dilution) for one hour at room 
temperature with on a rotor. The membrane was then removed and washed as described 
previously. ECL solution I (250 mM luminol (3-aminophthalhydrazide (Fluka) in 
DMSO, 90 mM p-coumaric acid (Sigma) in DMSO, 0.1 M Tris-HCL pH 8.5) and 
solution II (0.18% hydrogen peroxide, 0.1 M Tris-HCl pH 8.5) were prepared. Equal 
volumes of these solutions were mixed and the blot immersed in the resulting solution 
for one minute. The membrane was then briefly rinsed in TBS-T, placed inside two thin 
layers of plastic in a cassette and exposed to X-ray film (Konica) which was developed 
in an automatic developer.
2.6.6 2-Dimensional gel electrophoresis using the ZOOM® IPG Runner
System
1 ml of cells was obtained from a culture grown until the optical density of the 
culture was approximately OD600 = 0.5. Cells were harvested by centrifugation at full 
speed for 2 minutes in a benchtop microfuge. The cell pellet was then washed twice in 
200 IÜ of Rehydraüon Buffer (8 M Urea, 2% CHAPS, 0.5% (125 /il) ZOOM® Carrier 
Ampholytes of the appropriate pH (Invitrogen) and 0.002% Bromophenol Blue). 100 fx\ 
of glass beads was then added to the pellet, in addition to 50/xl of Rehydration Buffer, 
and the cells vortexed for 60 seconds. A further 100 jul of Rehydration Buffer was 
added and the sample centrifuged at 10000 rpm for 2 minutes to clarify the extract. 8 
of this lysate was then added to 155 /rl of Rehydration Buffer, a ZOOM® strip of the 
appropriate pH gradient placed in a ZOOM® Cassette and the solution added to the 
cassette to allow strip hydration overnight in accordance with the manufacturer’s 
protocol.
After rehydration overnight, the ZOOM® strip was then removed from the 
cassette and prepared for Isoelectric Focusing (lEF). The first dimension was run under 
the following conditions; STEPl, 175 V for 15 minutes; STEP2, 175-2000 V ramping 
for 45 minutes; STEP3, 2000 V for 1 hour. Before running the second phase, the 
ZOOM® strip was first equilibrated by soaking in 5 ml Reducing Solution (500 pi 
NuPAGE® Sample Reducing Agent (Invitrogen), 4.5 ml NuPAGE® LDS Sample 
Buffer (Invitrogen) for 15 minutes, followed by 5 ml Alkylating Solution (116 mg 
iodoacetamide in 5 ml Ix NuPAGE® LDS Sample Buffer (Invitrogen)) for 15 minutes. 
The ZOOM® strip was then placed on top of a 4-20% NuPAGE® Novex Bis-Tris SDS
66
gradient gel and encased in 0.6% agarose in IxMOPS buffer (Invitrogen). The gel was 
then placed in a XCell SureLock™ Mini-Cell tank and electrophoreses at 200 V for 1 
hour. Western blotting was then performed (section 2.6.4).
2.6.7 Induction of a tagged protein in bacterial cells
Transformation of an appropriate plasmid into bacterial cells was performed as 
described (section 2.3.9). Cells were then grown overnight at 37°C in 5 ml of YT 
containing ampicillin at 100 pg/ml to enable the selection of plasmid containing cells. 
This culture was then used to inoculate 20 ml of YT containing ampicillin which was 
grown for 1 hour at 37“C. This culture was used to inoculate 1 litre of YT containing 
ampicillin which was grown for approximately 4 hours at 37°C until the ODeoo was 
between 0.5-0.6. Expression of the tagged protein was induced by the addition of 1 mM 
IPTG (Isopropyl“P-D-thiogalactopyranoside) and the cultures grown at 37°C for 2 
hours. Cultures were then pelleted by centrifugation at 4000 rpm for 30 minutes at 4°C, 
the supernatants discarded and the pellets frozen at -20°C until required.
2.6.8 Purification of GST tagged proteins using Glutathione Sepharose®
4B Beads
Bacterial cultures were induced as described in section 2.6.7. Fusion proteins 
containing a glutathione S-transferase (GST) tag were purified using glutathione 
sepharose® 4B Beads (Amersham Pharmacia). Cell pellets from induced cultures were 
thawed on ice, washed once in 20 ml of PBS (20 mM phosphate, 50 mM NaCl, pH7.5) 
and the pellet resuspended in 4 ml of PBS containing 20 [ig of lysozyme, Protease 
Inhibitors (0.5 mg/ml leupeptin, aprotinin, chymostatin, pepstatin A) and 1 mM PMSF 
(phenylmethylsulfonyl fluoride). This cell suspension was then sonicated for 5 seconds 
to lyse the cells and the lysate incubated at room temperature for 30 minutes on a 
horizontal rotor. Following addition of 1 (xM MnClz, 10 jaM MgCl2 and 4/xl of lOmg/ml 
DNase I (Boeringer Mannheim) and a further 10 minute incubation, the lysate was 
centrifuged at 45000 rpm for 20 minutes at 4°C. The supernatant from this spin was 
added to 0.5ml of pre-washed glutathione sepharose® 4B Beads and incubated on a 
rotor for one hour at 4“C. Beads were then washed three times with for 15 minutes with 
PBS + 1% Triton-X-100, transferred to a column, allowed to drain and the column 
capped. The fusion protein was eluted from this column by addition of 1 ml glutathione 
elution buffer (10 mM reduced glutathione, 50 mM Tris-HCl pH 8) to the column. The
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elution buffer was allowed incubate with the beads for 10 minutes at room temperature, 
before removal of the cap and collection of the elutant. This elution step was repeated 
five times and each fraction analysed by SDS-Page gel electrophoresis.
2.6.9 F-actin sedimentation assays
Purified fusion proteins were tested for binding to actin by high speed 
sedimentation assays. F-actin was prepared from a known concentration of purified 
rabbit muscle G-actin (Cytoskeleton Inc.) in G-buffer (5 mM TRIS pH7.5, 0.2 mM 
ATP, 0.2 mM DTT, 0.2 mM CaCh) by resuspension in 1 x KME (50mM KCl, ImM 
MgS0 4 , ImM EGTA, lOmM TRIS-HC, pH 7.5) overnight at 4°C. The solution became 
viscous overnight due to the formation of actin filaments. The concentration of the 
protein of interest was then accurately determined by spectrophotometry, and increasing 
amounts tested for F-actin binding ability. Assays were carried out using TLIOO 
centrifuge tubes (Beckman). To each tube 5 /xl of 10 x ABB (200 mM TRIS-HCl pH8, 1 
M NaCl, 20 mM MgCl2, 10 mM ATP, 10 mM DTT, 1 mM CaCl2) was first added. 
Known concentrations of the protein of interest held in 35 pi of glutathionine elution 
buffer (GEB; lOmM Reduced Glutathionine, 50mM Tris-HCL pH 8) were then added 
to tubes in duplicate. Finally lOpl of F-actin was added to every second tube while the 
remaining tubes received the same volume of 1 x KME. In addition control reactions 
containing either actin alone or protein alone, in addition to buffers, were also prepared. 
Tubes were then left to incubate at room temperature for 15 minutes after which all 
tubes were centrifuged at 100,000 rpm for 20 minutes at 4°C in an Optima TL Benchtop 
Ultracentrifuge (Beckman) to pellet F-actin. Following centrifugation, the supernatant 
from each tube was removed and added to 50pl of 2x SDS Sample Buffer (20% 
glycerol, 100 mM TRIS pH 6.8, 4% SDS, 0.2 % Bromophenol Blue, 2 % (3- 
mercaptoethanol). In addition, 50 pi of 2x Sample Buffer was added to each tube and 
left to incubate with, and soften, the very viscous pellet for 15 minutes at room 
temperature. The pellets were then resuspended in this solution and transferred to fresh 
microfuge tubes containing an additional 50 pi of 1:9 lOx ABB: Ix GEB. lOpl aliquots 
from supernatant and pellet fractions from each tube was then analysed by SDS page gel 
electrophoresis. Standard assay conditions are also described by Winder and Walsh, 
1990.
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2.6.10 Falling ball assays
The effect of a specific ligand on the polymerisation of an actin gel was assessed 
by analysis of the time taken for a metal ball to pass though 10 cm of actin, polymerised 
in the presence and absence of the ligand. Monomeric actin was resuspended in G- 
Buffer (5 mM TRIS pH7.5, 0.2 mM ATP, 0.2 mM DTT, 0.2 mM CaC12) at a 
concentration of 7.5 pM. 80 pi aliquots of actin were then added to lOpl of known
concentration of ligand held in glutathione elution buffer (GEB; lOmM Reduced
Glutathionine, 50mM Tris-HCL pH 8). To this 10 pi of lOx Polymerisation Salts (lOx; 
20 mM MgC12, 5 mM ATP, 1 M KCl) was added and the 100 pi reactions vortexed to 
allow mixing of the solutions. Reactions were used to fill a 10 cm length of glass 
capillary tube, capped at the base using a small plasticine bung. Tubes were then left 
overnight to allow polymerisation of the actin matrix. The time taken for passage of a 
metal ball bearing through 10 cm of the actin was then recorded.
2.6.11 Fluorescent actin assays
Alexa Fluor labelled actin monomers were incorporated into polymerising actin 
filaments allowing visualising of actin filaments using fluorescence microscopy. Alexa 
Fluor® and Alexa Fluor® labelled actin monomers (Molecular Probes) were used 
to allow visualisation of filaments at two wavelengths. Rabbit skeletal muscle G-actin 
(Cytoskeleton Inc.) was resuspended in general actin binding buffer (5 mM Tris-HCl 
pH8, 0.2 mM CaC12, 0.002% Chlorohexidine (Cytoskeleton Inc.)) at 7.2 pM. 10 pg of 
Alexa Fluor® 488 labelled actin monomers was added to 25 pi of unlabelled G-actin 
and 2.5 pi of 10 x polymerisation salts (100 mM Tris-HCl pH 7.5, 500 mM KCl, 20 
mM MgC12, 10 mM ATP) added to the solution. Incubation of the reaction for 1 hr at 
room temperature enabled polymerisation of labelled actin filaments. Prior to this 
incubation the actin stabilising drug phalloidin (Cytoskeleton Inc.) was added as 
detailed in sections 4.2.7 and 4,2.8, at equimolar concentrations to actin. Known 
concentrations of the proteins of interest were then added to the polymerised, labelled 
actin and the effect on polymerisation examined by fluorescence microscopy after a 30 
minute incubation at room temperature. If dual labelling experiments were to be 
performed, following this 30 minute incubation time with the protein of interest, a 
further 10 pg of Alexa Fluor® labelled actin monomers were added to the reaction 
and allowed to incubate for a further 1 hour at room temperature before visualisation of 
dual labelled filaments.
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2.6.12 Coomassie staining of SDS-polyacrylamide gels
Proteins separated by SDS-PAGE gel electrophoresis were visualised by 
staining of protein with Coomassie Brilliant Blue. Gels were fixed and stained in a 
solution of 40% methanol, 10% acetic acid and 50% water which contains 0.1 % (w/v) 
Coomassie Brilliant Blue R250 for 5 minutes at room temperature. Gels were then 
transferred to a de-staining solution (40% methanol, 10% acetic acid and 50% water) for 
30 minutes. This de-staining solution was then refreshed and de-staining allowed to 
proceed until the background of the gel was clear of stain.
2.6.13 Determination of protein concentration by spectrometry
The concentration of purified proteins in solution was calculated using Beer’s 
Law, following determination of the absorbance of the protein sample at 280 nM by 
spectrophotometry. Concentrations were calculated using the equation:
A = 8 c 1
where ‘c’ is the concentration of protein in the sample in moles/liter, ‘A’ is the 
Absorbance of the sample at 280 nm, ‘e’ is the extinction coefficient for the protein of 
interest as determined by analysis of protein residues in the protein of interest, and T  is 
length of the light path in centimetres. The extinction coefficient of a protein at 280 nm 
was estimated by identification of the number of tyrosine, tryptophan and cysteine 
residues present in the protein, and multiplication of these numbers by 1280, 5690 and 
120 respectively.
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2.7 Microscopy methods
2.7.1 Equipment details
Microscopy was performed using an Olympus microscope BX-60 fluorescence 
microscope with a 100 W mercury lamp and an Olympus 100" Plan-NeoFluar oil- 
immersion objective. Images were captured using a Roper Scientific Micromax 140IE 
cooled CCD camera using IP lab software (Scanalytics, Fairfax, VA) on an Apple 
Macintosh G4 computer.
2.7.2 Indirect immunofluorescence
5 ml of cells were grown to mid-log phase (ODeoo = 0.5), formaldehyde added to 
a final volume of 5 % and the cultures incubated at room temperature for at least 1 hour. 
Cells were then harvested by centrifugation at 2500 rpm for 3 minutes in a 15 ml falcon 
tube and washed twice in 2 mis of sorbitol buffer (1.2 M sorbitol, 0.1 M potassium 
phosphate buffer, pH 7.5). After resuspending the cell pellet in 0.5 ml of sorbitol buffer 
and transferring the sample to a 1.5 ml microfuge tube, 1 jxl of P-mercaptoethanol and 
20 jal 1 mg/ml lOOT zymolyase was then added. Tubes were incubated at 37°C for 30 
minutes and 20 jLtl of the resulting cell suspension placed onto a poly-l-lysine coated 
slide well. The suspension was left on the slide for 10 minutes at room temperature to 
allow the cells to settle, after which the excess solution was gently aspirated from the 
well and the slide immersed for 6 minutes in -20‘^ C methanol. The slide was then 
transferred to -20*^ C acetone for 30 seconds and left to air-dry. Wells were washed 10 
times with Ix PBS/1 mg/ml BSA (Bovine Serum Albumin) and 20 /rl of Ix PBS/1 
mg/ml BSA containing the primary antibody at a 1:100 dilution added to the well and 
allowed to incubate overnight at 4°C. The well was then again washed 10 times with Ix 
PBS/1 mg/ml BSA and 20/tl of Ix PBS/1 mg/ml BSA containing the secondary 
antibody at a 1:100 dilution added. This was allowed to incubate with the fixed cells for 
a further hour in the dark at 4°C. Following incubation the well was again washed 10 
times with Ix PBS/1 mg/ml BSA and drop of mounting solution (90 ml glycerol, 10 ml 
Ix PBS, 100 mg DAPI) containing DAPI (4',6'-diamidino-2-phenylindole 
hydrochloride) was placed onto each well. A cover slip was placed over the wells, and 
the edges sealed with nail polish and the slides examined by fluorescence microscopy.
71
2.7.3 Rhodamine phalloidin staining
2 ml of cells were grown to an OD6oo=0.2-0.4, formaldehyde added to a 5 % 
final volume and the culture left to incubate for one hour at room temperature. 1 ml of 
this culture was then harvested at 5000 rpm in a microfuge, the supernatant discarded 
and the cell pellet washed three times in Ix PBS/1 mg/ml BSA/0.1 % Triton-X-100. 
After resuspending the pellet in 4 0  /tl of Ix PBS/1 mg/ml BSA/1 % Triton-X-100, 5 fxl 
(lU) of rhodamine phalloidin (Molecular Probes) was added and the cells incubated at 
room temperature for 30 minutes in the dark. Following incubation, the cells were 
washed three times with 0.1 M PBS/1 mg/ml BSA and resuspended in 100 [il of the 
solution. 20 jx\ of cell suspension was then placed in a poly-l-lysine coated slide well 
and allowed to settle for 10 minutes. The well was then washed twice with 0.1 M PBS/1 
mg/ml BSA, a drop of mounting solution placed into the well and covered with a 
coverslip. The edges of the coverslip were then sealed with nailpolish and the slide was 
viewed by fluorescence microscopy.
2.7.4 Lucifer Yellow uptake assay
2 ml of cells were grown to an optical density of approximately ODeoo = 0.25. 
0.5 ml of these cells were harvested by centrifugation at 5000 rpm for 3 minutes and 
resuspended in 40 /il YPAD liquid. 5 jxl of 40 mg/ml lucifer yellow (Fluka) was then 
added and the suspension left to incubate at room temperature for one hour in the dark. 
1 ml of ice-cold succinate/azide buffer (50 mM succinic acid, 20 mM NaNa, pH 
adjusted to 5 with NaOH) was then added to the suspension, the tube inverted to mix the 
contents and a cell pellet obtained by centrifugation at 5000 rpm for 3 minutes. After 
discarding the supernatant, this succinate/azide buffer wash was repeated twice. Cells 
then resuspended in 10/tl of buffer and 2 pi of the suspension placed on a slide for 
immediate observation. This method is adapted from a method described by Dulic and 
colleagues (Dulic et al 1991). For quantitative analysis of lucifer yellow uptake, 200 
cells from each strain were examined.
2.7.5 FM4-64 assay
2 ml of cells were grown to an optical density of approximately OD^oo = 0.1. 1 
ml of these cells was harvested by centrifugation at 5000 rpm for 3 minutes and 
resuspended in 0.5 ml YPAD liquid. 20 pM FM4-64 (Molecular Probes) was added to 
the suspension and the cells incubated with shaking for 15 minutes at 29°C. Following
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this incubation, cells were again harvested by centrifugation at 5000 rpm for 3 minutes 
and resuspended in 0.5 ml of fresh YPD media. Cells were then incubated with shaking 
at 29°C for 30 minutes, following by harvesting by centrifugation, resuspension in 40 pi 
YPAD, and 5 pi of this suspension placed onto a slide for viewing. This method is 
adapted from a method described by Vida and Emr (Vida and Emr, 1995). For 
quantitative analysis of FM4-64 internalisation, 200 cells from each strain were 
examined.
2.7.6 Latrunculin-A treatment of cells
The strain to be examined was first grown in liquid culture in 2 ml of YPAD 
media at 29°C until in log phase growth. To this culture Latrunculin-A (a generous gift 
from Phil Crews, University of California, CA) was added at a concentration of 400 pM 
and the culture incubated with shaking for a further 15 minutes at 29‘^ C. 1 ml of this 
culture was then fixed and processed for visualisation of actin structures by rhodamine 
phalloidin staining to confirm disruption of the actin cytoskeleton (section 2.7.3), while 
1 ml of the culture was used for the localisation of GFP-tagged proteins by direct 
microscopic observation of GFP fluorescence.
2.8 Antibody Production
2.8.1 Raising an immune response in rabbits
The GST-Ysc84-Nt fusion protein was purified over a Glutathione Sepharose 
column as previously described in section 2.6.8, This purified protein was then used to 
generate polyclonal rabbit antisera. Four injections of approximately 50 pg of protein 
were administered to two rabbits (R1414 and R1415) at 28 day intervals (Diagnostics 
Scotland). An initial pre-immune serum was obtained from these animals as were 
subsequent primary and secondary serums taken 7 days after each injection. A final 
exsanguination bleed was performed 13 weeks after the first injection and the serum 
obtained.
2.8.2 Purification of serum over a Protein A column
Protein A sepharose™ CL-4B beads (Amersham Pharmacia) were prepared by 
allowing 0.75 g of Protein A sepharose™ CL-4B bead powder to incubate with 30 ml of 
distilled water for 30 minutes at room temperature. The swollen beads were then
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centrifuged at 1000 rpm for 2 minutes, the supernatant discarded and the beads washed 
in 30 ml of 50 mM Tris-HCl pH 7.0 and centrifuged as before. 0.3 ml of 1 M Tris-HCl 
pH 7.0 was then added to 3 mis of serum from the final bleed of rabbit R1415. This 
serum was then added to the Protein A sepharose™ CL-4B beads in a 15ml Falcon tube 
and left to incubate for 1 hour at room temperature on a rotor. The beads were pelleted 
by centrifugation at 1000 rpm for 5 minutes and the supernatant removed and retained. 
Beads were then transferred to a 50 ml Falcon tube, 30 ml of 50 mM Tris-HCl pH 7.0 
added and the beads left to wash in this solution for 20 minutes on a rotor. This solution 
of beads and wash buffer was then applied to a column and the wash buffer allowed to 
drain from the beads. Beads were washed with a further 60ml of 50 mM Tris-HCl pH 
7.0 applied directly to the column, before proceeding to the elution of the antibodies. 10 
ml of elution buffer (0.1 M glycine pH 2.5) was applied to the column in 1 ml fractions. 
Each fraction was collected separately in a 1.5 ml microfuge tube containing 100 pi of 1 
M Tris-HCl pH 8.8 to neutralise the solution. The concentration of protein in the sample 
was then measured by spectrophotometry and 10 pi samples of each fraction analysed 
by SDS-page gel electrophoresis. Specificity of these antibodies was determined by 
testing these aliquots at 1:1000 and 1:2000 dilutions by western blotting against whole 
cell extracts as described in section 4.2.9. Antibodies were also tested for identification 
of protein in vivo, however the specificity of these antibodies was not high enough to 
enable this, and a high level of background staining was seen.
2.9 RNA Methods
2.9.1 Yeast RNA extraction using the Promega SV Total RNA Extraction
Kit and Qiagen RNeasy Mini Kit
This method for RNA isolation from yeast cells uses reagents from both the SV 
Total RNA Isolation Kit (Promega) and the RNeasy Mini Kit (Qiagen). 0.25ml of cells 
from an overnight yeast culture were used to inoculate 4.5 ml of YPD media which was 
grown for 4 hours until the optical density was approximately OD600 ~ 0.5. 2 ml of this 
culture was then harvested by centrifugation at 5000 rpm and the pellet resuspended in 2 
ml of buffer Y1 (1 M sorbitol, 0.1 M EDTA pH 7.4 (Qiagen), containing 0.1% (3- 
mercaptoethanol and 250pl of 2mg/ml lOOT zymolase). Spheroplasts were generated by 
incubating the cells in this solution for 20 minutes at 30oC in a water-bath. Spheroplasts 
were pelleted by centrifugation at 1000 rpm for 5 minutes, the supernatant discarded 
and resuspended in 350 pi of buffer RLT (Qiagen) containing 1% p-mercaptoethanol.
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Spheroplasts were then lysed by vigorous vortexing, 350pl of absolute ethanol added to 
the lysate and gently mixed by pipetting, and the lysate poured into a spin column 
assembly (Promega). The isolation proceeded from this stage according to the SV Total 
RNA Isolation Kit (Promega) Protocol. The assembly was centrifuged at top speed for 1 
minute, flow-through discarded and the column washed with 600 pi of SV RNA wash 
solution (60 mM potassium acetate, 10 mM Tris-HCl pH 7.5 and 60% ethanol 
(Promega). Following centrifugation and discarding of the wash flow-through, the spin 
column was left at room temperature while a mixture containing 40 pi yellow core 
buffer (0.0225M Tris pH 7.5, 1.125M NaCl (Promega)), 5 pi 0.09M MnC12 and 5 pi 
DNase 1 was prepared. This solution was then applied directly to the membrane and the 
column left to incubate at room temperature for 15 minutes. Following this incubation 
200 pi of SV DNase Stop Solution (2 M guanidine isothiocyanate, 4 mM Tris-HCl pH 
7.5, 57% ethanol (Promega)) was added to the membrane and the assembly centrifuged 
for one minute. The column was then washed twice with 600 pi SV RNA wash solution, 
and then with 250 pi of SV RNA wash solution, after which the column was centrifuged 
for an additional one minute to dry the membrane. RNA was eluted by applying 100 pi 
of Nuclease Free Water (Qiagen) to the membrane and centrifuging for one minute into 
a fresh 1.5 ml microfuge tube. RNA was then immediately placed on dry ice and 
transferred to the -80“C freezer.
2.9.2 Quantification of RNA using an Agilent Bioanalyzer2100
Quantification of the RNA (section 2.9.1) using an Agilent BioAnalyzer2100 
was performed, as it was recommended that 10 pg of high quality total RNA be used for 
each GeneChip® Array. Quantification was performed at the Sir Henry Wellcome 
Functional Genomic Facility (SHWFGF) at Glasgow University according to Agilent 
Bio Analy zer2100 protocols.
2.9.3 RNA concentration using Pellet Paint ® co-precipitant
Suitable RNA preps (section 2.9.1-2.9.2) were concentrated using the Pellet 
Paint® Co-precipitant Kit (Novagen). 2 pi of Pellet Paint® was added to each sample, 
followed by the addition of 0.1 x volume of 3 M sodium acetate. 2 volumes of absolute 
ethanol were then added and the samples vortexed briefly followed by a 2 minute 
incubation at room temperature. Samples were then spun at top speed in a benchtop 
microfuge for 5 minutes after which the supernatant was removed and discarded. The
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pellet was washed with 70% ethanol, vortexed briefly and spun again at top speed for 5 
minutes. The supernatant was removed and this step was repeated using 100% ethanol 
to wash the pellet. The pellet was then left to air dry and once suitably dry, the pellet 
was resuspended in a volume of RNase free water to give a concentration of 2 pg per pi 
of RNA.
2.9.4 DS cDNA Synthesis and cleanup
Double stranded cDNA was synthesised from the RNA preps (section 2.9.3) 
using the Superscript™ Double-Stranded cDNA Synthesis Kit (Invitrogen). First strand 
synthesis was performed by adding 1 pi of T7-(dT)24 primer (100 pmol/ul) to a RNase 
free microfuge tube, 10 pg of total RNA from the pellet paint precipitation and sterile 
water to increase the sample volume to 10 pi. The sample was then incubated at 70*^ 0 
for 10 mins, spun at top speed in a benchtop microfuge for 10 seconds and placed on 
ice. 4 pi of first strand cDNA buffer, 2 pi 0.1 M DTT and 1 pi 10 mM dNTP was added 
to the tube and the tube contents mixed by gentle vortexing, again spun for 10 seconds 
and then incubate at 42°C for 2 mins. 1 pi of Superscript™ II RT enzyme was added, 
the samples mixed by gentle pipetting and incubated at 42”C for 1 hour, after which the 
tubes were placed on ice.
Second stranded synthesis was performed by adding to the tube, 91 pi of 
nuclease free water, 30 pi of 5x second strand reaction buffer (100 mM Tris-HCl pH 
6.9, 450 mM KCl, 23 mM MgC12, 0.75 mM P-NAD+, 50 mM (NH4)2S04), 3 pi of 10 
mM dNTPs, 10 U E.coli DNA ligase, 40 U E.coli DNA Polymerase I and 2U RNase H 
to a final volume of 150 pi. The contents of the tube were mixed by gentle tapping, spun 
briefly in a benchtop microfuge and incubated at 16°C for 2 hours. After this step 2ul 
(lOU) of T4 DNA Polymerase was added and the tube incubated for a further 5 mins at 
16°C, followed by the addition of lOpl of 0.5 M EDTA (pH8). The samples were then 
transferred to 1.5 ml microfuge tubes and used in the DS cDNA cleanup protocol.
Cleanup of the double stranded cDNA was achieved using the Phase Lock Gel™ 
system (Eppendorf). 162 pi of (25:24:1) phenol : chloroform : is oamy lalcohol (saturated 
with 10 mM Tris-HCl pH8/l mM EDTA) and the cDNA synthesis preparation was 
mixed in a 1.5 ml microfuge tube by vortexing. The mixture was then transferred to the 
Phase Lock Gel™ tube and immediately spun at full speed in a benchtop microfuge for 
2 mins. The upper aqueous layer held the cleaned DS cDNA which was then transferred 
to a fresh 1.5 ml tube.
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DS cDNA was then concentrated by repeating the Pellet Paint® (Novagen) 
protocol and resuspending the pellet by gentle pipetting in 12 pi RNase free water. The 
sample was then left on the benchtop for 30 minutes.
2.9.5 Synthesis of Biotin Labelled cRNA using a High Yield RNA 
Transcript Labelling Kit
The BioArrayTM HighYield RNA Transcript Labelling kit (T7) (Enzo Life 
Sciences) was used to produce Biotin labelled cRNA. To a 0.2 ml RNase free microfuge 
tube the following components were added: 5 pi of DS cDNA (section 2.9.4), 17 pi of 
nuclease free water, 4 pi of lOx HY Reaction Buffer, 4 pi of lOx Biotin labelled 
ribonucleotides, 4pl of lOx DTT, 4pl of lOx RNase Inhibitor Mix and 2pl of 20x T7 
RNA polymerase. The mixture was then mixed by gentle pipetting and collected in the 
base of the tube by a pulse spin in a benchtop microfuge. An in vitro transcription (IVT) 
reaction was performed by transferring the tube into a PCR machine set to incubate the 
sample at 37oC for 5 hours. The sample was then stored at -20°C overnight before 
cleanup and quantification of the product.
2.9.6 Cleanup of labelled cDNA using the RNeasy™ Mini Kit
Unincoiporated dNTPs were removed so that the concentration of RNA could be 
measured accurately via absorbance at 260nm.The IVT reaction (section 2.9.5) was 
thawed and transferred into a 1.5 ml microfuge tube and the sample made up to a total 
volume of 100 pi by addition of RNAse-free water. To this sample 350 pi Buffer RLT 
(Qiagen) containing 1% P-mercaptoethanol was added and mixed thoroughly. 250 pi of 
absolute ethanol was then added and mixed by pipetting only. This sample was added to 
a RNeasy minispin column in a 2 ml collection tube and centrifuged at 12000 rpm for 
15 seconds, after which the flow through was reapplied to the column and the 
centrifugation repeated. Flow-through held in the collection tube was then discarded and 
the RNeasy column transferred into a new 2 ml collection tube. 500 pi of wash buffer 
RPE (Qiagen) was added to the column and the column centrifuged for 15 seconds at 
12000 rpm, the flow-through discarded and the column wash repeated by the addition of 
another 500 pi of buffer RPE. Again the column was centrifuge for 2 minutes at full 
speed to dry the RNeasy membrane, the flow-through discarded and the column 
centrifuged for an addition 1 minute at 12000 rpm.
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The RNeasy column was then eluted by transfer of the column into a 1.5 ml 
microfuge tube and the addition of 30 pi of RNase-free water onto membrane. The 
column was then left to stand for 1 minute at room temperature, followed by
centrifugation for 1 min at 12000 rpm to elute the first fraction which was stored on ice.
A second elution was then preformed as before, using again 30 pi of RNase-free water. 
A 0.5 pi aliquot of both elutions was used for analysis of the cleaned IVT product on the 
Agilent Bioanalyser2100. The remaining IVT fractions were stored on at -20oC
2.9.7 Quantification of labelled cDNA
Quantification of the product was performed on the Agilent BioAnalyzer 2100 at 
a 1:4 dilution (0.5 pi IVT reaction (section 2.9.5-2.9.6) + 1.5 pi H20) of the first elution 
and an undiluted 0.5 pi aliquot of the second elution. An OD of 1 at 260 nm is known to 
equate to 40 pg/ml RNA. A A260/A280 ratio close to 2 suggests good quality, pure 
RNA.
The formula:
Adjusted cRNA yield = RNAm -  (total RNAi)(y)
was used to quantify the cRNA while allowing for adjustment to reflect 
carryover of unlabelled total RNA. Carryover of 100% was estimated. RNAm = amount 
of cRNA measured after IVT (pg, unpurified). Total RNAi = starting amount of RNA 
(pg, prior to cDNA synthesis). Y = fraction of cDNA reaction used in IVT reaction (i.e. 
3.3 pl/12 pi)
2.9.8 Fragmentation of RNA
Fragmentation of the labelled RNA sample must be performed before 
hybridisation to the Affymetrix GeneChip® Arrays. This was done by referring to the 
unadjusted cRNA concentration of the sample and using 20.5 pg of RNA to which a 
volume of RNase free water was added to bring the total to 32 pi. To the 32 pi, 8 pi of 
5x Fragmentation Buffer (200 mM Tris-acetate pH 8.1, 500 mM KG Ac, 150 mM 
MgOAc) was added and the sample mixed by pipetting. Incubation at 94°C for 35 
minutes was followed by placing the sample on ice. This fragmentation produced a 
distribution of RNA fragments the size of which varied from approximately 35 to 200 
bases. These fragments formed the probe used for hybridisation.
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2.9.9 Hybridisation of RNA to oligonucleotide arrays
Hybridisation of the probe to Genechip Yeast Microarrays was performed at the 
Sir Henry Wellcome Functional Genomic Facility (SHWFGF) at Glasgow University 
by Catriona Young.
2.9.10 Analysis of RNA data using SAM software
SAM (Significance Analysis of Microarrays) is a statistical technique for finding 
significant genes in a set of microarray experiments. It was proposed by Tusher, 
Tibshirani and Chu (Tusher et al, 2001). The software was written by Balasubramanian 
Narasimhan and functions as an add-on to the Microsoft Excel program.
Data inputs into the SAM program are in the form of gene expression 
measurements from a set of microan*ay experiments. Data from our three wild type 
arrays and three slal null arrays were input into the program. SAM generates a statistic 
di for each gene i, measuring the strength of the relationship between gene expression 
and each group. Repeated permutations of the data are then used to determine if 
expression of any genes are significantly related to each group. The cut-off for 
significance was determined by a tuning parameter delta, chosen in this case as a 1% 
false positive rate.
2.9.11 RT-PCR using the Titan One Tube RT-PCR System
RT-PCR was performed using approximately 400 ng of total RNA from a yeast 
RNA isolation (section 2.9.1) held in a volume not exceeding 3 |li1. The Titan One Tube 
RT-PCR system (Roche) was used. The reaction was initially setup on ice in two 0.2 ml 
thin walled PCR tubes. 4 p.1 of 10 mM dNTPs (Bioline), 0.5 |al of each primer at 50 
pmol/p,l, 400 ng of RNA, 2.5 pi of 100 mM DTT and sterile water to make up the total 
volume to 25 pi was added to the first tube. 5 pi of 25 mM MgC12, 5 pi of 5x RT-PCR 
Reaction buffer, 1 pi Titan One Tube enzyme mix and sterile water to make up the total 
volume to 25 pi was then added to tube 2. The contents of both tubes were then added 
to a fresh 0.2 ml thin walled PCR tube on ice and mixed by gentle pipetting. This tube 
was transferred immediately to a pre-heated PCR machine which would incubate the 
sample initially for 30 minutes at 50°C, followed by dénaturation of the sample at 94®C 
for 2 minutes and 27 PCR cycles. The first ten cycles consisted of thermoycling at 94°C
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for 10 seconds, 53°C for 30 seconds and a 68”C extension step of 45 seconds for a 
transcript less than 1 Kb or 60 seconds for transcripts between 1Kb and 1.5 Kb. The 
following 17 cycles were identical except from the 68°C extension step which was set to 
add an additional 5 seconds to the length of this step after every cycle. Thermocycling 
was ended with a five minute incubation at 68°C. The temperature of the 53°C 
annealing step was variable to allow optimum annealing of oligonucleotide primers to 
the template, 10 pi of the 50 pi reaction was then analysed by agarose gel 
electrophoresis (section 2.3.1).
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3 CHARACTERISATION OF NUCLEAR SL A l
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Abstract
Prior characterisation of Slalp has shown the protein to function as an adaptor 
molecule linking endocytic proteins with the actin cytoskeleton in S. cerevisiae 
(Ayscough et al, 1999; Tang et al, 2000; Warren et al, 2002). In this chapter I further 
the study of Slalp with an analysis of nuclear Slalp. Two particular aspects of nuclear 
Slalp have been the focus of this study. Firstly, the nucleocytoplasmic trafficking of 
Slalp has been investigated and additionally, an investigation into the possible roles of 
Slap in the nucleus has been undertaken. Briefly, in this study it is shown that 
remodelling of the actin cytoskeleton, both during cell-cycle progression, and during the 
mating response does not affect the nuclear localisation of Slalp. This suggests that 
nuclear accumulation of Slalp occurs independently of the cytoplasmic actin network. 
Slalp is also shown to contain several potential nuclear localisation and nuclear export 
motifs and following analysis of slal mutants, we identify specific regions of Slalp 
important for nuclear localisation. Furthermore, mutation of the nuclear transport 
receptor Rsllp is shown to prevent nuclear accumulation of Slalp, suggesting the 
mechanism of Slalp nuclear entry. To investigate the possible role of nuclear Slalp, 
microarray analysis of both a àslal strain and a wild-type strain was performed. This 
technique was used to provide insight into the roles of nuclear Slalp.
3.1 Introduction
Prior analysis of Slalp has demonstrated that the protein is multifunctional and 
is required for normal cortical actin patch structure and organisation. Previous studies 
have shown that Slalp links the regulation of the cortical actin cytoskeleton to 
endocytic proteins, through interactions with several proteins regulating these processes 
(Ayscough et al, 1999; Zeng and Cai, 1999; Uetz et al, 2000; Drees et al, 2001; Warren 
et al, 2002; Gourlay et al, 2003). Slalp localises to punctuate patches at the cell cortex, 
which partially co-localise with cortical actin patches (Ayscough et al, 1999).
Slalp has been shown to interact with the Arp2/3 complex regulating proteins 
Abplp and Lasl7p/Beelp (Warren et al, 2002). These proteins enhance actin 
polymerisation by increasing the activity of the Arp2/3 complex (Madania et al, 1999; 
Winter et al, 1999a; Goode et al, 2001). The involvement of Slalp in the regulation of 
actin dynamics is further demonstrated by studies demonstrating the increased 
resistance of a Isslal strain to Latrunculin-A treatment and the identification of aberrant
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actin structures in slal mutant strains (Ayscough et al, 1997; Ayscough et al, 1999). 
Increased resistance to Latrunculin-A suggests a decrease in the dynamic nature of the 
actin cytoskeleton in these cells. Slalp is also involved in endocytic uptake and has 
been shown to form a trimeric complex with the endocytic proteins Pan Ip and End3p 
(Tang et al, 2000), Additionally, localisation of Slalp to the cell cortex is dependent on 
Bnd3p (Wan'en et al, 2002). These interactions demonstrate the role of Slalp as an 
adaptor protein at the cell cortex, while multiple interactions suggest many interactions 
made by Slalp may be transient. Recent studies have also shown Slalp to have a role in 
ubiquitination of proteins by interaction with Rsp5p, a ubiquitin ligase (Stamenova et 
al, 2004). Slalp may also have a role in the regulation of vesicle trafficking as Slalp 
has been shown to interact with Lsb5p, a protein with homology to the GGA proteins 
(Dewar et al, 2002). To date only cytoplasmic roles of Slalp have been described.
Prior localisation studies performed in this lab suggested that Slalp is also found 
in yeast nucleus (Kathryn Ayscough, unpublished data). Immunofluorescence studies 
using Slalp specific antibodies demonstrate a diffuse immunofluorescence signal which 
co-localises with DAPI fluorescence of nuclear DNA, in addition to the previously 
reported cortical fluorescence. Additionally, and in support of nuclear Slalp, previously 
unpublished data from this lab has identified an interaction between Slalp and the 
nuclear protein CinSp by a yeast 2-hybrid screen (Hilary Dewar, unpublished data). 
Large scale screen have also shown synthetic lethality between a ctf4/poblmvitmi and 
deletion of SLAl (Tong et al, 2004), and a two hybrid interaction between Slalp and 
Slx2p (Uetz et al, 2000), a nuclear protein with endonuclease activity. CTF4/P0B1 
encodes a nuclear chromatin associated protein. A nuclear role for Slalp is also 
suggested by genetic interactions with the gene encoding the nuclear protein 
Tafl4p/Anclp (Welch and Drubin, 1994). The TAF14/ANC1 (actin noncomplementing) 
gene was identified during screening for mutations that enhanced the defect caused by 
mutation of the actin gene. In addition tafl4/ancl mutants were shown to have defects 
in the organisation of cortical actin cytoskeleton (Welch et al, 1993; Welch and Drubin, 
1994) and to be defective in mating projection formation, suggesting a role for Anclp in 
the regulation of the cytoskeleton. An anclAl::HIS  mutation has been shown to be 
synthetically lethal in combination with SLAl deletion (Welch and Drubin, 1994), 
suggesting the two proteins may perform overlapping cellular roles. The localisation of 
Tafl4p/Anclp occurs independently of Slalp and overexpression of neither Slalp nor 
Anclp is able to rescue the phenotypic defects caused by deletion of the other protein, 
which suggests similar but not identical roles for these proteins (Welch and Drubin,
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1994). Tafl4p/Anclp is a component of the yeast TFIID and yeast TFIIF complexes 
(Cairns et al, 1996; Auty et al, 2004). These are two factors are required for basal 
transcription by RNA Polymerase II. The aims of this study were therefore to examine 
the nuclear localisation of the Slalp protein and investigate the potential roles of nuclear 
Slalp.
Due to the localisation of Slalp to the nucleus, a brief overview of the 
mechanisms of nuclear entry in S. cerevisiae is detailed here. In contrast to mammalian 
cells, the nuclear envelope of S. cerevisiae remains intact throughout the cell cycle. 
Molecules are able to enter the nucleus at the time of nuclear envelope reformation, 
while also undergoing active transport in mammalian cells. In S. cerevisiae however, 
nuclear entry and export always involves translocation across the nuelear membrane. 
Cargo molecules enter and exit the yeast nucleus by two mechanisms. Passive diffusion 
occurs when molecules smaller than 40 kDa freely diffuse through the nuclear envelope. 
Larger molecules must however be translocated across the membrane by active 
transport. Active import and export of molecules is mediated by a family of nuclear 
transport receptors collectively termed karyopherins (importins and exportins). These 
proteins recognise specific sequences on cargo molecules and transport the cargo into or 
out of the nucleus via the nuclear pore complexes (NPCs), as determined by signal 
sequences in the cargo (figure 3-1). NPCs are large complexes which span the nuclear 
envelope and which aie composed of approximately 40 proteins in S. cerevisiae 
(nucleoporins) (for review see Weis, 2003). Many nuclear import and export signal 
sequences have been identified and this has led to the classification of nuclear 
localisation signals (NLSs) which specify nuclear import of cargo molecules, and 
nuclear export signals (NESs), which specify nuclear export. Additionally, many 
proteins are known to undergo nuclear transport but which do not show homology to 
known signal sequences, suggesting that several as yet unidentified signal sequences 
may exist or that another mechanism controlling nuclear translocation may be active. 
Known NLS and NES sequences are summarised in table 3-1. Nuclear translocation is 
additionally dependent on the gradient of the small Ras-like GTPase Ran, which cycles 
between the nucleus and cytoplasm, assuming a predominantly GTP bound form in the 
nucleus and a GDP bound form in the cytoplasm. This gradient is a consequence of the 
different cellular localisations of the yeast Ran-specific GTPase activating protein 
(RanGAP) and guanine-nucleotide exchange factor (RanGEF).
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Figure 3-1 Active transport across the nuclear membrane. Transport occurs via 
nuclear pore complexes (black) which span the nuclear membrane. The direction of 
transport is determined by sequence signals in the cargo known as nuclear localisation 
sequences (NLSs) and nuclear export signals (NESs). Transport receptors or 
karyopherins; importins (Imp) or exportins (Exp) recognise cargo either directly or 
indirectly, escorting the cargo through the NPC. Transport is dependent on a RanGTPase 
gradient across the nuclear membrane.
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Sequence element Conserved Sequence NLS source
Monopartite NLS- Lys rich PKKKRKV SV40 T-antigen
Monopartite NLS PAAKRVKLD c-myc
Monopartite Consensus KKxK
Bipartite NLS -Lys rich KRPAATKKAGQAKKKKL Nucleoplasmin
Bipartite Consensus 2K/R (10-12 aa) 3K/R
Leu-rich NES LQLPPLERLTL HIV-1 Rev
Table 3-1 Consensus sequence of conserved NLS and NES elements.
Examples of known NLS and NES sequences from specific proteins are shown with the general
consensus sequence also demonstrated. Essential residues are shown in bold. The SV40 NLS was 
identified by Kalderon and colleagues (Kalderon et al, 1984), c-myc NLS by Dang and Lee, (Dang and 
Lee, 1988) and the nucleoplasmin NLS by Robbins and colleagues (Robbins et al, 1991).
The monopartite or classical NLSs were initially identified and characterised as 
a short cluster of basic amino acids. Bipartite NLSs, composed of two short stretches of 
basic amino acids separated by a linker sequence were then identified. NESs identified 
to date are rich in hydrophobic amino acids such as leucine or isoleucine.
In order to investigate the localisation of Slalp in the nucleus, Slalp localisation 
during the S, cerevisiae cell-cycle was examined (sections 3.2.1 -  3.2.3) and the 
phenotypes of the slal mutants, slal~AG2 and slalA-118-511 studied (sections 3.2.4 -  
3.2.5). Slalp localisation in a specific nuclear transport receptor (Karyopherin) mutant 
strain was examined and was shown to be abnormal (sections 3.2.7 -  3.2.10), 
suggesting the mechanism of Slalp nuclear uptake. Microarray analysis of gene 
expression changes in a SLAl deletion strain and a wild-type strain was also performed 
in order to examine potential nuclear Slalp roles (section 3.2,11). Determining the 
effects of SLAl deletion on gene expression should provide new insight into the 
functions of nuclear Slalp.
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3.2 Results
3.2.1 The localisation of Slalp to the nucleus is not a cell-cycle associated
event
Nuclear Slalp was initially identified during localisation of myc-tagged Slalp in 
the wild-type strain KAY303 (Kathryn Ayscough, unpublished data). This strain was 
generated by integration of a short region of DNA encoding a 9x myc tag (9 x 
EQKLISEEDL) into the wild-type strain (KAY302) at the 3’ end of the SLAl gene. 
Localisation of the Slal-myc fusion protein was then performed by indirect 
immunofluorescence (section 2.7.2). Polyclonal rabbit anti-myc primary antibodies 
were used to label the myc-tagged protein, while goat anti-rabbit FITC labelled 
secondary antibodies allowed the localisation of the primary antibodies by fluorescence 
microscopy. Pictures were obtained using an Olympus BX-60 fluorescence microscope 
as described in section 2.7.1. The immunofluorescence pattern in this strain clearly 
shows accumulation of Slal-myc at punctuate structures at the cell cortex as previously 
reported. Additionally, a diffuse fluorescence across the yeast nucleus is seen (figure 3- 
2A). The location of the nucleus in these cells was confirmed by DAPI fluorescence, 
which incorporates into the nuclear DNA (figure 3-2B). This data suggested that Slal- 
myc localises both to the nucleus and the cell cortex.
Due to the lack of previous reports of nuclear Slalp, nuclear Slalp has 
remained unstudied. Several possibilities exist regarding the nuclear localisation of 
Slalp. Accumulation of the protein at this localisation could be a transient occurrence, 
with accumulation occurring at specific points in cell-cycle or during specific cell 
processes. This may potentially occur as a sequestering event to remove the active 
protein from the cytoplasm. Slalp may also however be consistently found in the 
nucleus with a definable specific role. In order to study nuclear Slalp in more detail, 
localisation of the protein was performed under specific conditions to ascertain if 
nuclear Slalp was apparent throughout. Due to the confirmed roles of Slalp in the 
regulation of actin dynamics, localisation of the protein was performed throughout the 
cell cycle, when extensive cytoskeletal remodelling occurs, and which may have 
affected nuclear Slalp. During budding and cytokinesis, the actin cytoskeleton polarises 
towards sites of cell growth, in the developing bud and at the bud neck respectively. 
Slalp-myc localisation was therefore examined by immunofluorescence at specific 
points in the cell-cycle in the wild-type strain (KAY 303). Data demonstrated that 78% 
of unbudded cells demonstrated a co-localisation of Slalp-myc fluorescence with
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nuclear DAPI fluorescence (figure 3-3). Similarly, 76% of budded cells showed a co­
localisation of Slalp-myc fluorescence with nuclear DAPI fluorescence. Remodelling of 
the actin cytoskeleton and other cell-cycle specific processes did not therefore affect the 
percentage of cells demonstrating nuclear Slal-myc, suggesting that nuclear Slalp  
accumulates independently of cell-cycle progression.
B
Figure 3-2. Slalp shows both a partial co-localisation with cortical actin patches 
and a nuclear co-localisation.
The localisation of Slal-myc as determined by immunofluorescence in a wild-type (KAY 303) 
strain. A) The KAY303 strain expresses myc-tagged Slalp and was processed for 
immunofluorescence by methanol fixation during log-phase growth. Examination of Slal-myc 
localisation was undertaken by immunofluorescence with rabbit polyclonal anti-Myc A -14 
antibodies (1:100). B) DAPI fluorescence allows the localisation of the yeast nucleus by DAPI 
incorporation into nuclear DNA.
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Figure 3-3. The nuclear localisation of Slalp-myc is cell-cycle independent.
KAY303 cells expressing myc-tagged Slalp were processed for immunofluorescence during 
log-phase growth and the localisation of Slal-myc examined using anti-myc rabbit polyclonal A- 
14 antibodies. Localisation of Slalp-myc was examined in over 200 cells at specific cell-cycle 
stages. The presence of nuclear Slalp recorded as shown. 78% of unbudded cells demonstrated 
nuclear Slal-myc, while 76% of unbudded cells demonstrate nuclear Slal-myc.
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3.2.2 Nuclear Slalp response to heat shock
To examine the effect of the heat-shock response on the localisation of nuclear 
Slal-myc, the wild type, Slal-myc expressing strain (KAY 303) was incubated at 37”C, 
following initial 29°C growth. Extensive remodelling of the actin cytoskeleton occurs in 
response to heat shock. Previous studies have demonstrated the substancial 
depolarisation of cortical actin patches and loss of actin cables in budding yeast cells, 
following heat shock (Gu et al, 1997). In addition, the heat shock response is associated 
with the increased expression of proteins involved in specific stress response pathways.
To examine the effect of heat shock and the associated depolarisation of the 
actin cytoskeleton on the localisation of nuclear Slal-myc, a strain expressing Slal-myc 
was first grown normally at 29°C, and then transferred to incubation at 37°C, in order to 
induce the heat shock response. Cells were then examined by immunofluorescence to 
localise Slal-myc. The wild-type strain (KAY303) was cultured overnight in liquid 
YPAD media, and this culture used to innoculate 5 ml of fresh media which was grown 
for a further four hours at 29°C, to allow cells to enter log phase growth. These cultures 
were then transferred to incubation at 37°C and examined by immunofluorescence at 
time points 5, 15, and 30 minutes after temperature shift. The immunofluorescence 
pattern of Slalp-myc at these time points demonstrates the continuing co-localisation of 
Slal-myc fluorescence with nuclear DAPI fluorescence (figure 3-4). Slal-myc also 
continued to localise to partially polarised punctuate patches at the cell cortex. The 
immunofluorescence pattern of nuclear Slalp-myc was therefore unaffected by 
induction of the heat-shock response.
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Figure 3-4. The localisation of Slalp-myc is unaffected in heat shocked cells
Haploid cells expressing myc-tagged Slal (KAY 303) were initially grown into log-phase at 
29°C, followed by transfer to 37“C for 30 minutes. Cells were fixed and examined by 
immunofluorescence microscopy at time points A) 5 minutes B) 15 minutes and C) 30 minutes 
following temperature shift. Slal-myc immunofluorescence (left) and DAPI fluorescence (right) 
is shown.
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3.2.3 Nuclear Slalp is not affected by induction of the mating response
In order to continue examining the effect of specific cellular responses on the 
localisation of Slalp, the effect of inducing the mating response and the associated actin 
remodelling on Slal-myc localisation was examined. During mating, haploid cells 
secrete cell-type specific mating pheromones. MATa cells secrete a-factor, while 
MATa cells secrete a-factor. These peptide pheromones bind to receptors on the surface 
of cells of the opposite mating type, initiating a response which enables the formation of 
a mating projection. In this way, haploid cells are able to detect cells of opposite mating 
type with which they can successfully mate to form diploids. Mating pheromones bind 
to membrane bound G-protein coupled pheromone receptors which initiate activation of 
a signalling pathway, which promotes the remodelling of the actin cytoskeleton and the 
activation of Stel2p, a transcription factor which promotes the expression of mating 
factor response genes. Cells responding to mating pheromones have a characteristic 
‘shmoo’ appearance due to the formation of the mating projection and the associated 
polarisation of cellular growth.
A MATa strain expressing the Slal-myc fusion protein (KAY303) was 
incubated with cells of the opposite mating type but which did not express Slalp-myc 
(KAY389) to induce the mating response in both strains (section 2.4.10). Strains were 
initially grown individually on YPAD plates at 29°C. A  small amount of one strain was 
then patched onto the other on a fresh YPAD plate, and the cells returned to the 29°C 
incubator for a further 2 hours. Cells were then removed from this plate and 
resuspended in 1ml of liquid YPAD media. This culture was then fixed and examined 
by immunofluorescence microscopy with anti-myc antibodies as described in section 
2.7.2. Cells undergoing the mating response were identified by the formation of the 
characteristic elongated, mating projection as shown in figure 3-5. The 
immunofluorescence pattern shows Slalp-myc localising both to punctuate patches at 
the cell cortex, and also to the nucleus in cells with undergoing the mating response. 
These images demonstrate that the nuclear localisation of Slalp-myc is unaffected by 
the induction of mating response.
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Figure 3-5. The nuclear localisation of Slalp is unaffected during the mating response.
MATa cells expressing myc-tagged Slal (KAY 303) formed the characteristic mating projection 
following incubation with strain of the opposite mating type (KAY389). Slal-myc was then 
localised in the MATa, KAY303 strain by immunofluorescence using anti-myc A14 antibodies 
(left panels). Nuclear DNA was also identified by DAPI incorporation and fluorescence (right 
panels). Bar = lOpM.
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3.2.4 The localisation of Slal-AG2 and slal-A118-511 mutants
Given that the co-localisation of nuclear Slalp-myc was unaffected during cell- 
cycle progression, the induction of the mating response and the heat shock response, the 
localisation of previously generated Slalp mutants was undertaken. Removal of specific 
regions of Slalp was known to affect the organisation of the actin network and 
endocytic function in these mutant strains (Ayscough et al, 1999; Gourlay et al, 2003). 
These regions may therefore also be important for mediating nuclear interactions or in 
localising Slalp to the nucleus.
Slalp mutant strains lacking specific regions of the protein were examined. 
These strains carry functionally inactive genomic copies of SLAl, disrupted by 
integration of the LEU2 o.t the SLAÎ locus. The first strain examined additionally carried 
a carboxy-terminal myc-tagged slal-A l 18-511 construct (KAY 367) (Ayscough et al, 
1999). This slal-A 118-511-myc mutant constmct was inserted into the genome by 
homologous recombination at the URA3 locus. The deleted region of Slalp was 393 
amino acids in length and encompassed the last 10 amino acids of the second SH3 
domain, the Gapl region, third SH3 domain and a small section of the Gap2 region, 
including the first 20 amino acids of SHDl (figure 3-6). This region of Slalp has been 
previously shown to be required for the actin regulating activity of the Slalp (Ayscough 
et al, 1999). Slal-A118-511 was shown to localise to small punctuate spots at the cell 
cortex which did not co-localise with the aberrant actin structures generated in this 
mutant (Ayscough et al, 1999; Gourlay et al, 2003). This strain is temperature sensitive 
in addition to its actin phenotype, which shows fewer, and enlarged cortical actin 
patches; an actin phenotype similar to that seen in a S lA l  deletion strain. Slal-A118- 
511 is however able to rescue the Abplp dependence associated with SLAl deletion, 
suggesting some functionality of the protein is retained (Ayscough et al, 1999). The 
nuclear localisation of Slal-A118-511-myc had not previously been examined.
The second strain to be examined carried a carboxy-terrainally tagged slal-AG2 
construct (KAY 387) (Ayscough et al, 1999). This slal-AG2 construct lacks a 1495 bp 
fragment (figure 3-6), and was inserted into the genome by homologous recombination 
at the URA3 locus. The Gap2 (G2) region of Slalp is partially removed in this mutant. 
This region contains the SHDl region reported to interact with Lsb5p (Dewar et al, 
2002; Costa et al, 2005).
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The sla l-A l 18-511-myc and slal-AG2-myc mutant strains were grown in liquid 
YPAD media at 29°C until in log phase growth, then fixed and processed for 
immunofluorescence with anti-myc A 14 antibodies. The immunofluorescence pattern of 
sla l-A l 18-511-myc and slal-AG2-myc is shown in figure 3-7. Slal-AG2-myc 
fluorescence co-localises primaiily with nuclear DAPI fluorescence and demonstrates 
an almost total loss of fluorescence at cortical patch sites (figure 7A). Only a very low 
level of fluorescence is apparent in the cytoplasm in these cells. Slal-A l 18-511-myc has 
been previously reported to localise to punctuate patches at the cell cortex, indicating 
that the protein still retains the ability to localise to cortical sites (Gourlay et al, 2003). 
Our data confirms the localisation of sla l-A l 18-511-myc to punctuate cortical patches 
(figure 3-7B), however a partial loss of co-localisation with the nucleus was also noted. 
Removal of the Gapl and third SH3 domains of Slalp in this Slal-A l 18-511 mutant 
caused a marked decrease in the intensity of nuclear staining in all cells examined. This 
data suggests the importance of the Gapl and SH3#3 region, and the Gap2 region for 
normal localisation of the Slalp to the cell cortex and nucleus. Deletion of either region 
has a marked effect on Slalp localisation.
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Figure 3-6. Diagram of Slalp mutant constructs, slal-JI 18-511 and slaI-AG2.
Previously generated genomic Slal constructs lacking residues 118-511 and the AG2 
region (amino acids 507-1008) were used in this study. The Slalp mutants encoded are 
shown in the diagram and termed slal-Al 18-511 and slal-AG2. A carboxy-terminal 
9xmyc tag was also fused to these constructs. Constructs are thus expressed as myc- 
tagged fusions in KAY 351 {slal-Al 18-511) and KAY 387 (slal-AG2) strains. Deletion 
of amino acids 188-511 removes the last 10 amino acids o f SH3#2, the Gapl region, 
SH3#3, and the first 20 amino acids o f SH D l. In the slalAG2 mutant a significant region 
of the Gap2 domain is lost including homology domains 1 and 2 (SHD1+SHD2). SH3 
domains are shown in red, homology domains in grey and the carboxy-terminal repeat 
region in blue.
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A) S ia1-AG2-myc DAPI
Sia1-A118’511-myc DAPI
Figure 3-7. Localisation of slal~AG2-tnyc and slal-Al 18-511-myc mutants constructs.
Haploid cells expressing A) slaI-AG2-myc (KAY 387) and B) slal-Al 18-511-myc (KAY 367) 
were examined by immunofluorescence microscopy using anti-myc A -14 antibodies (left panels) 
and DAPI fluorescence (right panels).
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3.2.5 Slal-AG2-myc and slal-A118-511-myc mutants have endocytic and
actin defects
Given the mislocalisation of the slal-A 118-511-myc and slal-AG2-myc 
mutants, with accumulation occuring primarily in the nucleus in the slal-AG2 mutant, 
and predominantly in the cytoplasm in the sla l-A l 18-511-myc mutant, additional 
effects of the deletion of these regions of Slalp were examined. Effects on the actin 
cytoskeleton were studied by rhodamine phalloidin staining (section 2.7.3), while 
lucifer yellow uptake assays were then performed to examine endocytic uptake (section
2.7.4) in these mutant strains.
A slal-A l 18-511 and Aslal strain have previously been shown to display an 
aberrant actin cytoskeleton, with fewer and enlarged cortical actin patches (Holtzman et 
al 1993, Ayscough et al 1999). A slal deletion strain expressing plasmid borne slal- 
AG2 has however been previously reported to display a normal actin phenotype in 90% 
of cells studied (Ayscough, 1999). Results of experiments performed during this study 
confirm these actin phenotypes (figure 3-8). 85% of slal-A 118-511-myc cells examined 
displayed enlargement of, and a decrease in the number of cortical actin patches. 80% of 
slal-AG2-myc cells examined however displayed a normal actin phenotype. The region 
of Slalp from residues 118-511, has previously been shown to act as the actin 
regulatory region within Slalp (Ayscough et al, 1999). Slal-A 118-511-myc retains 
partially functionality however, with the ability to rescue Abplp dependence of a Aslal 
strain but lacking the ability to rescue the temperature sensitive growth phenotype 
associated with Aslal. The slal-AG2 mutant is able to rescue both the growth defect 
and Abplp dependence of a slal deletion strain and exhibits a generally wild-type actin 
cytoskeletal staining (Ayscough et al, 1999).
Endocytic uptake is intimately linked with the function of the cortical actin 
cytoskeleton. Given the aberrant actin phenotypes displayed in our sla l-A l 18-511-myc 
mutant and the mild actin defect displayed in our slal-AG2-myc mutant, effects on 
endocytosis were assayed. Uptake of the dye Lucifer Yellow from the growth medium 
is used to quantify the extent of fluid phase endocytic activity occurring in a specific 
strain (section 2.7.4). Lucifer Yellow uptake assays performed on the slal-A188-511- 
myc mutant showed an approximate 50% reduction in uptake in all cells examined, as 
determined qualitatively (figure 3-9). Assays performed on the slal-AG2-myc mutant 
showed approximately a 90% decrease in uptake in all cells examined, as determined 
qualitatively, similar to that seen in a Aslal strain (Warren et al, 2002).
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Figure 3-8. F-actin structures in haploid yeast strains expressing slal-A118-511- 
myc and slal-AG2-myc.
Strains expressing slal-Al 18-511-myc (KAY367) and slal-AG2-myc (KAY387) were cultured 
into log-phase growth and stained with rhodamine phalloidin to visualise the F-actin structures. 
Wild-type (KAY302) and Aslal (KAY300) strains were also examined.
Wild-typc
s l a l - A  I I 8 - 5
Figure 3-9. Fluid phase endocytosis assays in haploid yeast strains expressing slal- 
A llS-SIl-m yc  and slal-AG2-myc.
Uptake of the dye Lucifer Yellow was assayed to identify defects in fluid phase endocytosis in 
wild-type (KAY302), Aslal (KAY300), slal-A511-811-myc (KAY367) and slal-AG2-myc 
(KAY387) strains.
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3.2.6 The sequence of Slalp suggests multiple NLSs and NESs
Slal-AG2-myc localises predominantly to the nucleus, while slal-A 118-511- 
myc demonstrates a decrease in nuclear co-localisation, as shown previously (section 
3.2.3). In order to determine the mechanism of nuclear entry of Slalp, the amino acid 
sequence of Slalp was examined for the presence of known nuclear localisation signals 
(NLSs) and nuclear export signals (NESs). The Slalp sequence contained six regions 
with significant homology to known NLS, and two regions with a high degree of 
homology to known NES. Regions were identified by motifs scanning at 
http://mvhits.isb-sib.ch/cgi-bin/motif scan. Three of the potential NLSs identified 
displayed similarity to monopartite NLSs, characterised by a short stretch (5-20 
residues) of basic amino acids (Dingwall and Laskey, 1991). The remaining three NLS 
regions showed similarity to bipartite NLSs, which are composed of two short stretches 
of basic amino acids separated by a linker sequence. Two regions were also identified 
that showed significant homology to leucine rich NESs. The localisation of the residues 
forming these potential signal sequences in Slalp are shown in figure 3-10. NLSs are 
generally recognised and imported by the importin a and importin p homologues in 
yeast, Kap60p/Srplp and Kap95p/Rsllp respectively. While Kap95p/Rsllp can import 
cargo directly, Kap60p/Srplp requires Kap95p/Rsllp to cross the NPC, forming a 
Kap60p/Srplp-Kap95p/Rsllp complex following identification of an NLS. Signal 
mediated nuclear import is not however exclusively carried out by Kap60p/Srplp and 
Kap95p/Rsllp, and many Kap95p/Rsllp isoforms exist in yeast which mediate the 
uptake of specific molecules. Leucine rich NES sequences are thought to be primarily 
recognised by, and exported by the Crmlp exportin protein in S. cerevisiae (for review 
see Jans et al, 2000). Identification of these sequences suggests a mechanism for the 
uptake and export of Slalp from the nucleus
The loss of several potential NLS or NES motifs in the slal mutants, sla l-A l 18- 
511 and slal-AG2 is demonstrated in figure 3-10. Specifically, five potential nuclear 
import signals are lost in the slal-A188-511 mutant, while one potential nuclear import 
signal and both nuclear export sequences are lost in the slal-AG2 mutant.
1 0 0
695-701 801-809
1 8 70 170 1244 aa353 415 501
□ □ □ Slalp
265-270
353-357 416-433
589-593
□ □ Sla1-AR1
□ □ Sla1-AG2
Figure 3-10. Slalp contains several potential NLS and NES motifs, several of 
which are lost in the slal-A l 18-511 and siaI-AG2 mutants. The location o f SH3 
domains (red), HDl and HD2 domains (grey) and the C-terminal repeats region (blue) 
in slal-A I I8-511 and slal-AG2 mutants is demonstrated. Possible NLS and NES sites 
identified by analysis o f the protein sequence are shown as small boxes shown at the 
appropriate location in the protein. Black boxes represent the location o f monopartite 
NLSs, green represents Bi partite NLSs and yellow demonstrates possible NESs. The 
residues numbers at which these motifs are located are also shown.
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3.2.7 Characterisation of karyopherin mutants
Following the identification of several potentially functional NLSs and NESs in 
the Slalp sequence (section 3.2.6) and the abnormal localisation of the slal-A l 18-511- 
myc and slal-AG2-myc mutants (section 3.2.4), mechanisms which may control the 
nuclear translocation of Slalp were examined. In order to determine whether a specific 
karyopherin protein mediated nuclear translocation of Slalp, several karyopherin and 
nucleai’ transport mutants were studied, as listed in table 3-2. These strains were a 
generous gift from Dr Paul Ko Ferrigno (University of Cambridge). 14 p-karyopherins 
and 1 a-karyopherin have been identified in yeast (for review see Mosammaparast and 
Pemberton, 2004). 11 karyopherin mutants are examined here. Additionally, 
prp20/srml and rnal mutants are examined. PRP20/SRM1 and RNAl encode the yeast 
RanGEF and RanGAP respectively. The small GTPase Ran is crucial to the nuclear 
transport process, existing predominantly in the GTP bound form in the nucleus and in 
the GDP bound form in the cytosol due to the action of nuclear Prp20p and cytosolic 
Rnalp. Ran is a highly conserved protein which is essential for cell viability. Interfering 
with the cyclic nature of Ran has been shown to produce many pleiotropic phenotypes, 
due in part to the role of Ran in nuclear transport, but also due to the role of Ran in 
other cell processes (for review see Sazer and Dazzo, 2000).
Nuclear transport mutants were examined by rhodamine phalloidin staining for 
visualisation of F-actin structures and identification of actin cytoskeletal abnormalities 
(section 2.7.3), and lucifer yellow uptake (section 2.7.4), to assess fluid phase endocytic 
defects. In each strain over 200 cells were examined by rhodamine phalloidin staining, 
while lucifer yellow uptake assays were performed in triplicate and over 200 cells 
examined in each strain. Results of these assays are summarised in table 3-2. Mutation 
of the RanGAP and RanGEF, Prp20p/Srmlp and Rnalp produced significant 
depolarisation of the actin cytoskeleton but did not affect fluid phase endocytic uptake. 
Actin defects were identified in all mutants examined with varying degrees of severity.
Strains for further study were selected on the basis that mutation of proteins 
involved in the normal localisation of Slalp may cause actin and endocytic defects, as 
seen in Aslal and slal mutant strains. Strains selected contained mutations in the 
CRMl/XPOl, RSLl and SRPl genes (strains KAY616, KAY610 and KAY607 
respectively). Uptake of the dye lucifer yellow was defective in 100% of srpl-1 and 
crml/xpol mutant cells examined, while 60% of rsll-1 mutant cells showed defects in
1 0 2
fluid phase endocytosis (table 3-2 and figure 3-11). Images demonstrating the results of 
rhodamine phalloidin straining performed on these mutants are shown in figure 3-11.
Mutation KAY
number
% with 
actin defect
Defects identifîed Endocytic defect
kapJ23 608 7.1 Enlargement of cells 
Depolarisation 
Some multibudding
decreased uptake 
Fragmentation of 
vacuoles
losl 615 27 Enlargement of dividing cells 
and depolarisation
No
lph2 609 8.9 Depolarisation No
msnS 614 2 Polarisation defects No
mtrlO 613 6 Enlargement of dividing cells 
and depolarisation
No
nmdS 619 8.5 Depolarisation in budding 
Enlargement of dividing cells
No
pip20/srml 622 27 Enlarged of cells 
Depolarisation
No
psel 621 25.6 Elongated budding cells Some 
multibudding
No
rnal 606 2.5 Depolarisation No
rsll 610 3 Polarisation defects 40% no defect 
60% defective
srpl 607 5.4 Polarisation defects, some 
enlarged unbudded cells
100% defective
sxml 620 2.9 Depolarisation No
wild-type 617 3.6 Polarisation defects No
xpol/crml 616 38 Polarisation defects 100% defective
Table 3-2 Phenotypic analysis of karyopherin and nuclear transport mutants
Rhodamine phalloidin staining and lucifer yellow uptake assays were performed the nuclear
transport mutants listed. PRP20/SRM1 and RNAI encode the yeast RanGEF and RanGAP 
respectively. All other mutants listed encoded known yeast karyopherins. Assay results are 
summarised in the table. The gene mutated is listed in the first column, strain identifiers are 
listed in the second column, while assay results for actin phenotype (columns 3 + 4) and 
endocytic uptake (column 5) are also listed.
Mutation of XPOl/CRMl, the gene encoding the general yeast exporter
Crmlp/Xpolp, produced severe defects in both actin organisation and fluid phase
endocytosis. This was perhaps unsurprising due to the variation and number of
molecules which Crmlp is known to export from the nucleus. Deletion of CRMl/XPOl
is lethal, while mutation of the protein has been shown to produce severe phenotypic
defects. Severe endocytic defects were also seen in srpl and rsll mutants. In addition,
each of these strains also displayed defects in polarisation of the actin cytoskeleton.
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W i l d - t y p c  ,
crml/xnol
Figure 3-11. Three karyopherins mutants displayed distinct endocytic and actin defects.
Lucifer yellow uptake assays and rhodamine phalloidin staining was performed on wild-type 
(KAY302) rsll (KAY610), srpl (KAY607) and crmUxpol (KAY616) mutant strains. A) 
Images obtained from lucifer yellow uptake assays B) Images obtained from rhodamine 
phalloidin staining.
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3.2.8 Generation of Slal-myc in specific karyopherin mutant strains
Following the identification of karyopherin mutants which displayed marked 
endocytic and actin defects, and with reference to data showing the conelation of 
mislocalised sla l-A l 18-511-myc and slal-AG2-myc (section 3.2.4) with defects in fluid 
phase endocytosis (section 3.2.5), I proposed that Slalp may also mislocalise in these 
karyopherin strains. Three karyopherin mutant strains, crm l/xpol, rsll and srpl 
(KAY616, KAY610 and KAY607 respectively) were examined for localisation of 
Slalp. To examine the localisation of Slalp in these mutants, 13x myc-tagging of Slalp 
was attempted using a PCR product integration method, in both the srpl and rsll 
mutant strains (section 2.4.6). Oligos oKA132 and oKA133 were used to PCR (section
2.3.5) a short sequence of DNA from the pFA6-13xmyc-TRPl plasmid, which contains 
a region encoding a 13x myc-tag and a selectable TRP marker, integration of which 
would allow cells to grow on drop-out tryptophan media. Oligonucelotides were 
designed to amplify the TRP marked myc-tagging cassette so as to allow specific 
integration of the product at the C-terminus of the genomic SLAl gene, by homologous 
recombination. Using this method Slalp was myc-tagged in the rsll mutant strain 
(KAY610). Myc-tagging of Slalp in the srpl strain was not however achieved, as the 
tagging cassette consistently integrated at incoiTect sites in the genome of this strain.
Localisation of Slal-myc in a crml strain was performed using a 
previously generated strain, KAY 444 (K. Ayscough unpublished work). The CRMl 
gene is required for viability in S. cerevisiae. This strain therefore carried a plasmid 
copy of CRMl to maintain viability in a crml genomic deletion strain. This strain also 
contained genomically tagged Slal-myc. The action of plasmid borne Crmlp was 
inhibited by cell growth in the presence of the potent cytotoxin Leptomycin B (Fornerod 
et al, 1997; Fukuda et al, 1997). Data suggests that Leptomycin B acts by blocking the 
formation of Crml p/car go/RanOTP nuclear export complex by interaction with Crmlp 
(Daelemans et al, 2005).
105
3.2.9 Slalp mislocalisation in an rsll mutant
Expression of myc-tagged Slalp was verified in the rsll mutant (KAY610) by 
Western blot analysis with anti-myc antibodies. Identification of a band at 190 KDa in 
this mutant suggested specific integration and expression of myc-tagged Slalp (figure 
3-12). Myc tagging allowed localisation of Slal-myc in this rsll mutant strain. To 
examine the localisation of slal-myc in this rsll mutant, the strain was cultured into 
log-phase growth, and was then processed for immunofluorescence with anti-myc 
antibodies (section 2.7.2). Fluorescence was predominantly seen in the cytoplasm with 
no significant nuclear accumulation of Slal-myc (figure 3-13). The cytoplasmic 
fluorescence identified small, punctuate structures in the cell cortex, suggesting that the 
cortical localisation of Slalp-myc is unaffected in this mutant, however nuclear 
accumulation was lost in all cells examined.
Rsllp (Kap95p) is the homologue of mammalian Importin p i. P-karyopherins 
can identify and transport cargo directly following NLS recognition. Rsllp is however 
also known to import cargo in conjunction with the adaptor protein Srpl p. Srplp 
(Kap60p) is the homologue of mammalian Importin a and identifies and binds to cargo 
molecules containing classical and bipartite NLSs. Srplp and bound cargo then form a 
complex with Rsllp (Kap95p), which is only then actively imported into the nucleus. 
Following import, cargo and importins dissociate and the importins are recycled back to 
the cytosol to continue functioning as importing transport receptors (for review see 
Yoneda, 2000).
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Figure 3-12. Expression of myc-tagged Slalp in an rsll mutant as determined by 
western blotting. An immunoblot of total cellular extracts from: Lane 1 ) wild type 
cells (KAY 302), Lane 2) a Slal-myc strain (KAY303) and Lane 3) rsll mutant strain 
(KAY610) which expresses Slal-myc. Blots were probed with anti-myc A -14 primary 
antibodies. Molecular weight markers (KDa) are also shown on the left of the image.
rsll slal-myc DAPI
Figure 3-13. Slalp-myc is mislocalised in an rsll-1 mutant. Localisation of myc- 
tagged Slalp in rsll mutant strain (KAY610) was performed by immunofluorescence 
with anti-myc antibodies.
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3.2.10 Mutation of crml does not affect the nuclear localisation of Slalp
To examine the localisation of Slal-myc in the crm l/xpol mutant strain (KAY 
444), the strain was cultured into log-phase growth in drop-out leucine synthetic media 
to retain the CRMl encoding plasmid during growth. Cells were then resuspended in 
drop-out leucine media containing Leptomyocin B at a working concentration of 
lOOng/ml for two hours to inhibit the formation of Crmlp nuclear export complexes. 
Cells were then processed for immunofluorescence with anti-myc antibodies. 
Fluorescence images obtained are shown in figure 3-14. The immunofluorescence 
pattern demonstrates a punctate cortical fluorescence, suggesting that the localisation of 
Slalp-myc to cortical sites is unaffected. Due to the effects of Crmlp inhibition, cortical 
actin patches do not however polarise correctly in this strain (K.Ayscough unpublished 
data). Fluorescence is also seen to accumulate and co-localise with the nucleus in this 
strain. Slalp-myc localisation therefore appeals unaffected by Crmlp inhibition.
Crmlp/Xpolp is a general exporter of cargo from the nucleus in S. cerevisiae. 
Crmlp/Xpolp homologues are known to be involved in export of various proteins 
including: mRNAs, ribosomes and snRNAs (Jans et al, 2000), and while less studied in 
yeast, this broad substrate specificity of Crmlp is thought to be retained. Crmlp 
recognises cargo by identification and interaction with leucine rich NESs present in 
cargo molecules.
108
crml/xpol slal-myc DAPI
#
Figure 3-14. Slalp-myc localisation in a crml mutant.
Localisation of Slal-myc in the crml mutant strain (KAY444) was preformed by 
immunofluorescence using anti-myc antibodies. Crmlp activity was inhibited by growth of the 
strain in synthetic media containing Leptomyocin B for 2 hours.
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3.2.11 Microarray analysis of gene expression in wild-type and Aslal cells
Identification of nuclear Slalp and the identification of a potential nuclear 
import mechanism raise many questions as to the possible function of nuclear Slalp. An 
investigation into the function of nuclear Slalp was therefore undertaken. Several 
possibilities for Slalp accumulation in the nucleus exist. Nuclear accumulation of the 
protein could be a regulatory mechanism, controlling the cytoplasmic action of the 
Slalp and rendering the protein inactive by sequestering to the nucleus. Equally, Slalp 
may be retained in the nucleus by direct interaction with a nuclear protein, and may 
have a structural or transcriptional role in the nucleus. A nuclear role for the Slalp is 
plausible, particularly in light of data detailing the existence of actin and many other 
actin regulating proteins in the nucleus. As with the cytoplasmic role of Slalp, the 
potential for Slalp to play several overlapping roles in the nucleus was also considered.
MicroaiTay analysis is a relatively new technique which provides invaluable data 
on levels of gene expression. Such data can be used to elucidate both signalling 
pathways and the mechanistic function of molecules. Total cellular RNA is first isolated 
from a strain of interest, from which biotin labelled cRNA probes are generated. Probes 
are then used to hybridise and label oligonucleotide anays which contain short 
oligonucleotides sequences from genes spanning the entire genome of the species of 
interest. Several control oligonucleotides are also present and are used for normalisation 
of results. By comparing the hybridisation levels of probes to individual 
oligonucleotides, changes in gene expression levels can be compiled when compared to 
other strains.
Microarray analysis of a slal deletion mutant (KAY300) was performed. For 
analysis and comparison of gene expression levels, a wild-type strain (KAY302) was 
selected due to having a congenic genetic background, opposing mating type and having 
undergone prior cellulai' analysis. Yeast GeneChip® Arrays were used (Affymetrix). 
Total RNA was prepared in triplicate from each strain as described in section 2.9.1. 
Quantification and quality checks were then performed on each preparation (section 
2.9.2) and this starting material used to generate double stranded cDNA (Section 2.9.4) 
Biotin labelled cRNA was produced directly from these cDNA preparations (section 
2.9.5 - 2.9.6), and was then quantified (sections 2.9.7) and fragmented (section 2.9.8) in 
preparation for hybridisation to Genechip® Arrays (section 2.9.9).
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The analysis and the normalisation of microarray data is a highly specialised 
technique. Analysis of this data was therefore kindly performed for us by Dr Pawel 
Herzyk at the Sir Henry Wellcome Functional Genomics Facility (SHWFGF) in the 
University of Glasgow. As hybridisations were performed in triplicate for each strain, 
data from six arrays was normalised using SAM (Significance Analysis of Microarrays) 
software. SAM uses a statistical technique to finding significant gene expression 
changes in a set of microarray experiments (Tuscher et al, 2001). 95 gene identifiers 
were selected using this software. These genes showed a significant change in 
expression level between the wild type and slal deletion strain. A false positive rate of 
1 % was chosen to limit both the number of genes identified and possible errors. Of 
these 95 genes, 9 duplicates were removed; identified through recognition of different 
oligonucleotides derived from the same gene. A further 18 genes specific to mating type 
were also removed from our analysis. Of the 68 genes remaining, the expression of 39 
was significantly upregulated in the Aslal strain, while the expression of 29 was 
significantly downregulated. Results are shown in table 3-3 and are summarised in 
figure 3-15. The URA3 gene shows the largest upregulation. This gene serves as an 
excellent control, as the SLAl gene was disrupted by integration of URA3. Equally, 
downregulation of SLAl is also identified in our analysis.
Effects on gene expression may be direct or indirect following the loss of a 
specific protein. For this reason microarray results require further experimental 
exploration before specific interactions or signalling events are conclusively identified. 
Several membrane transporters were however noted to be downregulated in the Aslal 
strain. SLT2 expression was also upregulated by 2.8 fold in the Aslal strain. SLT2 
encodes Slt2p, a constituent of the cell integrity MAP kinase pathway. This pathway 
involves the activation of Pkclp signalling, which is activated by R holp in a GTPase 
dependent manner. Slt2p activates the heterodimeric transcription factor, SBF, which 
promotes expression of SBF targets, including cell wall biosynthesis genes during the 
G 1/S transition of the cell cycle. Slt2p is also known to activate the transcription factor 
Rlm lp (Jung and Levin, 1999, Zu et al, 2001). WSC4 plays a role the environmental 
stress response pathway and is required for viability of yeast cells under heat stress 
conditions (Verna et al, 1997; Zu et al, 2001). WSC4 is also significantly 
downregulated.
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Table 3-3A; Genes upregulated in Aslal strain (KAY300) as identified by SAM analysis
F o ld  c h a n g e N a m e O R F R o le
19.86 URA3 YEL021W Pyrim idine base biosynthesis
11.20 PRM8 YGLOSBw M em brane protein
6 .49 YBR056W U nknow n
5 .36 MST27 YGL051W V esic le  formation and organisation, G olg i and ER membrane protein
5 .22 PRM5 YILI17C Plasm a membrane protein, cell integrity signalling
4 .09 CWPl YKL096W C ell w all protein, cell wall organisation
3 .78 YPS4 YLR12IC Endopeptidase (protein m etabolism )
3 .77 DIAl YMR316W C ytoplasm ic protein
3 .44 MCH5 YOR306C M em brane transporter
2 .79 SLT2 YHR030C M ap  k in ase
2 .72 CMK2 YOL016C C alm odulin dependent protein kinase, am ino acid phosphorylation
2 .64 LSRI NLT026C N uclear m R N A  splicing
2 .58 YGL052W U nknow n
2 .49 YOR385W U nknow n
2.48 YLR152C U nknow n
2 .45 YÎL023C U nknow n
2.41 YBR005W U nknown
2 .34 YNL208W U nknow n
1.99 DFG5 YMR238W C ell w all biosynthesis, plasm a m em brane localised
1.98 YDL027C U nknow n
1.95 YETI YKL065C Endoplasm ic reticulum  protein
1.92 ASG7 YJL170C Expression increased by alpha factor
1.90 YAL053W U nknow n
1.87 RTS3 YGR161C Protein phosphatase, type 2A  activity
1.86 PPM l YDR435C Carboxyl m ethyl transferase, am ino acid m éthylation
1.86 ARP2 YDL029W C om p o n en t o f  A rp 2 /3  com p lex
1.85 RKBl YCR036W A T P binding -  ribokinase activity
1.78 YER163C U nknow n
1.78 YIL108W U nknow n
1.78 CRGl YGR189C C ell wall g lycosidase
1.71 RODI YOR018W Plasm a m embrane protein, contains a PY  m otif
1.70 GTT2 YLL060C Glutathione S-transferase, glutathione m etabolism
1.69 APM4 YOLX)62C C om ponent o f  A P -2 adaptor com plex
1.67 SAM2 YCR502C M ethionine m etabolism
1.67 YGR259C U nknow n
1.65 CMP2 YML057W C ytoplasm ic C a2+ dependent serine/threonine phosphatase
1.60 YER034W Unknow n
1.49 YPKl YKL126W S er ln e /th r eo n in e  p ro te in  k in ase . E n d o cy to sis  an d  sp h in g o lip id  
m eta b o lism
1.46 YLIJ058W U nknow n
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Table 3-3B: Genes downregulated in the ISslal strain (KAY300) as identified by SAM analysis
Fold change Name ORF Role
29 .49 SLAl YBL007C Involvem ent in endocytosis and actin regulation
13.13 YLR040C U nknow n
8.49 PH084 YML123C Phosphate transporter
6.17 MDH2 YOL126C M alic enzym e, m etabolism
4.95 YNL034W Unknow n
4.85 YCL065W Unknow n
3.97 GGA2 YHR108W Golgi to vacuole transport
3 .59 URAl YKL2I6W Pyrim idine nucleotide biosythesis
3 .56 RIB4 YOL143C Vitam in B 2 b iosynthesis
3.35 GAPl YKR039W A m ino acid perm ease, am ino acid transport
3 .14 LEUl YGL009C L eucine b iosynthesis
3.13 URA4 YLR420W Pyrim idine nucleotide biosy thesis
2 .98 YLR126C U nknow n
2 .84 FVIl YBL042C Uridine transporter
2 .66 YBL029W U nknow n
2.55 GATJ YFL021W R N A  Polym erase II transcription
2.51 COS8 YHL048W U nfolded  protein response
2.45 WSC4 YHL028W Transmembrane receptor involved in actin organisation and Rho 
signalling
1.99 SHM2 YLR058C One-carbon com pound m etabolism
1.94 YJL037W Unknow n
1.93 RPRl SCUYLEFT tR N A  processing
1.88 THI7 YLR237W Thiam ine transporter
1.86 TNAl YGR260W N icotinam ide m ononucleotide transport
1.86 MDLl YLR188W A B C  transporter
1.79 HSXl TR(CCU)J Translational elongation
1.77 0PT2 YPR194C O ligopeptide transporter
1.52 YHL026C U nknow n
1.37 YNL181W U nknow n
1.36 TESl YJR019C A cyl-C oA  thioesterase
Table 3-3 Genes identiHed by microarray and SAM analysis.
Following analysis and normalisation of microarray data comparing gene 
expression in wild-type (KAY302) cells with àsla l (KAY300) cells, 68 genes with 
significant changes in expression were identified. A) 39 genes were identified as 
npregulated in à.slal cells. B) 29 genes were identified as downregulated in iS^slal cells. 
Genes of specific interest are highlighted.
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Metabolism Upregulated Genes
GTT2 URA3 l s r i OtherYPS4SAM2 PPM1
ASG7RBK1Signalling DIA1SLT2
RTS3 PRM5
YET1CMK2
YPK1 PRM8
DFG5CMP1
Endocytosis *R P2 GRH1
CWP1APM4
R0D1 YLR152C
YIL023CMST27Vesicle
YGR259C YBR056W
YGL052Wtransport YOR385W
YLL058W YER163C
YIL108WYER034W
YBR005WYAL053W
YNL208WYDL027C
Cell wall 
maintence
Transcription Unknown
Stress response Other
GAT1 SLA1WSG4 RPR1 Downregulated GenesC 0S8OPT2
Membrane HSXlMDL1
transport PH084 TES1
THI7 MDH2
URA4
FUI1 IRAI
MetabolismLEU1GAP1
Vesicle GGA2 SHM2
transport RIB4YNL181W
YHL026C YLR040C
YBL029W YCL065W
YJL037WYLR126C YNL034W
Unknown
Figure 3-15. Graphical display of microarray results showing functional groupings.
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3.2.12 RT-PCR confirmation of microarray data
Following the generation and normalisation of microarray data comparing gene 
expression levels between a wild-type and à^slal strain, a crucial second confirmation 
step was performed to in order to validate these results. Quantitative RT-PCR (real-time 
PCR) is a highly sensitive technique which allows the detection and quantification of 
mRNA levels using only small amounts of RNA. This technique was used to validate 
our microarray data. RT-PCR reactions use cDNA generated from total RNA isolations 
to provide the template for PCR reactions. In this way the amount of PCR product 
generated is dependent on the amount of mRNA transcript present in the RNA isolation. 
RT-PCR was performed using RNA isolated from our wild-type strain (KAY302), 
iS^slal strain (KAY300) and the MATa slal-AG2 strain (KAY382). RNA from the slal- 
AG2 strain was included in this analysis to provide further insight into the effects of 
nuclear accumulation of the mutant protein, demonstrated in section.3.2.4.
RT-PCR was performed using the Titan One Tube RT-PCR System (Promega). 
Template cDNA was first generated from total cellular RNA isolations (section 2.9.1) 
using the Reverse Transcriptase enzyme. Primers specific for the gene of interest were 
then used in PCR reactions, to amplify transcripts from the cDNA templates using Taq 
DNA polymerase (Section 2.9.11). RT-PCR was performed on several control genes 
which included TUBl, as expression was unchanged in our microarray analysis. TUBl 
encodes alpha tubulin, a microtubule component. The STE2 gene was also amplified as 
a control. The YSC84 gene was also amplified as a control as expression of this gene 
was not reported to change significantly between the wild-type and Aslal strains in our 
microarray analysis. Expression of STE2 was reported to increase by 33 fold in our 
Aslal strain, according to microarray analysis. Expression of STE2 is mating type 
specific, as the gene encodes the alpha factor pheromone receptor. STE2 was therefore 
additionally used as a control. RT-PCR was also performed on WSC4, ARP2, YPKl, 
SLT2 and GGA2. Known functions of the proteins encoded by these genes are 
summarised in table 3-4. Products from RT-PCR reactions were analysed by agarose gel 
electrophoresis (Section 2,3.2) (figure 3-16). Images were then quantified using image 
analysis software (NIH Image) (figure 3-17).
Expression of YSC84 and TUBl did not vary significantly between the 
Aslal and wild type strain, with fold changes of 1.12 and 1.02 respectively. These two 
control genes demonstrated slightly higher expression levels in RT-PCR analysis of the
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slal-AG2 strain, potentially due to a maiginal increase in the amount of RNA used 
when performing the slal-AG2 RT-PCR reactions. This was considered upon analysis 
of subsequent slal-AG2 RT-PCR results. Expression of the STE2 gene was increased by 
38.11 fold between the Aslal and wild type strain, similar to the 33 fold increase 
identified by microarray analysis (data not shown). GGA2 was downregulated 2.04 fold, 
and WSC4 downregulated 4.35 fold, while SLT2 was upregulated by 2.26 and YPKl 
upregulated by 1.31 fold between the Aslal and wild type strain, as determined by RT- 
PCR and analysis of agarose gel images. Microarray analysis reported GGA2 to be 
downregulated 3.97 fold, WSC4 to be downregulated by 2.45 fold, while SLT2 was 
upregulated by 2.79 and YPKl upregulated by 1.49 fold between the Aslal and wild 
type strain. While the figures obtained from RT-PCR analysis do not directly correlate 
with the fold-changes reported by microarray analysis, these results do however confirm 
the trend in either upregulation or downregulation of specific gene expression between 
these strains. RT-PCR results from the slal-AG2 strain were therefore interpreted 
cautiously, and were used only as an indicator of the potential regulation of specific 
genes. STE2 upregulation in the slal-AG2 strain confirms the mating type of this slal- 
AG2 strain, while SLT2 expression also appears to be significantly upregulated in this 
strain.
Gene Fold change reported  
by m icroarray
Encoded protein and known function
TUBl n/a Alpha tubulin. Micro tubule component.
YSC84 n/a Cortical patch protein, function unknown.
STE2 33.3 upregulation a-factor mating receptor. Response to mating 
pheromone.
SLT2 2.8 upregulation Map kinase. Involvement in PKCl signalling pathway.
ARP2 1.85 upregulation Subunit of the Arp2/3 complex. Actin nucléation, 
regulation and branching.
YPKl 1.49 upregulation Serine/threonine protein kinase. Modification of 
endocytic proteins.
WSC4 2.45 downregulation Membrane receptor. Involved in cell integrity pathway
GGA2 3.97 downregulation Golgi localised Arf interacting protein. Golgi to vacuole 
transport.
Table 3-4 Genes selected for R T-PC R  analysis.
Known functions of the genes selected for RT-PCR analysis are listed. Changes in gene 
expression, as reported by microarray analysis are also shown in the table. Expression of the 
control genes TUBl and YSC84 were not significantly changed in our microarray analysis.
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A)
2 Kb -
1.5 Kb -
1 Kb “
YSC84 ARP2 STE2 TUB1
Wt A s/at AG2 Wt Aslal AG2 Wt Aslal AG2 Wt Aslal AG2
1 2 3 4 5 6 8 9 10 11 12
B)
2 Kb 
1.5 Kb 
1 Kb
GGA2 SLT2 WSC4 YPK1
wt Aslal AG2 Wt Aslal AG2 Wt Aslal AG2 Wt Aslal AG2
1 2 3 4 5 6 8 9 10 11 12
Figure 3-16. RT-PCR results confirm the trends in gene expression change identified by 
microarray data. To assess changes in gene expression of specific genes RT-PCR was 
performed using RNA from both wild-type cells (KAY 302)(lanes 1,4,7+10), SLAl deletion 
cells (KAY 300) (lanes 2,5,8+11) and slalAG2 cells (KAY382) (lanes 3,6,9+12). Primers 
specific for the genes, YSC84, ARP2, STE2, YPKl, GGA2, SLT2, WSC4 anàYPKl were used 
in these reactions. (A) Agarose gel showing products from YSC84 amplification (Lanes 
1,2+3), ARP2 amplification (Lanes 4,5+6), STE2 amplification (lianes 7,8+9) and TUB! 
amplification (Lanes 10,11 + 12). (B) Agarose gel showing products from GGA2 amplification 
(Lanes 1,2+3), SLT2 amplification (Lanes 4,5+6), WSC4 amplification (Lanes 7,8+9) and 
YPKl amplification (Lanes 10,11+12).
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RT-PCR fold change In Aslal a s  determined using by NIH Image software
38.11
4 ■ -
3 -
2.26
1.31
1 ■ -
0 -,
YSC Sr  ^TUBl A R P2 STE2 SLT2 WSC4 YPK l
- 1.02- 1.12
-2.04
-4.35
Genes of interest
Figure 3-17. Fold changes in gene expression as identified by RT-PCR.
Analysis o f agarose gels images o f specific RT-PCR products using NIH Image 
analysis software. The results shown demonstrate the fold change in product 
amplified from s la là  (KAY300) RNA compared to product from wild-type 
(KAY302) RNA.
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3.3 Discussion
Slalp is known to act as a multifunctional adaptor protein at the cell cortex, with 
roles in the regulation of endocytic and actin regulating proteins. Slalp is required for 
the normal organisation of the cortical actin cytoskeleton in budding yeast (Holtzman et 
al, 1993), which has recently been shown to be intimately linked to endocytic uptake. 
Slalp localises to a subset of cortical patches which partially co-localise with actin 
patches (Ayscough et al, 1999). In this chapter however, I investigate the localisation of 
Slalp to the nucleus. Based on experimental results to date, a direct interaction between 
Slalp and a nuclear protein has yet to be shown. Progress has however been made in the 
study of nuclear Slalp, by determining the import mechanism of S lalp and by studying 
the effect of gene deletion on genome-wide gene expression.
In this study Slalp was shown to localise to the nucleus in S. cerevisiac. As 
demonstrated by myc-tagging of the protein, Slalp shows a diffuse co-localisation with 
nuclear DAPI fluorescence, in addition to its previously reported co-localisation with 
cortical patches (section 3.2.1). Nuclear accumulation of Slal-myc was unaffected by 
the cytoplasmic remodelling of actin and additional adaptive cellular responses which 
occurred during induction of the heat shock and mating response pathways, and during 
cell cycle progression. Cdc24p, the guanine nucleotide exchange factor for Cdc42p is 
known to export from the nucleus in response to induction of the mating response and 
during bud development, at which point it is known to activate the actin regulating Rho 
GTPase Cdc42p at sites of cell growth (Nern and Arkowitz, 2000). Nuclear Slalp 
however does not response in a similar manner.
Analysis of the slal-A 118-511-my c deletion mutant (section 3.2.4), 
demonstrated the importance of residues 118-511 of Slalp in the localisation of the 
protein to the nucleus. Deletion of these residues caused a decrease in nuclear co­
localisation of slal-A 118-511-myc but did not affect the localisation of the protein to 
cortical patches. Previous characterisation has shown that residues 118-511 of Slalp are 
critical for the actin regulating abilities of Slalp, with rhodamine phalloidin straining of 
a slal-A118-511 mutant showing fewer, and enlarged cortical actin patches (Ayscough 
et al 1999). This phenotype is similar to that seen in I5slal cells, which have 
additionally been shown to demonstrate an increased resistance to Latrunculin-A, 
suggesting that the actin in these cells is less dynamic. Slal-A118-511-myc is able to 
localise to patch structures at the cell cortex. These patches do not however co-localise
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with the aberrant actin structures associated with this mutant (Gourlay et al, 2003). 
Slal-A 118-511-myc therefore retains the ability to localise to the cell cortex and is 
partially functional, as it has previously been shown to rescue the Abplp dependence 
associated with slal deletion (Gourlay et al, 2003).
Analysis of endocytic uptake in the slal-A 118-511-myc mutant demonstrated 
that fluid phase endocytic uptake is only marginally defective in a slal-A 118-511-myc 
strain (section 3.2.5). 2-hybrid analysis has shown that residues 118-511 of Slalp 
interact with the central coiled-coil region of the Sla2p. This interaction has been 
confirmed biochemically (Gourlay et at, 2003). Studies suggest that Sla2p recruits the 
actin cytoskeleton to sites of endocytosis via interaction with Slalp (Gourlay et al, 
2003; Kaksonen et al, 2003). In support of this, in both a slal deletion strain and a 
strain expressing slal-A l 18-511, Sla2p is mislocalised; retaining a cortical localisation 
which does not significantly overlap with the aberrant actin structures seen in these cells 
(Ayscough et al, 1999; Gourlay et al, 2003), This data suggests that deletion of this 
region of Slalp severs the link between Sla2p actin, blocking recruitment of actin to 
endocytic sites. Our study of the sla l-A l 18-511-myc mutant confirms a decrease in 
endocytic uptake, concurrent with this model. Levels of endocytosis in this mutant are 
however above that seen in the JSslal strain. In Aslal cells a significant reduction, but 
not total loss of endocytic uptake has been reported (Warren et al, 2002) and this 
observation has been confirmed in this study (section 3.2.5). Actin is less dynamic in 
Aslal cells as demonstrated by Latrunculin-A assays, however the demonstration of low 
levels of endocytic uptake in Aslal and slal-A 118-511 strains suggests that the enlarged 
actin ‘chunks’ seen these cells may still be partially dynamic, allowing endocytosis to 
proceed at a reduced level. The increased uptake seen in the slal-A 118-511 mutant 
when compared to Aslal suggests that while regulation of actin and interaction with 
Sla2p is lost in this mutant, the C-terminal regions of Slalp may continue to promote 
endocytosis through C-terminal interactions.
Analysis of the localisation of the slal-A l 18-511-myc mutant revealed a 
significant decrease in the nuclear localisation of the mutant protein of approximately 
80%, as determined by image analysis software when compared to wild-type cells 
(section 3.2.4). Decreased nuclear accumulation of slal-A 118-511-myc suggests that 
residues 118-511 are critical for the nucleai' localisation of Slalp. Loss of this region 
may either prevent nuclear uptake of the protein or may prevent a nuclear interaction 
which normally retains the protein in the nucleus. These observations lead to an 
investigation of the mechanism of Slalp uptake into the nucleus. Subsequent
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investigation and sequence analysis identified several potential NLSs between residues 
118-511 of Slalp (section 3.2.6). The loss of these NLSs may prevent uptake of slal- 
A l 18-511-myc into the nucleus due to loss of cargo recognition by karyopherins. 
Analysis of several karyopherin mutants was undertaken to determine the mechanism of 
nuclear translocation of Slalp. Studies demonstrated that nuclear uptake of Slal-myc 
was lost in an rsll mutant (section 3.2.9), suggesting that the nuclear entry of Slalp is 
mediated by Rsllp. This protein is able to recognise cargo directly for nuclear 
translocation or in conjunction with the nuclear transport receptor, Srplp. Due to 
recognition of NLSs by Rsplp and Srplp, one of the five NLSs identified between 
residues 118-511 is likely to mediate the nuclear translocation of Slalp. Identification of 
the active NLS or NLSs however requires further investigation.
Analysis of the slal-AG2-myc mutant strain was also undertaken (section 3.2.4 
and 3.2.5). Partial deletion of the Gap2 region from residues 507-1008 caused a 
substantial increase in the nucleai* accumulation of slal-AG2-myc. Actin staining 
appeared similar to wild-type in these cells, as has been previously reported for a slal - 
AG2 strain (Ayscough et al, 1999). This lack of actin defect suggests that a low level of 
slal-AG2-myc is functioning in actin regulation at the cell cortex and that this protein 
interacts with Sla2p, allowing recruitment of actin to endocytic sites. The slal-AG2- 
myc strain however displays a reduction in endocytic uptake comparable to that seen in 
Aslal cells. A potential mechanism for this endocytic inhibition is the abrogation of the 
ability of slal-AG2 to dissociate from endocytic complexes in the cytosol. Previous data 
has shown that the unphosphorylated form of Slalp integrates into a trimeric 
Slal/End3/Panl complex at the cell cortex, the dissociation of which is regulated by 
phosphorylation of Pan Ip and Slalp (Zeng et al, 2001). Endocytic defects have been 
previously reported following overexpression of GST-Slal-118-511 (Gourlay et al,
2003), a mutant which lacks the C-terminal repeat region thought to undergo 
phosphorylation by Prklp (Zeng et al, 2001). Slal-118-511 is thereby predicted to be 
unable to dissociate from this endocytic trimeric complex. C-terminal Panlp 
phosphorylation motifs are however present in the slal-AG2-myc mutant, suggesting 
that slal-AG2-myc undergoes phosphorylation. Deletion of domains in close proximity 
to the phosphorylated region may however interfere with the function of the 
phosphorylated form of slal-AG2-myc.
Sequence analysis of the region removed in the slal-AG2 construct which 
encompasses residues 507 to 1008 of Slalp, identified one potential bi-partite NLS and 
two potential NESs. The loss of these NESs would correlate with the nuclear
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accumulation of slal-AG2-myc, by blocking nuclear export of the mutant protein 
(section 3.2.6). Analysis of a crml/xpol karyopherin mutant, which encodes the general 
yeast exporter Crmlp/Xpolp and which recognises and transports cargo containing 
leucine rich NLSs, did not however affect Slalp localisation (section 3.2.10). Export of 
Slalp may therefore be mediated by other yeast exportins. Some karyopherins are 
known to function bidirectionally; for example Msn5p which has been shown to export 
multiple proteins including Farlp, M iglp and Pho4p (Blondel et al, 1999; Devit and 
Johnston, 1999; Kaffman et al, 1998) while also mediating import of the trimeric 
replication protein A (Yoshida and Blobel, 2001). Further analysis of both importins 
and exportins may therefore identify the karyopherin(s) mediating Slalp export, as 
nuclear accumulation of the slal-AG2-myc suggests Slalp cycles through the nucleus.
Our studies suggest that Slalp localises both to the cytosol and the nucleus in 
yeast. An interesting possibility is that activity and cellular localisation of Slalp may be 
regulated primarily through its state of phosphorylation. Regulation may occur in a 
similar manner to Slt2p, whereby phosphorylation promotes nuclear entry and activity 
of the protein. Phosphorylation of proteins involved in actin regulation and endocytosis 
is mediated by members of the Aik/Prk serine/threonine family of protein kinases (for 
review see Smythe and Ayscough 2003). Slalp has several potential Prklp 
phosphorylation motifs found in the carboxy-terminal repeat region of the protein (Zeng 
et al, 2001). Previous data from this lab has determined 4 modified forms of Slalp by 2- 
Dimensional gel analysis, suggesting modification as a mechanism of protein regulation 
(Derek Warren and Campbell Gourlay, unpublished data). In addition, Slalp has been 
reported to interact with Glc7p, the catalytic subunit of protein phosphatase 1 (PPl), a 
major serine/threonine protein phosphatase, by yeast 2-hybrid analysis (Venturi et al, 
2000). Déphosphorylation of endocytic proteins has been previously shown to involve 
Scd5p, a protein which partially co-localises with cortical actin patches and which 
interacts with Glc7p (Chang et al, 2002). Scd5p may be involved in targeting Glc7p to 
substrates that require dephosphorylation in order to regulate actin and endocytosis. 
Prklp additionally negatively regulates Scd5p by phosphorylation (Henry et al, 2003), 
providing a mechanism for control of ScdSp recruitment of Glc7p to cortical patches. 
Slalp may therefore be phosphorylated by the action of Prklp and dephosphorylated by 
PPl recruitment. Phosphorylation has been proposed as the mechanism of regulation for 
nuclear entry of a number of actin binding proteins, including cofilin (Ohta et al, 1989). 
Nuclear entry of the actin binding protein cofilin has been shown to be linked to the 
phosphorylation state of the protein, with dephosphorylated cofilin being transported
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into the nucleus following DMSO treatment or heat shock. Based on our data and 
previous findings, a mechanism for Slalp regulation and nuclear entry is proposed in 
figure 3-18.
Progress has also been made in the investigation of a potential nuclear role of 
nuclear Slalp. Microarray analysis of total RNA from wild-type and Aslal cells was 
performed to in order to identify transcriptional effects of slal deletion. Our results 
demonstrate significant changes in the expression of 69 genes following slal deletion 
(section 3.2.11). Variable gene expression may be caused by a variety of mechanisms 
following gene deletion, including loss of direct interactions made by the protein, 
dysregulation of signalling cascades or adaptive changes in expression, promoted in 
order to counteract protein loss. Seven membrane transporters have been identified as 
being downregulated in the Aslal strain. These receptors are Opt2p, Pho84p, Thi7p, 
Tnalp, Fui Ip and Gaplp. Previous reports have shown that Aslal cells fail to undergo 
normal cell cycle aiTest in response to nutrient starvation (Care et al, 2004). This 
inability to respond to nutrient starvation may be a consequence of the downregulation 
of membrane transporters in this strain and an inability to sense nutritional deficiencies 
in the surrounding environment. Many additional actin and endocytosis mutants 
including end3A, rvslôlA , vrplA, and sla2A (Care et al, 2004), also do not undergo this 
cell cycle arrest, during which preparation to survive nutrient limitation and other 
adverse environmental conditions occurs. Slalp may therefore be involved directly or 
indirectly in the regulation of transcription of membrane transport receptors.
Upregulation of SLT2, ARP2 and YPKl occurs in slal deletion cells. Arp2p is a 
component of the actin nucleating and filament branching complex Arp2/3. Slt2p is a 
component of the cell integrity MAP kinase pathway. Phosphorylated Slt2p is known to 
dimerise and enter the nucleus, activating the transcription factor SBF and expression of 
SBF targets, which include genes involved in cell wall repair. SLAl deletion induces 
upregulation of SLT2, potentially either by mislocalisation of Rho Ip or by defects 
endocytic uptake, and therefore potentially in response to cell wall damage (Ayscough 
et al, 1999). Mislocalisation of Rho Ip and aberrant cell wall synthesis may therefore 
promote SLT2 upregulation, or potentially nuclear Slalp may regulate gene 
transcription directly. Ypklp is a serine/threonine protein kinase which has a role in the 
cell wall integrity pathway. Deletion of ypkl has been shown to cause depolarisation 
and enlargement of cortical actin patches and temperature sensitivity, a phenotype 
which was rescued by growth of cells in the presence of sorbitol, an indication of cell 
wall integrity defects (Roelants et al, 2002; Hampsey, 1997). Slal deletion and cell wall
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Figure 3-18. Proposed mechanism for Slal entry into the nucleus. Phosphorylation and 
dephosphorylation of Slalp, mediated by Prkl and a phosphatase such as Glc7p is 
proposed to regulate the localisation of Slal. Translocation into the nucleus is mediated by 
the nuclear transport receptor Rsllp, possibly in conjunction with Srplp. Nuclear entry 
occurs by an undefined mechanism but is thought to require specific NLSs in the Slalp 
sequence. Dephosphorylated Slalp forms a trimeric complex with End3p and Panlp, 
which localises to endocytic sites. Phosphorylation of Slalp may therefore specify nuclear 
uptake.
124
defects therefore appear to be intimately linked. This may be due to a lack of 
Slalp at the cell cortex or due to transcriptional effects cause by slal deletion. In 
addition, downregulation of GGA2 and WSC4 is also shown. Gga2p is involved in Golgi 
to vacuole transport while Wsc4p is thought to play a role in the cell wall integrity 
response pathway.
This study has not defined a specific role for nuclear Slalp. It should be 
considered however that nuclear Slalp may continue to regulate actin in a nuclear 
structural role. Studies have provided mounting evidence of actin, actin regulating 
proteins and actin related proteins in the nucleus (for review see Rando et at, 2000). 
Recent studies have also identified actin as a component of nuclear filaments in 
Xenopus oocytes (Kiseleva et al, 2004), suggesting nuclear actin may form part of a 
structural ‘nucleoskeleton’. Rhodamine phalloidin staining does not recognise nuclear 
actin, which suggests that actin may either form novel structures or short filaments in 
the nucleus, or that additional proteins may block the phalloidin binding sites on actin 
filaments. Identification of nuclear actin with the monoclonal anti-actin antibody (2G2) 
however reveals a punctate pattern of immunogold labelling on nuclear filaments 
(Kiseleva et al, 2004), reminiscent of actin incorporation in the flexible filamentous 
network present in red blood cells (figure 3-19). These nucleai' filaments additionally 
show sensitivity to the actin disrupting macrolide Latrunculin-A and the actin stabilising 
drug Jasplakinolide. Due to space constraints in the nucleus, any filamentous network 
may also require this flexible quality, of which actin may form a part. Cytoskeletal 
filaments found in red blood cells are composed primarily of flexible spectrin rods, 
linked at ‘junctional complexes’ containing short actin filaments and other cytoskeletal 
proteins including protein 4.1. The nuclear filaments with which actin was found to 
associate also contain protein 4.1 (Kiseleva et al, 2004).
Actin has also been identified as a component of chromatin remodelling 
complexes in the nucleus. Actin is known to form part of the mammalian BAF complex 
and yeast Ino80 complex, both of which are SWFSNF-like chromatin remodelling 
complexes which alter the topology of nucleosomal DNA (for review see Clave et al, 
2002; Blessing et al, 2004). Additionally, the NuA4 complex; a chromatin remodelling 
complex with histone acetylase activity, has also been shown to contain actin and recent 
studies have also shown the requirement of nuclear actin for transcription by RNA 
Polymerase II (Philimonenko et al, 2004). These studies demonstrate functional roles 
for nuclear actin.
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Figure 3-19. The flexible cytoskeletal network found in red blood cells.
The filamentous network present in red blood cells is composed primarily of flexible spectrin 
heterodimers (red). Spectrin molecules are linked at ‘junctional complexes’ (shown enlarged 
on the left) which contain small actin polymers (light green), protein 4.1 (blue), tropomyosin 
(yellow rods) and adducin. Additional proteins are involved in the linkage of the filamentous 
network to the cell membrane. Figure adapted from Alberts et al, 2002.
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Many ARP (actin related proteins) have been shown to form part of nuclear 
complexes. Although similar to actin at the amino acid level (between 16-60% sequence 
identity) most ARPs are not functionally similar to actin (Olave et al, 2002). Only 
Arp Ip is known to be able to form filaments and interact with some actin binding 
proteins. The presence of nuclear ARPs does not therefore argue for the presence of 
actin and actin binding proteins in the nucleus. Studies have however determined the 
presence of many actin regulatory proteins in the nucleus (for review see Bettinger et al, 
2004). CapG is a member of the gelsolin related capping protein family that has been 
localised to the nucleus (Onoda et al, 1993). Dephosphorylated cofilin has also been 
localised to the nucleus, and studies suggest it is responsible for nuclear entry of actin 
(Ohta et al, 1989; Pendleton et al, 2003). The actin monomer binding protein profilin is 
also implicated in the export of actin from the nucleus (Stuven et al, 2003), while 
emerin is a nucleai" inner membrane thought to form part of the nuclear lamina, a 
scaffold structure thought to control chromosome architecture by anchoring chromatin 
components. Recent studies have shown emerin to be an actin regulatory protein which 
promotes actin polymerisation by binding to and stabilising the pointed ends of actin 
filaments in vitro (Holaska et al, 2004). It is proposed therefore that emerin stabilises 
and promotes formation of a nuclear actin network, involving short actin filaments and 
linking lamin filaments with other nuclear membrane proteins (Bengtsson and Wilson,
2004).
Actin binding proteins known to localise to the nucleus therefore include: 
cofilin, CapG (a gelsolin homologue), emerin. Protein 4.1, cofilin and profilin (for 
review see Rando et al, 2000; Bettinger et al, 2004). Many of these proteins are small 
enough to passively diffuse into the nucleus, however others require active transport. 
The identification of actin in nuclear isolations of Xenopus oocytes, forming part of a 
filamentous matrix (Kiseleva et al, 2004) and in filamentous structures inside the 
permeabilised nuclei of mouse cells (Nakayasu et al, 1985) suggests nuclear actin 
retains its structural role. The nuclear matrix is tentatively regarded as a potential 
homologue of the cytoplasmic cytoskeleton, and as such Slalp and additional actin 
regulatory proteins may continue to regulate actin in this location.
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4 CHARACTERISING THE ROLE OF YSC84
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Abstract
Ysc84p is a cortical patch protein, required in conjunction with Lsb5p for the 
polarisation of the actin cytoskeleton, normal growth rates and growth at high 
temperatures (Dewai* et al, 2002). Using purified protein, our studies show the direct 
binding of the Ysc84p protein to filamentous actin. In addition, we also show the first 
evidence of the ability of Ysc84p to both sever and cap actin filaments. Ysc84p has a 
highly conserved N-terminal region and C-terminal SH3 domain (figure 1-14). Our 
studies show the actin binding, capping and severing ability to be a function of the 
highly conserved N-terminal region. Data presented in this chapter suggests Ysc84p 
plays a direct role in the regulation of actin at cortical actin patch sites, enabling 
breakdown of filaments and preventing further polymerisation at filament ends.
4.1 Introduction
Ysc84p is a cortical patch protein known to interact with Slalp (Uetz et al, 
2000; Drees et al, 2001; Dewar et al, 2002). Ysc84p has also been shown to interact 
with Lasl7p in a 2-hybrid assay. Lasl7p is an Arp2/3 complex activator which also 
localises to cortical patches (Madania et al, 1999). A genetic interaction between YSC84 
and LSB5 has also been shown. LSB5 encodes a protein with an involvement in vesicle 
trafficking and similarity to the GGA (Golgi-localizing, gamma-adaptin ear homology 
domain, ARF-binding) proteins. This genetic interaction suggests overlapping roles for 
Ysc84p and Lsb5p (Dewar et al, 2002). Localisation of Ysc84p to cortical actin patches 
is dependent on F-actin but independent of Slalp (Dewar et al, 2002). This localisation 
and its dependence on the actin network suggesting a possible role for Ysc84p in the 
regulation of actin.
Previous studies did not find a specific role for Ysc84p at cortical patch sites nor 
did they identify an actin binding domain in the protein. A phosphorylation site at serine 
residue of Ysc84p has however been determined by large scale phosphoproteome 
analysis (Ficaro et al, 2002), and Ysc84p homologues in S. cerevisiae (Madania et al, 
1999; Dewar et al, 2002), mouse (Dewar et al, 2002; Aoki et al, 2000), and human cells 
have been identified. The N-terminus of Ysc84p, and the C-terminal SH3 domain are 
both highly conserved between Ysc84p homologues (figure 1-14). SH3 domains have 
been shown to bind specifically to proline rich regions including PxxP motifs (Macias et 
al, 2002; Cestra et al, 1999). It is proposed that SH3 domains are involved in regulating
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the interactions of signalling molecules with cytoskeletal proteins (Drubin, 1990). SH3 
domains, such as the one present in Ysc84p have been identified in many actin- 
associated proteins (Lila and Drubin, 1997).
Localisation of Ysc84p to cortical patches suggests a potential role in the 
regulation of actin. Many known cortical patch proteins affect actin dynamics by 
regulation of the Arp2/3 complex, as in the case of Lasl7p, Panlp and Abplp, or by 
direct interaction with actin, as in the case of Coflp and Pfylp. While an actin binding 
domain has not been identified in Ysc84p or its homologues in previous studies, the 
mammalian Ysc84p homologue, hSH3yl-l has been shown to interact with the actin 
cytoskeleton of S. cerevisiae. Overexpression of hSH3yl-l in wild-type yeast cells 
caused depolarisation of the actin cytoskeleton, indicating that the mammalian protein is 
able to interact with the yeast actin network, either directly or indirectly (Dewar et al, 
2002).
To investigate the conservation between Ysc84p and its mammalian homologue, 
the ability of hSH3yl-l to functionally replace Ysc84p in the yeast cell was examined. 
To examine the function of Ysc84p, fragments of Ysc84p were expressed and purified 
as fusion proteins, coupled to a glutathionine-S-transferase (GST) tag (section 4.2.2). 
Fusion proteins were then used for antibody generation (section 4.2.8) and for analysis 
with F-actin (section 4.2.3 - 4.2.7). Our results demonstrate the ability of Ysc84p to 
bind directly to F-actin and to cap and sever actin filaments in vitro (sections 4.2.3- 
4.2.7). Determination of these in vitro abilities of the protein may provide insight into 
the precise role of Ysc84p at cortical patches.
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4.2 Results
4.2.1 hSH3yI-l can partially replace the function of Ysc84p
Deletion of both YSC84 and LSB5 generates cellular phenotypes not seen 
following deletion of either single gene. YSC84 and LSB5 deletion generates phenotypic 
defects including a decreased growth rate at 3TC, depolarisation of the actin network 
and endocytic defects. Previous studies have demonstrated the functional conservation 
between homologues of actin regulating proteins in different species, as in the case of 
profilin (Rothkegel et al, 1996) and members of the ADF/cofilin family (for review see 
Moon and Drubin, 1995). Mammalian homologues have in many cases been able to 
functionally replace the yeast proteins when expressed in S. cerevisiae. Conservation 
between the conserved amino-terminal region (43% identity) and SH3 domain (46% 
identity) of Ysc84p and its homologues suggested functional conservation may exist 
between these proteins (figure 1-14) (Dewar et al, 2002).
To examine the ability of human SH3yl-l (hSH3yl-l) to functionally replace the 
yeast protein, hSh3yl-l encoding cDNA (pKA252) was obtained (a generous gift from 
Dr. Hata, University of Tokyo) and cloned into a methionine inducible yeast expression 
vector which utilised the MET25 promoter. The hSH3yl-l encoding cDNA was cloned 
into this yeast expression vector (pKA256) at the Xhol restriction enzyme site. Yeast 
expression plasmid, pMET-hSH3yl-l (pKA392) was therefore generated. This construct 
was transformed into a Aysc84Alsb5 mutant (KAY516). Prior experience of the 
p416MET25 expression plasmid (pKA256) has demonstrated low levels of expression 
from the promoter, which do not require methionine induction. This ‘leaky’ expression 
of hSH3yl-l was tested and was shown to be able to rescue the temperature dependent 
growth defect of the Aysc84Alsb5 mutant and partially rescue its endocytic defect 
(figure 4-1 and figure 4-2). Induction of the protein at these levels did not however 
rescue the actin or slow growth phenotype (data not shown) of this strain. This data 
demonstrates that hSH3yl-l is partially functional in S. cerevisiae. Increased expression 
of hSH3yl-l by growth of the cells in media lacking methionine failed to rescue the 
slow growth phenotype or further rescue the endocytic defect in these cells. 
Overexpression of hSH3yl-l however produced enlarged cells which showed total 
depolarisation of the actin cytoskeleton (data not shown). Prior analysis of Aysc84Alsb5 
mutants had highlighted extreme depolarisation of actin (Dewar et al, 2002). Some actin 
patches were however seen to localise to the cytokinetic ring. This minor polarisation of
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actin was however lost following overexpression of hSH3yl-l, indicating that the 
protein interacts with actin.
Aysc84Alsb5 
+ pMET25
29°C
Aysc84Alsb5 
+ pMET25
37°C
Aysc84Alsb5 
+ pMET25-hSH3yl-1
Aysc84Alsb5 
+ pMET25-hSH3yl-1
Figure 4-1. hSH3yl-l expression in yeast rescues the temperature dependent growth 
phenotype of a Aysc84Alsb5 strain.
Aysc84Alsb5 (KAY516) cells transformed with, (top) empty vector (pMET25) or ,(lower) 
hSH3yl-l expressing plasmid (pMET25 + hSH3yl-l) were grown on synthetic drop-out media at 
29’C or 37°C for 2 days. Expression of hSH3yl-l rescued the growth defect of the Aysc84Alsb5 
strain at 37“C. This data has been published by Dewar and colleagues (Dewar et al, 2002).
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Aysc84Alsb5 + pMET25
Aysc84Msb5 + pMET25-hSH3yl-1
Figure 4-2. hSH3yl-l expression in yeast partially rescues the endocytic defect but not the 
actin defect of a Aysc84AIsb5 strain.
Aysc84Alsb5 (KAY5I6) cells transformed with, (top panels) empty vector (pMET25) or, (lower 
panels) hSH3yl-l expressing plasmid (pMET25-hSH3yl-l) were analysed by lucifer yellow 
uptake assay. Expression of hSH3yl-l demonstrates a partial rescue of the endocytosis defects 
seen in this Aysc84Alsb5 mutant strain.
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4.2.2 Generation of Ysc84p fusion proteins
Functional characterisation of Ysc84p was undertaken with the generation of 
several Ysc84p fusion constructs. These constructs allowed high level expression and 
purification of specific regions of the protein. Due to the presence of an intron, the 
YSC84 coding sequence was initially amplified by RT-PCR (section 2.9.11) from RNA 
isolated from wild-type (KAY 302) yeast cells (section 2.9.1). 1 pg of RNA and 
oligonucleotides oKA236 and oKA237 were used to perform this RT-PCR reaction, and 
the RT-PCR product obtained was analysed by agarose gel electrophoresis. The product 
generated was 1.4 Kb in size (figure 4-3). The intron in the YSC84 gene lies between 
nucleotides 47 and 217. Introns are found infrequently in S. cerevisiae, although an 
intron is also present in the LSB3 gene, which encodes the S. cerevisiae homologue of 
Ysc84p, Lsb3p. Amplification of YSC84 from RNA ensured removal of the intron from 
the gene sequence by mRNA splicing. The size of the YSC84 coding sequence was 
therefore expected to be 1407 bp.
The RT-PCR product was cloned directly into the pCR®4-TOPO-TA vector 
(Invitrogen), which uses the end terminal overhangs generated by PCR for cloning of 
the product. Integration generated plasmid pCR®4-TOPO-YSC84 (pKA259). The 
presence of the YSC84 gene in the correct orientation in this plasmid was confirmed by 
sequencing with oligonucleotide primers M l3.Rev and T7. This plasmid was then used 
as template for the amplification of full length YSC84 and YSC84 fragments. PCR 
amplification using oligonucleotides oKA236 and oKA237 engineered BamHl 
restriction enzyme sites onto the ends of YSC84. This PCR product from was then 
incubated with BamHI to digest the ends of the product and to enable cloning into the 
BamHl site of a linearised pGEX4Tl GST-fusion vector (pKA142). This cloning 
generated plasmid pGEX4Tl-75'C<54 (pKA279), which encoded full-length Ysc84p in 
fusion with an amino-terminal GST tag (GST-Ysc84). A region encoding the highly 
conserved N-terminal region of Ysc84p was also amplified from the pKA259 plasmid 
(figure 4-4). PCR was performed using oligonucleotides oKA236 and oKA239 which 
generated BamHl restriction sites at product ends, which were then used to clone the 
654 bp product which encoded residues 1-218 of Ysc84p, into the BamHl site of 
pGEX4Tl (pKA142). Cloning generated plasmid pGEX4Tl-y.scS4(1-654) (pKA278), 
which encoded a 218 amino acid fragment of Ysc84p in fusion with an amino-terminal 
GST tag (GST-Ysc84-Nt). An additional 24 residues of the central region of Ysc84p
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was included in this fragment, in order to encompass a region highly conserved between 
Ysc84p and its S. cerevisiae homologue Lsb3p, which may have been important for the 
function of the N-terminal region. A diagram of the Ysc84p and the amino terminal 
fragment cloned is shown in figure 4-4. Clones were checked by sequencing to ensure 
correct amplification of the gene and integration in-frame with the encoded GST tag.
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Figure 4-3. YSC84 amplifed by RT-PCR. RT-PCR was performed using oligonucleotides 
oK236 and oK237 and RNA from wild-type cells (KAY 302). The product was analysed by 
agarose gel electrophoresis as shown. The generated product was 1.4 Kb in size.
Ysc84 N-terminal 
Homology domain
1 184
SH3 domain 
468
Ysc84
218
Ysc84-Nt
Figure 4-4. Diagram of Ysc84p and the Ysc84-Nt fragment fused to GST. Full length 
Ysc84p is a 468 residue protein containing a conserved amino-terminal domain and 
car boxy-terminal SH3 domain. The highly conserved amino-terminal o f Ysc84p 
encompasses residues 1-184. An additional 24 residues were included in fragment Ysc84- 
Nt to include a region highly conserved between Ysc84 land Lsb3.
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4.2,3 Ysc84p and the conserved N-terminal region of Ysc84p bind directly
to F-actin
While previous analysis did not identify a region of Ysc84p which contained 
significant homology to known actin binding motifs (Dewar et al 2002), localisation of 
Ysc84p to cortical actin patches and the ability of hSH3yl-l to interact with the yeast 
actin cytoskeleton suggested that the actin binding ability of Ysc84p should be 
investigated. F-actin binding abilities of GST-tagged full length Ysc84p (GST-Ysc84) 
and the partial coding sequence (GST-Ysc84-Nt) were determined by high speed F- 
actin sedimentation assays. The central principle of this assay is the ability to pellet F- 
actin in solution, by ultracentrifugation for 20 minutes at 100000 rpm. Unbound protein 
molecules will remain in the supernatant, whereas F-actin binding proteins will be 
found in the pellet fraction.
pGEX4Tl-KS'C54 (pKA279) and pGEX4Tl-y.yc54( 1-654) (pKA278) expression 
plasmids were transformed (section 2.3.9) into bacterial E, coli DH5a cells. These 
expression plasmids encoded GST-tagged Ysc84p fusions constructs corresponding to 
full length Ysc84p and a fragment encompassing residues 1-218 respectively. 
Expression of these fusion constructs was induced as described in section 2.6.7. Cell 
lysates were incubated with glutathionine sepharose® 4B beads and fusion proteins 
released by incubation of the beads with 10 mM reduced glutathionine, as described in 
section 2.6.8. Eluted proteins were stored at -20°C. The purity of the fusion proteins was 
determined by SDS-page analysis (figure 4-5) and their concentration determined by 
spectrometry (section 2.6.13). The expected molecular weights of Ysc84p and Ysc84-Nt 
are 50.2 kDa and 22 kDa respectively. Addition of the GST tag increases the molecular 
weight of these fusion proteins by 26 kDa. High speed F-actin sedimentation assays 
were performed with these purified fusion proteins as described in section 2.6.10. 
Increasing concentrations of GST-Ysc84 and GST-Ysc84-Nt were incubated with 
known concentrations of F-actin and incubations performed in actin binding buffer 
(ABB; 20 mM TRIS, 0.1 M NaCl, 2 mM MgCU, 1 mM ATP, 1 mM DTT, 0.1 mM 
CaCU ) at 25°C for 20 minutes. Reactions were then centrifuged at 100,000 rpm for 20 
minutes to allow F-actin to form a pellet. Equivalent volumes of supernatant and pellet 
fractions from each of these reactions were then analysed by SDS-page gel 
electrophoresis. Assays results are shown in figure 4-6.
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The effect of coupling Ysc84p and a Ysc84p fragment to a GST tag was 
considered. GST tags have been previously reported to dimerise in solution, potentially 
causing aggregation of the tagged protein and invalidation of results. By performing 
sedimentation assays in duplicate, both in the presence and absence of actin however, 
this effect was examined. Significant aggregation and pelleting of the fusion proteins in 
the absence of actin was not seen. Recloning of the fragment into additional tagging 
vectors was however undertaken in order to remove this potential consideration. 
Expression of amino-terminally histidine tagged Ysc84p and Ysc84p fragments from 
the pTrcHis vector (Invitrogen) was however unsuccessful.
Analysis of the results of both F-actin sedimentation assays (figure 4-6) 
demonstrates a significant increase in the amount of fusion protein in the pellet fraction 
when incubated with F-actin. This is most obviously demonstrated in the comparison of 
reactions 3 and 4 (figure 4-6A) which show an increase in the quantity of GST-Ysc84 in 
the pellet fraction when incubated with F-actin. Equally, the same trend is seen when 
comparing reactions 5 and 6 (figure 4-6B) in which an increase in the quantity of GST- 
Ysc84-Nt in the pellet fraction is seen, when incubated with F-actin, This data 
demonstrates that both GST-Ysc84 and GST-Ysc84-Nt binding directly to F-actin in 
vitro. Additionally, the result shown in reaction 3 and 4 (figure 4-6B) is intriguing. 
Actin in reaction 3 is primarily found in the supernatant fraction suggesting a 
breakdown of F-actin into small filaments or monomers which would not pellet, 
following incubation with GST-Ysc84-Nt. This result suggests a depolymerising or 
severing activity in the GST-Ysc84-Nt fusion construct.
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Figure 4-5. Purification of GST-Ysc84 and GST-Ysc84-Nt fusion proteins. The
purity o f GST-Ysc84 and GST-Ysc84-Nt was examined by electrophoresis on a 12% 
SDS-polyacrylamide gel and coomassie staining of the gel as shown above. The expected 
molecular weights o f GST-Ysc84 and GST-Ysc84-Nt are 76.2 kDa and 48 kDa 
respectively. Whole cell extracts before purification o f the induced proteins are also 
shown.
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Figure 4-6. Analysis of GST-Ysc84 and GST-Ysc84-Nt interaction with F-actin.
Decreasing concentrations o f protein were incubated with or without F-actin and 
subjected to high-speed centrifugation. Equivalent amounts of the supernatant 
fraction (s) and pellet fraction (p) obtained were then analysed by SDS-page gel 
electrophoresis. Controls reaction containing actin alone (reaction 1) and protein alone 
(reaction 2) are also shown. (A) Decreasing concentrations of GST-Ysc84, from 6 to 
0.1 pM, were incubated with or without 6.8 pM F-actin and subjected to high-speed 
centrifugation. An increased amount o f GST-Ysc84 is seen in the pellet fraction when 
incubated with actin. (B) Decreasing concentrations of GST-Ysc84-Nt, from 3 1.5 to 
0.6 pM, were incubated with or without 6.8 pM F-actin and subjected to high-speed 
centrifugation. Reaction 3 demonstrates the presence of actin primarily in the 
supernatant fraction, suggesting a severing activity for GST-Ysc84-Nt. The predicted 
Mwt of actin is 43 kDa. Predicted Mwts o f GST-Ysc84 and GST-Ysc84-Nt are 76.2 
kDa and 48 kDa respectively. A molecular weight standard is shown on the far left of 
the gel with standard molecular weights shown in kilodaltons (kDa).
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4.2.4 Analysis of the Ysc84p sequence for actin binding regions
Previous studies had not identified regions of Ysc84p which showed homology 
to known actin binding motifs, and as such had not identified Ysc84p as a potential 
actin binding protein (Dewar et al, 2002). Prior cellular evidence did however suggest a 
close association of Ysc84p with the actin network, as demonstrated by Ysc84p 
mislocalisation upon depolymerisation of the actin cytoskeleton with Latrunculin-A 
(Dewar et al, 2002). Data shown in section 2.4,2 demonstrates the ability of GST- 
Ysc84p and GST-Ysc84-Nt to bind directly to F-actin in vitro. This suggested that 
Ysc84p localisation to cortical actin patches may be mediated by direct binding of the 
protein to filamentous actin and not as previously suggested, via another protein or 
complex. Close analysis of the Ysc84p sequence subsequently identified two regions of 
Ysc84p which contained a high concentration of hydrophobic residues including 
leucine, which are known to be highly conserved in actin binding WASP homology 2 
(WH2) domains (Dominguez, 2004). These regions were thought most likely to mediate 
direct binding to F-actin, in the absence of significant homology to known actin binding 
motifs. The location and sequence of these regions is shown in figure 4-7.
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MGINNPIPRSLKSETKKAAKVLRS^KPNQVFGADQVIPPYVLKRAKGLAIITVLKAGFLFS
GRAGSGVIVARLKDGTWSAPSAIAMAGAGAGGMVGVELTDFVFILNSEEAVRSFSEFGTIT
LGGNVSVSAGPLGRSAEAAASASTGGVSAVFAYSKSKGLFAGVSVEGSAILERREANRKFY
184
DNCTSKMILSGRVKVPPAADPLLRILESRAFN
218
FTRHDHDDNASGDDFYDDGQYSDNTSH
*
YYDDIPDSFDSTDESSTRPNTRSSRRRGMSLGSRSRYDDDYDDDGYGRGRGYGDFDSED
EDYDYGRSPNRSSRNRGPQIDRGTKPRANTRWEDDLYDRDTEYSRPNHSGRDYDNTRG
NRRGYGRERGYSLGHGPTHPSNMSNVDDLSHKMSKTGLGNESTATNSATPrAl/ALYA/FA
GEQPGDLAPKKGDVITILKKSDSQNDWWTGRTNGKEGIFPANYVRVS
B
YSC84 N-terminal SH3 domainHomology domain_______ 184 468
Ysc84p
Figure 4-7. Ysc84p has two potential actin binding regions. A) Protein sequence o f the 468
amino-acid Ysc84 protein. The conserved C-terminal SH3 domain is shown in italics. The two 
regions shown in bold type were identified by sequence analysis as being possible actin binding 
regions. The two regions encompass residues 1 2 - 6 5  and 207 -  223. Arrows demonstrate the start 
sites for the Ysc84-Nt fragment at residue 1 and the Ysc84-*Nt fragment at residue 89 (described 
in section 4.3). Residues 184 and 218 are marked. The serine residue reported to undergo 
phosphorylation is asterisked. B) Diagram o f  the identified possible actin binding regions.
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4.2.5 Analysis of the severing activity of Ysc84p
Previous data has shown that GST-Ysc84 and GST-Ysc84-Nt interact directly 
with F-actin (section 4.2.3), while also suggesting an actin severing or depolymerising 
activity for residues 1 -  218 of Ysc84 in vitro. These residues encompass the highly 
conserved N-terminal homology domain of Ysc84p. In order to confirm and investigate 
the activity of this domain, further analysis was performed. Falling ball assays study the 
effect of ligand addition to a polymerising actin matrix. Actin is polymerised in the 
presence of increasing amounts of ligand and the effect on the viscosity of the filament 
matrix assayed (Pollard, 1982). The effect on viscosity is assayed by recording the time 
taken for passage of a small metallic ball through 10 cm of the polymerised actin 
matrix. Addition of a protein with actin severing activity would be expected to decrease 
the viscosity of the filament matrix allowing quicker passage of the falling ball. 
Conversely, addition of a protein with actin cross-linking activity would be expected to 
increase time of passage. 6fxM of rabbit muscle G-actin (Cytoskeleton Inc) was 
polymerised in the presence of increasing concentrations of GST-Ysc84-Nt from 2 /zM 
to 20 liM  (section 2.6.11). Results of these falling ball assays are shown in figure 4-8.
Assays were performed in the presence of 0.2 mM CaCl2 in light of reports of 
actin-severing proteins, such as villin, gelsolin and severin, which require calcium for 
activity (for review see Kumar and Khurana, 2004). The activity of gelsolin is 
additionally known to be regulated by pH (Lamb et al 1993). All assays were however 
carried about at pH 7.5 and performed in triplicate. The time taken for passage through 
an actin matrix polymerised in the absence of the protein was recorded. The addition of 
concentrations of GST-Ysc84-Nt between 2 and 15 jiiM were seen to dramatically 
decrease the relative viscosity of this actin matrix. Maximum effect was seen with 
addition of 5jitM of GST-Ysc84-Nt when the relative viscosity of the matrix decreased 
to 44%. This maximum effect was seen with addition of near equimolar amounts of 
GST-Ysc84-Nt to the 6 /xM of actin present in the matrix. The increase in viscosity 
following addition of 10 jU.M and over of GST-Ysc84-Nt is potentially attributable to the 
ability of the GST tag to dimerise, which at high concentrations may obscure the 
severing effect of the fusion protein.
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F igure 4-8. Biochemical analysis of GST-Ysc84-Nt with actin. Falling ball assays were 
performed to investigate the effect o f addition o f GST-Ysc84-Nt to an F-actin matrix. The matrix 
was polymerised from a solution o f 6pM G-actin in the presence of increasing concentrations of 
the GST-Ysc84 from 0 - 2 0  pM. Relative viscosity o f the matrix was assayed by passage o f a 
metal ball through 10 cm o f the actin matrix.
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4.2.6 Ysc84p severs fluorescently labelled actin filaments
Given the inhibitory effect of addition of GST-Ysc84-Nt to a polymerising actin 
matrix (section 4.2.5), and to examine Ysc84p in greater detail, the effect of addition of 
the protein to individual actin filaments was studied. The ability of the GST-Ysc84-Nt 
fusion protein to affect an actin matrix polymerised in the presence of calcium led to the 
hypothesis that Ysc84p may act in a similar manner to gelsolin or a related protein. The 
severing activity of gelsolin is regulated both by pH and calcium availability, and 
following severing of the actin filament, the protein remains attached to the newly 
generated filament barbed end. Gelsolin is therefore also a capping protein. In addition 
to regulation by calcium and pH, the severing activity of some capping proteins is 
inhibited by the binding of phalloidin to actin filaments. This inhibition is thought to 
occur by competition for a similar binding site on the actin filament. In order to 
visualise the effect of GST-Ysc84 and GST-Ysc84-Nt on individual actin filaments, and 
to test the inhibitory effect of phalloidin, the fusion proteins were incubated with 
fluorescently labelled Alexa Fluor® actin filaments in the presence or absence of 
phalloidin. Filaments polymerised from rabbit muscle G-actin (Cytoskeleton Inc) in the 
presence of Alexa Fluor® actin monomers (Molecular probes) enable the 
visualisation of individual filaments by fluorescence microscopy. Filaments were 
allowed to polymerise with or without phalloidin, and in the presence or absence of 
GST-Ysc84 and GST-Ysc84-Nt for 30 minutes. GST-Ysc84 and GST-Ysc84-Nt were 
incubated at equimolar concentrations to the actin in solution, as previously performed 
falling ball analysis had demonstrated the maximum depolymerising effect of GST- 
Ysc84-Nt was achieved at approximately equimolar concentrations to actin (4.2,5). 
Polymerisation of actin filaments in the presence of equimolar amounts of phalloidin 
was expected to increase the average filament length due to stabilisation of filaments.
Filament lengths from several microscope field images were counted and 
averaged. Examples of these images are shown in figure 4-9. Figures 4-10 summarises 
the results these assays. Surprisingly, filaments polymerised in the presence of 
phalloidin did not show a significant increase in overall filament length. 21.8 % ± 2.5 of 
filaments exceeded 10 pM in length in the absence of phalloidin, while 23.0 % ± 3.0 
exceeded 10 pM in length in the presence of phalloidin, in the GST-Ysc84-Nt control 
reaction. In the GST-Ysc84 control reaction, 19.5 % ± 2.0 of filaments exceeded 10 pM 
in length in the absence of phalloidin, with 18.5 % ± 1.1 exceeding 10 pM in length in
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the presence of phalloidin (figure 4-10). Both GST-Ysc84 and GST-Ysc84-Nt were 
however shown to sever actin filaments. Incubation of labelled filaments with GST- 
Ysc84 in the presence of phalloidin demonstrated a decrease in filament length. 
Filaments 10 pM and over in length decreased from 18.5% ± 1.1 of total filaments to 
9.6% ± 0.8 in the presence of phalloidin; a decrease of approximately 48%. Incubation 
of filaments with GST-Ysc84 in the absence of phalloidin did not however significantly 
affect filament length. The presence or absence of phalloidin therefore appears to affect 
the severing activity of GST-Ysc84.
Incubation of labelled filaments with GST-Ysc84-Nt in the absence of 
phalloidin decreased the number of filaments 10 pM and over in length by 
approximately 46%. Filaments 10 pM and over in length decreased from 21.8% ± 2.5 of 
total filaments in the absence GST-Ysc84-Nt, to 11.8% ± 2.2 in the presence of GST- 
Ysc84-Nt. A similar activity was seen in the presence of phalloidin, with the percentage 
of filaments 10 pM and over in length decreasing from 23.0% ± 3,0 in the absence of 
the protein, to 11.0 % ± 1.7 in the presence of GST-Ysc84-Nt; a decrease of 
approximately 52%. Both GST-Ysc84 and GST-Ysc84-Nt are therefore able to sever 
actin filaments in vitro in the presence of phalloidin, but GST-Ysc84-Nt severing 
activity only was active in the absence of phalloidin.
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Figure 4-9. GST-Ysc84-Nt and GST-Ysc84 are able to sever actin fllaments. Microscope fields 
of fluorescently labelled, Alexa Fluor® actin filaments are shown. Filaments were polymerised A) 
in the absence of equimolar amounts of phalloidin or B) in the presence of equimolar amounts of 
phalloidin. The addition of 0.5 ^1 GEB (Glutatione Elution Buffer) acts as a control for the addition 
of equimolar amounts (6 fiM) of GST-Ysc84-Nt protein in GEB buffer. Addition of 1.5 gl of GEB 
acts as a control for the addition of equimolar amounts (6 (iM) of GST-Ysc84. 10 juM size bars are 
also shown.
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Figure 4-10. GST-Ysc84 and GST-Ysc84-Nt sever fluorescent actin filament in the 
presence of phalloidin. Filaments are grouped according to filament length and shown as a 
percentage o f the total filaments counted in each image. Filaments 0 - 4  pM in length are 
shown in blue, 4 - 1 0  pM in grey, and those 10 pM and over in yellow. The addition of 0.5 pi 
GEB (Glutathione Elution Buffer) acts as a control for the addition o f the 6 pM Gst-Ysc84-Nt 
protein held in the same buffer. Addition o f 1.5pl GEB (Glutathione Elution Buffer) acts as a 
control for the addition o f 6 pM GST-Ysc84 protein in GEB. A) Actin filaments polymerised in 
the absence o f phalloidin. B) Actin filaments polymerised in the presence o f equimolar amounts 
o f phalloidin. The addition o f both Gst-Ysc84-Nt and Gst-Ysc84 decreases the percentage o f 
filaments o f length 10 pM and over.
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4.2.7 Ysc84p can both sever and cap fluorescently labelled actin fllaments
Given the ability of both GST-Ysc84 and GST-Ysc84-Nt to sever actin 
filaments in vitro, and previous reports of actin severing proteins which additionally 
demonstrate filament capping activity (for review see McGough, 2003), the ability of 
these Ysc84p fusion proteins to cap actin filaments was investigated. Fluorescently 
labelled Alexa Fluor® (red) and Alexa Fluor® (green) actin monomers (Molecular 
probes) were used to generate dual labelled actin filaments. Alexafluor® and Alexa 
Fluor® labelled actin monomers were sequentially incorporated into polymerising 
actin filaments, allowing visualising of polymerised filaments by fluorescence 
microscopy at two wavelengths. Filaments were initially polymerised from rabbit 
muscle G-actin (Cytoskeleton Inc) in the presence of Alexa Fluor® with equimolar 
amounts of phalloidin for one hour, to generate filaments which fluoresced in green 
upon excitation. Purified fusion proteins held in Glutathione Elution Buffer (GEB) were 
then added to these filaments at an equimolar concentration to actin (6 pM), while GEB 
buffer alone was added in equivalent amounts to controls reactions. Alexa Fluor® 
actin monomers were then added to these reactions and filaments allowed to polymerise 
for a further hour. Filaments polymerised following addition of GST-Ysc84 or GST- 
Ysc84"Nt would therefore fluoresce predominantly in red upon excitation, due to 
polymerisation in an excess of Alexa Fluor® actin monomers. Filament severing 
activity exhibited by the fusion proteins would be apparent by a reduction in the length, 
and an increase in the number of Alexafluor"^^^ labelled filaments (green) filaments. 
Filament capping activity of the fusion proteins would be apparent by comparing the 
number of filaments polymerised in the presence of fusion protein which demonstrated 
both red and green fluorescence, with the number of dual labelled filaments 
polymerised in the absence of fusion protein. A reduction in the number of dual labelled 
filaments would suggest the presence of a capping protein, as capping of initial (green) 
filaments would prevent filament extension following addition of Alexa Fluor® actin 
monomers.
Images of filament spreads were taken using the fluorescence microscope at 
both wavelengths. These images were then merged and examined for the number of 
dual labelled filaments present, the total number of filaments, and the number and 
length of initial Alexa Fluor® (green) filaments. Examples of these images are shown 
in figure 4-11. Results of these counts are summarised in figure 4-12. A marked
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reduction in the number of dual labelled filaments is seen following addition of 
equimolar amounts of GST-Ysc84-Nt, as the number of dual labelled filaments drops 
from 42.1% ± 4.9 of total filaments in the presence of GST-Ysc84-Nt, to 23.4% ± 2 in 
the absence of GST-Ysc84-Nt; a reduction of approximately 44%. The addition of GST- 
Ysc84 did not however significantly affect the percentage of dual filaments seen, with 
dual filament accounting for 23.7% ± 3.4 of total filaments when incubated in the 
presence of GST-Ysc84 and 24.4% ± 1.0 of total filaments in the absence of GST- 
Ysc84. A reduction in the number of dual labelled filaments suggests that GST-Ysc84- 
Nt is able to cap actin filaments, preventing the addition of further actin monomers to 
existing filaments.
As demonstrated in section 4.2.6 both the GST-Ysc84-Nt and GST-Ysc84 
proteins were able to sever Alexa Fluor® labelled filaments, in the presence of 
phalloidin. In order to confirm this observation in our dual labelling assay, Alexa Fluor® 
(green) labelled filaments were counted individually. Results of these counts are 
summarised in figure 4-13. Incubation of filaments with GST~Ysc84 in the presence of 
phalloidin again generated a reduction in the number of filaments 10 pM and over in 
length, with numbers decreasing from 21.3% ±2.7  of total filaments in the absence of 
the protein to 7.2% ± 1.2 in the presence of GST-Ysc84; a decrease of approximately 
66%. Incubation of filaments with GST-Ysc84-Nt in the presence of phalloidin also 
decreased the number of filaments 10 pM and over. Numbers of filaments 10 pM and 
over decreased from 16.4% ± 3.6 of total filaments in the absence GST-Ysc84-Nt, to 
10.5% ± 1.6 of in the presence of GST-Ysc84-Nt; a decrease of approximately 36%.
Filament capping activity is demonstrated by a decrease in the number dual 
labelled filaments, and is therefore shown to be an activity of the GST-Ysc84-Nt fusion 
protein only. GST-Ysc84 may still cap actin filaments following severing, however 
significantly less efficiently than GST-Ysc84-Nt. A potential capping activity for GST- 
Ysc84 is proposed due to the rationale that filament severing without capping would 
generate an increase in the number of Alexa Fluor® (green) filaments available for 
continuing polymerisation in the presence of Alexa Fluor® (red) monomers. You 
might expect therefore, to see an increase in the number of dual labelled filaments 
polymerised in the presence of a severing protein which exhibits no capping activity, 
when compared to a control lacking this protein. Factors such as continued severing in 
the presence of Alexa Fluor® (red) monomers and the concentration of free actin 
monomers in solution may however affect this proposed outcome. Low levels of 
filament capping by actin GST-Ysc84 however cannot be ruled out by these results.
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Filament severing was demonstrated by GST-Ysc84-Nt and GST-Ysc84 in the 
presence of phalloidin, but for only GST-Ysc84-Nt in the absence of phalloidin (section 
4.2.6). Identification of GST-Ysc84~Nt filament capping activity suggests the stable 
association of a proportion of the fusion protein with filament ends and an associated 
decrease in the concentration of freely available fusion protein in solution, when 
compared to experiments performed with GST-Ysc84. This rationale may explain the 
increased severing activity of GST-Ysc84 demonstrated in this dual labelling assay, 
which generated a 66% decrease in the number of Alexa Fluor® (green) labelled 
filaments 10 pM and over in length, compared to a 36% decrease generated by the GST- 
Ysc84-Nt fusion protein.
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Figure 4-11. GST-Ysc84-Nt and GST-Ysc84 both cap and sever labelled actin filaments
Filaments were initially polymerised in the presence of Alexa Fluor® 488. 6 pM GST-Ysc84-Nt, 6 
pM GST-Ysc84 or control buffer GEB (Glutathionine Elution Buffer) was added, and the solution 
allowed to further polymerise in the presence of Alexa Fluor® 568 labelled actin monomers. 
Filament spreads were obtained by fluorescence microscopy and are shown above. The addition of 
0.5 pi GEB (Glutathione Elution Buffer) acts as a control for the addition of 6 pM GST-Ysc84-Nt in 
GEB. Actin was polymerised in the presence of equimolar amounts of phalloidin.
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Figure 4-12. GST-Ysc84-Nt dem onstrates filament capping activity in dual labelling 
fluorescent actin assays. Filaments were polymerised in the presence of Alexa fluor 
followed by addition of either the protein o f interest or GEB buffer as a control Filaments were 
then allowed to continue polymerisation following addition of Alexa fluor^* actin monomers. 
Filaments are grouped as continuous dual labelled fllaments or as single colour filaments. Dual 
labelled fllaments (blue) and single colour filaments (grey) are shown. The addition o f 0.5 pi 
GEB (Glutathione Elution Buffer) acts as a control for the addition o f 6 pM GST-Ysc84-Nt in 
GEB. Addition o f 1.5 pi GEB acts as a control for the addition o f the 6 pM GST-Ysc84. Actin 
was polymerised in the presence o f equimolar amounts of phalloidin.
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Figure 4-13. Counts of Alexa F lu o r^  labelled filaments in dual labelling experiments.
Filaments are grouped according to length o f filament and as a percentage of the total Alexa 
Fluor'*** fllaments counted in each image. Filaments 0 - 4  pM in length are shown in blue, 4 -  
10 pM in grey, and 10 pM and over in yellow. The addition of 0.5 pi GEB (Glutathione Elution 
Buffer) acts as a control for the addition o f 6 pM GST-Ysc84-Nt in GEB. Addition of 1.5 pi 
GEB acts as a control for the addition o f the 6 pM GST-Ysc84. Actin was polymerised in the 
presence of equimolar amounts o f phalloidin.
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4.2.8 Generation of Ysc84p antibodies
Biochemical analysis of Ysc84p fusion proteins has provided insight into the 
potential in vivo functions of Ysc84p. The generation of antibodies specific for Ysc84p 
would potentially however enable in vivo studies of protein location, 
immunoprécipitation and identification of Ysc84p by Western analysis to be performed, 
in addition to other studies. The generation of Ysc84p specific antibodies was therefore 
undertaken. Expression and purification of GST-Ysc84-Nt was performed as described 
in sections 2.6.7 and 2.6.8. Conservation of this amino terminal region between Ysc84p 
homologues raised the possibility generating antibodies specific not only for Ysc84p, 
but also for homologues in other species. The specificity of this region to Ysc84p and 
its homologues, as these residues showing little homology to known motifs or domains, 
suggested this region would act as an excellent antigen with which to raise a highly 
specific immune response.
Transformation of the plasmid pGEX4Tl-y5c54( 1-654) (pKA278) into DH5a 
cells was performed as described in section 2.3.9. Expression and purification of the 
encoded fusion protein GST-Ysc84-Nt from two litres of culture was then undertaken 
(section 2.6.7 and 2.6.8), with GST-tagged protein purified using glutathione 
sepharose® 4B beads. The purity and concentration of the purified protein was then 
determined by SDS-page analysis and spectrometry respectively. Analysis of the 
purified fusion protein by SDS-page gel electrophoresis is shown in figure 4-14. 
Approximately 200 /xg of purified protein was subsequently administered to two rabbits 
(R1414 and R1415) in four separate injections at 28 day intervals (Diagnostics 
Scotland) (section 2.8.1). An initial pre-immune serum, subsequent primary and 
secondary serums and a final exsanguination serum was obtained from these animals. 3 
ml of the final polyclonal rabbit antisera was then purified using Protein A sepharose™ 
CL-4B beads (Amersham Pharmacia) which bind specifically to immunoglobulin 
molecules (section 2.8.2). 1 ml fractions of protein were eluted from these beads by 
addition of 0.1 M glycine pH 2.5, which was subsequently neutralised. 10 fractions 
were obtained and were analysed by spectrometry to determine the concentration of 
protein held in each fraction. The two most concentrated fractions (fraction 6 and 7) 
were tested by Western blotting against whole cell extracts (section 2.6.4) at a dilution 
of 1:1000 in 1% milk + TBS-T (section 2.6.4) using ECL detection (section 2.6.5).
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Western blotting of lysates performed using fractions 6 and 7 (figure 4-15) 
identified a strong band between 60-62 kDa in wild type extracts (KAY302). Additional 
faint bands were identified in blots performed using fraction 6, at higher molecular 
weights in wild-type extracts, Aysc84IAlsb3 (KAY554) extracts and Aysc84 (KAY510) 
extracts. The predicted size of Ysc84p is 52.2 KDa. The identification of the 60-62 KDa 
band in wide type extracts only, suggested the specificity of these antibodies for 
Ysc84p. Identification of a single band in wild-type extracts and the lack of band 
identification in a Aysc84 extract also suggested that these antibodies did not recognise 
the Ysc84p homologue Lsb3p, which has a predicted molecular weight of 48.5 kDa.
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Figure 4-14. Purified GST-Ysc84-Nt. Purification of total cell lysate (lane 1) from DH5a cells 
expressing GST-Ysc84-Nt using Glutathione Sepharose* 4B beads yielded a single purified 
protein band (lane 2) with a molecular weight o f 39 kDa. Predicted size o f the fusion protein was 
45 KDa.
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Figure 4-15. Specificity of Ysc84 antisera as determined by western blotting. Purified 
polyclonal rabbit antisera fractions 6 and 7, purified over Protein A Sepharose**^ CL-4B beads, 
were tested at a 1:1000 dilution and detected by ECL. Both fraction 6 (A) and fraction 7 (B) 
were tested against whole cell wild-type (KAY302, Lane 1) extracts, Ayscfi4/Alsh3 (KAY554), 
lane 2) extracts and Aysc84 (KAY510, lane 3) extracts. Standard molecular weight markers are 
also shown.
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4.2.9 Ysc84p analysis by 2D-geI electrophoresis
Biochemical assays have localised the actin filament binding, severing and 
capping activity to the amino terminal 1-218 residues of Ysc84p (sections 4.2.3 - 4.2.7). 
Given the apparent lack of capping activity demonstrated by the full length fusion 
protein GST-Ysc84 (section 4.2,7), a regulatory function for the carboxy-terminal 
regions of the protein is suggested. In addition, a study by White and colleagues had 
identified a site of phosphorylation in the carboxy-terminal region of Ysc84p at serine 
residue 301 (Ficarro et al 2002), by phosphoproteome analysis and mass spectrometry. 
Phosphorylation is a widely occurring mechanism of protein regulation. Modification of 
Ysc84p was therefore investigated by 2-D gel analysis using our newly generated 
Ysc84p specific rabbit polyclonal antibodies (section 4.2,8).
Wild-type whole cell extracts (KAY302) were prepared and separated by 2- 
Dimensional (2-D) gel electrophoresis as described in section 2.6.6. Isoelectric focusing 
(IFF) strips of pH 6 -  10 were used. Ysc84p has a predicted pi of 8.38. 2-D gel 
electrophoresis allows the separation of proteins both by size and charge, enabling the 
identification of modified forms of individual proteins. Extracts separated by 2- 
Dimensional Gel Electrophoresis were transferred onto PVDF membrane and Western 
blotted using anti-Ysc84 antibodies at 1:2000 (section 2.6.5). Membranes were then 
analysed by ECL (enhanced chemiluminescence). The result of this analysis is shown in 
figure 4-16. Western blotting identified a single distinct spot at 57 KDa with a pi of 
approximately 7,3. The predicted molecular weight of Ysc84p is 51 KDa. This data 
suggest that several modified forms of Ysc84p do not exist under the experimental 
conditions examined.
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Figure 4-16. 2-Dimensional Gel analysis of wild-type extracts with anti-Ysc84 antibodies.
Extracts from wild-type strain KAY302 were separated by 2-D gel electrophoresis and Western 
Blotted using antibodies raised to the amino-terminus of Ysc84p. lEF strips o f pH 6 -  10 were 
used. Ysc84p has a predicted pi o f 8.38. A single spot is seen at 57 KDa (predicted size: 52.2 
kDa).
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4.3 Discussion
The cortical patch protcinYsc84p interacts with the cytoplasmic adaptor protein 
Slalp as determined biochemically (Dewar et al, 2002) and the Arp2/3 complex activator 
LaslVp as determined by yeast 2-hybrid analysis. Ysc84p co-localises with cortical actin 
patches, which are regarded as an integral component of the endocytic machinery, as their 
formation at endocytic sites is proposed to enables processes including of vesicle 
formation, fission and transport.
In this study considerable progress has been made towards establishing the role of 
Ysc84p. Previous studies had shown that the localisation of Ysc84p to cortical patches was 
dependent on F-actin, and the Arp2/3 activators Lasl7p and Abplp, A role for Ysc84p in 
the regulation of actin was also proposed (Dewar et al, 2002) but had not been 
investigated. Consistent with this proposal, F-actin sedimentation assays performed during 
this study have demonstrated the ability of both a GST-tagged N-terniinal fragment of 
Ysc84p and full length Ysc84p to bind directly to filamentous actin in vitro (section 4.2.3). 
Additionally, studies have demonstrated the actin filament severing and capping activity of 
Ysc84p in vitro, and have localised these activities to residues 1-218 of Ysc84p (section
4.2.6 and 4.2.7).
Ysc84p shows a high degree of conservation with its human homologue hSH3yl-l, 
particularly across two conserved regions. These proteins show 48% identity across the 
conserved N-terminal domain from residues 1- 184, and 58% identity across the carboxy- 
terminal SH3 domain. Transformation and expression of an hSH3yl-l expression construct 
in a Aysc84Alsb5 mutant strain demonstrated a partial rescue of the phenotypes associated 
with this double deletion. This demonstrates partial functionality of hSH3yl-l in a yeast 
system, previously suggested by the high degree of conservation between Ysc84p and 
hSH3yl-l. Previous studies have also shown that hSH3yl-l is able to affect the actin 
network in yeast, with overexpression of the protein in a wild-type strain causing 
depolarisation of the actin cytoskeleton (Dewar et al, 2002). Taken together, these studies 
demonstrate both conservation of function between Ysc84p and its human homologue, 
while also suggesting a direct role for the yeast protein in the regulation of the actin. Due 
to the high degree of conservation seen between Ysc84p and its S, cerevisiae homology 
Lsb3p, these studies also suggest potentially conservation of function with Lsb3p. 
Conservation may also extend to other Ysc84p homologues. Sequence conservation 
between Ysc84p and Lsb3p is extremely high, with 91% identity seen across the N- 
terminal homology domain and 86% identity across the SH3 domain (Dewar et al, 2002).
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High speed sedimentation assays performed to investigate the F-actin binding 
abilities of Ysc84p and an N-terminal Ysc84p fragment, demonstrated the ability of both 
GST-Ysc84 and GST-Ysc84-Nt to bind directly to F-actin (section 4.2.3). F-actin binding 
does not therefore require the carboxy terminal domain of the protein from residues 218- 
468. These assays also suggested an actin depolymerising or severing activity for GST- 
Ysc84-Nt, as seen by accumulation of actin in the supernatant fraction following 
incubation of 6 pM F-actin with 31.2 pM GST-Ysc84-Nt (figure 4-5B). Total 
accumulation of actin in the supernatant was only seen upon incubation with 31.2 pM 
GST-Ysc84-Nt, however substantial amounts of actin in the supernatant were also seen 
following incubation with all concentrations of the GST-Ysc84-Nt fusion protein tested. It 
was additionally noted that the activity of proteins tested may be substantially inhibited by 
experimental conditions, with activity potentially being regulated by additional factors 
such as pH or the availability of additional molecules. Subsequently, the prediction of two 
potential actin binding regions between residues 1-218 of Ysc84p was made due to a high 
density of hydrophobic residues at these sites. Hydrophobic residues are conserved in 
several known actin binding motifs and were used to suggest regions of Ysc84p which may 
bind directly to F-actin (Dominguez, 2004).
The suggested severing activity of GST-Ysc84-Nt was investigated using falling 
ball viscometry. Falling ball assays demonstrated the effect of addition of GST-Ysc84-Nt 
on the viscosity of an F-actin matrix polymerised in the presence of the protein. Additional 
studies later performed assessed the effect of addition of the fusion proteins to pre-existing 
actin filaments. Falling ball assays demonstrated the ability of GST-Ysc84-Nt to decrease 
the viscosity of a 6 pM actin matrix by up to 44% in the presence of 0.2 mM Ca^ "^ . 
Interestingly, the maximum severing activity of GST-Ysc84-Nt was seen to occur 
following addition of 5 pM of protein; an approximately equimolar concentration to that of 
actin used in this study. This effect on the viscosity of a polymerising matrix confirmed a 
severing or depolymerising activity for the N-terminal region of Ysc84p while also 
suggesting that maximum severing activity of the protein may occur at equimolar 
concentrations to actin. Previous studies have demonstrated the regulation of actin severing 
proteins by factors such as pH and calcium concentration, therefore it is proposed therefore 
that the actin severing activity of Ysc84 may be regulated by additional factors, and further 
analysis needs to be performed to identify these factors. In vivo resting intracellular 
calcium levels are reported as approximately 0.2 pM (Kinosian, 1998); however for the 
severing activity of previously identified severing proteins to occur in vitro, higher levels 
of calcium are known to be required. Half maximal severing activity of gelsolin was
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reported in the presence of 10 pM calcium, although this figure is variable with pH (Lamb 
et al, 1993).
Additional analysis of the severing activity of Ysc84p was performed by studying 
the effects of protein addition on previously polymerised fluorescently labelled actin 
filaments (section 4.2.6). Filaments were polymerised either in the presence or absence of 
phalloidin, both to assess the effects of filament stabilisation on Ysc84p severing activity 
(Cooper, 1987), and also in light of reports detailing the inhibitory effect of phalloidin 
binding on the severing activity of proteins including cofilin and actophorin (Yonezawa et 
al, 1988; Maciver et al, 1991). Actin severing activity was demonstrated for GST-Ysc84- 
Nt at similar levels both in the presence or absence of phalloidin, and for GST-Ysc84 in 
the presence of phalloidin. Intriguingly however, a lack of phalloidin was shown to inhibit 
the actin severing activity of GST-Ysc84. Inhibition of the actin severing by cofilin, 
actophorin and gelsolin by phalloidin has been previously reported, while severing by 
proteins such as the Dictyostelium gelsolin related protein severin have been shown to be 
unaffected by phalloidin (Giffard et al, 1984). Studies have suggested that the mechanism 
for inhibition of severing activity may be direct competition with phalloidin for a similar 
binding site on the actin filament. The presence of phalloidin has not however been 
previously shown to promote the activity of a filament severing protein. Stabilisation of the 
severing mechanism by phalloidin is however a potential explanation for this effect.
Dual labelling experiments were performed in order to assess the actin filament 
capping activity of GST-Ysc84 and GST-Ysc84-Nt. Filaments were polymerised in the 
presence of phalloidin, as lack of phalloidin had previously been shown to inhibit the 
severing activity of GST-Ysc84 (section 4.2.6). Filament capping activity by GST-Ysc84- 
Nt was clearly demonstrated (section 4.2.7). This was shown by a decrease in the number 
of dual labelled filaments by approximately 44% following addition of GST-Ysc84-Nt. 
GST-Ysc84 did not however show significant capping activity as the number of dual 
labelled filaments remained similar in the presence or absence of GST-Ysc84. The loss of 
capping activity upon incubation with the full length protein promotes interesting 
possibilities and suggests that the carboxy terminal regions of Ysc84p may regulate the 
amino terminal filament capping activity of Ysc84p. Potential regulatory mechanisms 
include conformational changes, which would allow the carboxy-terminal region of 
Ysc84p to mask the actin binding, severing and capping regions located in the amino 
terminus of the protein. Additionally, the possibility of protein modification as a regulatory 
mechanism exists. In support of this proposal, Ysc84p has been shown to undergo 
phosphorylation on serine residue (Ficarro et al, 2002), as determined by
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phosphoproteome analysis (Ficarro et al, 2002). This region is removed in the GST-Ysc84- 
Nt fragment; therefore modification by phosphorylation is a potential regulatory 
mechanism for Ysc84p. Initial 2-Dimensional gel analysis of Ysc84p in wild-type cells 
does not however support the suggestion of modified forms of Ysc84p. 2-Dimensional gel 
analysis identified a single spot with similar molecular weight and isoelectric point to that 
predicted for Ysc84p (section 4.2.9) suggesting that a single form of Ysc84p exists under 
the experimental conditions tested. Modification of the protein may occur under conditions 
not examined however, for example during a specific growth phase.
Dual labelling studies demonstrated that purified GST-Ysc84-Nt is able both to 
sever and cap actin filaments in vitro, while GST-Ysc84 is able to sever actin filaments, 
but does not exhibit significant capping activity. N-terminal filament severing and capping 
activity, coupled with potential self-regulation suggests similarity to Class I members of 
the gelsolin/villin family and in particular, gelsolin itself. Class I family members are 
known both sever and cap actin filaments, while Class II members show only severing 
activity. In addition to severing and barbed end capping, gelsolin is known to self-regulate. 
The activity of gelsolin and many related proteins is dependent on the availability of free 
calcium in solution. Recent X-ray crystallography studies of the inactive protein have 
demonstrated the arrangement of gelsolins six domains (Burtnick et al, 1997), which 
suggest regulation of the N-terminal actin binding domain by folding over of the C- 
terminal regions, which thereby mask the N-terminal domain in the absence of calcium. 
This model is supported by an earlier study in which deletion of specific carboxy terminal 
residues eliminated the calcium requirement for gelsolin activity (Way et al, 1992). To 
date, no gelsolin family members have been identified in yeast, despite being identified in 
various vertebrate and plant cells (Huang et al, 2005; for review see Silacci et al, 2004). 
Ysc84p and gelsolin do not show significant similarity at the amino acid level but as has 
been previously demonstrated, gelsolin does not always show a high level of sequence 
similarity to gelsolin family members (Hatanaka et al, 1996). This is particularly clear in 
the case of destrin. Conservation of a similar domain structure to gelsolin is however 
apparent in this protein. The localisation of filament binding, severing and capping activity 
to the N-terminal region of Ysc84p with potential self-regulation suggests similarity to the 
barbed end capping protein, gelsolin. Recent studies have also demonstrated 
conformational changes induced by tyrosine phosphorylation of the actin severing protein 
villin, and this may be another mechanism of regulation for severing proteins (Kumar and 
Khurana, 2004). Tyrosine phosphorylation has been shown to abrogate the requirement of 
calcium for severing by villin. Gelsolin has also been shown to be tyrosine phosphorylated
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in vivo (Wang et al, 2003) and this mechanism of regulation is proposed to extend to other 
related actin severing proteins.
Identification of two potential actin binding regions in the N-terminus of Ysc84p 
proposed subsequent studies which remain incomplete. In order to investigate the 
localisation of the actin binding region of Ysc84p, and following initial F-actin high speed 
sedimentation assays which localised the actin binding region of Ysc84p to the N-terminus 
of the protein, a third GST tagged fusion was generated. A 293 bp region of the Ysc84p 
coding sequence was amplified by PCR, corresponding to amino acids 8 7 -  184 of Ysc84p 
(figure 4-17). This fragment was amplified from plasmid pKA259 using oligonucleotides 
oKA366 and oKA251. Amplification engineered BamHI and EcoRl restriction sites at 
product ends, allowing cloning of the fragments into the pGEX4T2 vector (pKA143) at 
corresponding sites; generating a plasmid pGEX4Tl-y.rcS4(259-552) (pKA394) which 
encodes a 97 amino acid fragment of Ysc84p in fusion with an amino-terminal GST tag 
(GST-Ysc84-'*'Nt). Expression and purification of this fusion protein was successful, 
however due to the low yield of fusion protein obtained and limitations of time, the actin 
binding abilities of this construct remain untested. This construct lacks both predicted actin 
binding regions and it is proposed therefore that this fusion construct will not bind directly 
to F-actin. Further investigation must however be performed in order to ascertain the 
precise F-actin binding domain of Ysc84p, with the generation of further protein 
fragments. The actin binding ability of this fusion protein will however indicate whether 
the actin binding domain is lacking or incomplete in this construct.
While we have observed the binding, severing and capping activity of Ysc84p in 
vitro, the mechanism for these activities remains to be elucidated. Identification of capping 
activity in vitro is a however a significant development. Capping proteins are thought to 
play an important role in the regulation of actin dynamics by localising filament 
polymerisation to specific sites. By capping the ends of specific filaments, the availability 
of filament ends free to undergo polymerisation is affected, allowing polymerisation to be 
confined or ‘funnelled’ to filament sites which lack bound capping protein. This proposal 
has been strengthened by studies of Listeria (David et al, 1998). Capping protein is known 
to be a component of actin comet tails in Listeria. In a system comprising of pure proteins, 
decreasing the available amount of capping protein was shown to abolish the motility of 
Listeria, suggesting filament capping and ‘funnelling’ may drive motility (Loisel et al
1999). Studies have also shown that most cellular actin filament barbed ends are not freely
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Ysc84 N-terminal 
Homology domain 
1 _____  184
SH3 domain 
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218
Ysc84-Nt
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Ysc84-*Nt
Figure 4-17. TheYsc84-*Nt fragment fused to GST. The highly conserved amino- 
terminal o f Ysc84 encompasses residues 1-184. The Ysc84-Nt fragment encompassing 
residues 1 - 2 1 8  has previously been shown to bind, cap and sever actin filaments in 
vitro. Potential actin binding regions have been identified in Ysc84p and encompass 
residues 12-65 and 207-223 o f Ysc84p (marked above). A small fragment, Ysc84-*Nt 
has been generated encompassing residues 87 -  184 and lacking both potential actin 
binding regions.
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accessible, suggesting many may be capped. The low concentration of cellular actin 
in non-motile yeast cells (0.1% of total protein) compared to highly motile Dictyostelium 
(10% of total protein), suggests that the main function of actin regulating proteins in yeast 
may not be to hold back spontaneous polymerisation, but to act instead in the stabilisation 
and precise regulation of the actin network in yeast.
Capping protein (CP) has been shown to bind to the barbed ends of actin filaments 
in S. cerevisiae, preventing further monomer addition or monomer loss from filament ends 
(Karpova, 1995). Capping protein is conserved throughout the eukaryotes, with the 
heterodimeric protein being encoded by CAPl and CAP2 in yeast. CP is known to co- 
localise with F-actin both at cortical actin patches and with actin cables (Amatruda et al 
1992). CP deletion has been shown to affect the stability of actin, with a decrease in F- 
actin and increase in G-actin, and is lethal in conjunction with deletion of the actin filament 
binding protein yeast fimbrin (Sac6p). Deletion of Ysc84p appears not to affect the actin 
cytoskeleton of S. cerevisiae (Dewar et al, 2002) suggesting that the capping activity of 
Ysc84p is not a requirement for the control of actin dynamics in the yeast, or that 
functional redundancy with other proteins exists.
The co-localisation of Ysc84p with cortical actin patches (Dewar et al, 2002) and 
newly determined actin binding, severing and capping activity of the protein in vitro 
strongly implicate Ysc84p in the regulation of actin at endocytic sites in vivo. Actin is 
known to be recruited to endocytic sites in the later stages of vesicle development and is 
thought to be the driving force for endocytic vesicle fission and the movement of endocytic 
vesicles into the cell. The endocytic model proposed by Kaksonen and colleagues 
(Kaksonen et al, 2003) demonstrates the accumulation of LaslVp, Sla2p and Slalp at early 
endocytic sites, followed by recruitment of actin, Abplp and the Arp2/3 complex (figure 1- 
12). Actin, Arp2/3 and Abplp then dissociate from early endocytic proteins, moving off 
with newly endocytosed vesicles into the cytoplasm. A transient interaction between 
Ysc84p and Slalp, and co-localisation of Ysc84p with actin, suggests Ysc84p is recruited 
to endocytic sites at the same time as actin, and is in close proximity to Slalp for only a 
short time before moving off with actin, into the cell. The interaction between Ysc84p and 
LaslVp suggested by 2-hybrid analysis may also occur at this time. The requirement of 
both Abplp and LaslVp for localisation of Ysc84p to cortical patch sites (Dewar et al,
2002) additionally suggests that that the mechanism of Ysc84p recruitment to endocytic 
sites may involve these proteins.
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Studies of actin comet tails which associate with the motile bacterial pathogens, Listeria 
and Shigella demonstrate the orientation of polarised actin filaments, by decoration of the 
filaments with the SI fragment of myosin. These studies reveal that filament barbed ends 
are orientated towards the bacterial surface, indicating that polymerisation occurs on or 
near to the bacterial surface (Gouin et al, 1999). The barbed end capping protein CapZ has 
been shown to co-localise with actin comet tails in both Listeria and Shigella (David et al, 
1998; Gouin et al, 1999). These studies support a role for the requirement of filament 
capping in promoting F-actin linked motility, as suggested by models proposing 
‘funnelling’ of actin polymerisation. Ysc84p may therefore cap and sever actin filaments at 
cortical endocytic sites, promoting vesicle motility by the control of actin polymerisation. 
A model for Ysc84p recruitment and regulation of actin at endocytic sites is therefore 
proposed in figure 1-18.
Generation of Ysc84p specific antibodies was a significant development which was 
not exploited fully in this study, due to limitations of time. Studies performed following 
my departure from the lab have however made use of these antibodies, and have proved 
very successful. Antibodies were initially raised against the GST-Ysc84-Nt fusion protein 
and specifically recognise Ysc84p (section 4.2.8). Subsequent analysis has however shown 
that these antibodies also recognise a single band, by Western analysis of whole cell Ref52 
and Hela extracts. The band identified has an approximate molecular weight of 38 kDa, 
similar to the 34.8 kDa Mwt predicted for the Ysc84p human homologue hSH3yl-l. 
Antibodies were therefore used for immunofluorescence studies in Ref52 cells and 
identified a protein which localises both to membrane ruffles and focal adhesions (Steve 
Winder, unpublished data). A GFP-hSH3yl-l construct generated during the course of this 
study has also been transfected into, and localised in Ref52 cells (Steve Winder, 
unpublished data). The tagged protein localises to focal adhesions, lamellipodia and 
filopodia (data not shown). These studies suggest that rabbit antibodies raised to Ysc84p in 
this study also specifically recognise hSH3yl-l, and in combination with GFP localisation 
of hSH3yl-l, demonstrate the localisation of hSH3yl-l to sites of dynamic actin 
remodelling, suggesting that hSH3yl-l may have similar actin regulating abilities as 
Ysc84p.
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Figure 4-18. Proposed involvement of Ysc84p in endocytosis. Co-localisation of 
Ysc84p with cortical actin patches suggests this a role in the regulation o f actin at 
endocytic sites. The mechanism of recruitment of Ysc84p to endocytic sites remains 
unknown, however Lasl7p and Abplp have been implicated in this. The polymerisation 
of actin and formation o f cortical actin patches at developing endocytic sites places 
Ysc84p at this location. Transient interactions with the cortical adaptor Slalp may also 
occur at this time. Actin ‘comet tails’ are known to associate with vesicles following their 
release from the plasma membrane. The action of Ysc84p as an actin associated filament 
severing and capping protein strongly suggests an involvement in the generation of 
vesicle movement mediated by actin polymerisation.
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5 GTSl IS AN Arf-GAP HOMOLOGY PROTEIN THAT INTERACTS WITH
SLAl AND YSC84
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Abstract
Gts Ip has been shown to have a role in the regulation of budding in S. cerevisiae 
and to contain regions of homology to both a ubiquitin associated domain (UB A) and to an 
ADP-ribosylation factor GTPase activating (Arf-GAP) motif. Using GFP-tagged Gtslp, 
our studies have localised Gtslp to punctuate patches at the cell cortex, a localisation 
which is independent of both Slalp and F-actin. Yeast 2-hybrid analysis has also enabled 
confirmation and identification of domains of Slalp and Ysc84p which interact with Gtslp 
by yeast 2-hybrid analysis. Additionally, GTSl deletion suggests the protein plays a role in 
the regulation of endocytic uptake, a role which is potentially mediated by interaction with 
Slalp and Ysc84p.
5.1 Introduction
Gtslp/FGLiSiW has been shown to interact with the cortical patch proteins Panlp 
and Ysc84p, the actin regulating adaptor protein Rvsl67p, and the cortical adaptor protein 
Slalp, by large scale yeast 2-hybrid screen (Uetz et al, 2000). This screen also reported a 
2-hybrid interaction with Yapl802p, a member of the API 80 protein family known to bind 
both to clathrin and Panlp (Uetz et al, 2000). Gtslp was originally described by Mitsui and 
colleagues, when overexpression of Gtslp was shown to delay budding in S. cerevisiae and 
consequently increased cell size (Mitsui et al, 1994). Disruption of the gene was in addition 
shown to accelerate budding and subsequently to reduce cell size.
In yeast, oscillations in the rate of energy metabolism have been identified during 
continuous cell culture in aerobic conditions. These oscillations are seen as periodic 
changes in oxygen metabolism, carbon dioxide production and glucose and ethanol levels. 
Response to stresses including heat shock, oxidative agents and cytotoxic chemicals has 
also been shown to induce oscillations of the same frequency (Wang et al, 2001b). 
Disruption or overexpression of GTSl affects growth rates in the presence of cytotoxic 
drugs and the life span of cells. Energy metabolism oscillations were seen to become 
irregular in a Agtsl strain, suggesting Gtslp has an important role in the regulation of these 
oscillations (Akiyama and Tsurugi, 2003). Additionally, intracellular reactive oxygen 
species (ROS) levels are elevated in a Agtsl strains, and following overexpression of 
G tslp (Abudugupur et al, 2003). Cellular increases in ROS are known to conelate directly 
with a decrease in the life span of cells.
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G tslp was originally named due to the presence of glycine/threonine and serine 
repeats in the predicted amino acid sequence of the protein. Due to an error in the DNA 
sequence however, and subsequent frame shift, this G/T repeat has been replaced in the 
present version of the predicted amino acid sequence by an A/Q repeat. Gtslp also 
contains a CxxCx(16)CxxC motif in the N-terminus of the protein from residues 30-53, 
which resembles a zinc-finger (Zn-finger) motif. Additionally, the identification of a 
stretch of poly-Glutamine (Poly-Gln) in the C-terminus of the protein, commonly found in 
transcription factors and transcriptional activators, led to the protein originally being 
originally identified as a nuclear zinc-finger transcription factor (Bossier et al, 1997). The 
lack of a highly conserved nuclear localisation signal and homology to an Arf-GTPase 
activating (Arf-GAP) domain between residues 14 -141, however suggests that Gtslp is 
instead likely to be involved in cytoplasmic interactions with endocytic and actin 
regulating proteins. Reported 2-hybrid interactions with Ysc84p, Rvsl67p and Slalp 
support this suggestion, while a global GFP study in yeast suggested localisation of the 
G tslp to cortical punctate patches (Huh et al, 2003). Analysis by Bossier and colleagues 
has shown that the Gtslp protein is generally hydrophilic, with a weakly hydrophobic 
stretch of amino acids in its N-terminal domain (Bossier et al, 1997). This data suggests 
Gtslp is not a transmembrane protein due to the lack of a strong hydrophobicdomain.
The domains identified in Gtslp are shown in figure 5-1. Identification an Arf-GAP 
domain in the N-terminus of the protein, suggests that Gtslp may induce hydrolysis of 
GTP bound ADP-ribosylation factors (Arfs) (for review see Randazzo and Hirsch, 2004). 
Three Arf proteins have been identified in yeast: Arflp, Arf2p and Arf3p (Lee et al, 1994; 
Stearns et al, 1990). Members of the Arf protein family regulate vesiclar trafficking 
pathways by reversible association with membranes and recruitment of coat proteins to 
sites of vesicle development. The central region of Gtslp from residues 194-234, contains 
a UBA (Ubiquitin associated domain) or TS-N domain. Proteins which contain UBA 
domains have previous been shown to be involved in the ubiquitination of membrane 
proteins. UBA domains consist of three alpha helices and are approximately 45 amino 
acids in length. Additionally, a glutamine rich region has been identified in the C-terminus 
of the protein from residues 311-360.
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A)
1 MRFRSSSHSLKHVDRELKELINSSENANKCGECGNFYPTWCSVNLGVFLCGRCASVHRKV 
61 FGSRDDDAFSNVKSLSMDRWTREDIDELVSLGGNKGNARFWNPKNVPFPFDGDDPKAIVE
121 HYIRDKYILGKFRYDEIKPEDFGSRMDDFDGESDRFDERNRSRSRSRSHSFYKGGHNRSD 
181 YGGSRDSFQSSGSRYSRQLAELKDMGFGDTNKNLDALSSAHGNINRAIDYLEKSSSSRHS 
2^1 VSAAATTSTPPLPRRRATTSGPQPAIFDGTNVITPDFTSNSASFVQAKPAVFDGTLQQYY
DPATGMIYVDQQQYAMAMQQQQQQQQQLAVAQAQAQAQAQAQAQVQAQAQAQAQAQAQAQ
QMQQLQMQQQQQAPLSFQQMSQGGNLPQGYFYTQ
B)
Zinc finger
Gtslp GTPase activating 
domain
ubiquitin associated 
domain
glutamine rich
Figure 5-1. Predicted domains of G tslp. A) The 393 amino acid protein sequence is shown. 
Residues 14 -  141 form a putative GTPase activating domain (underlined and shown in bold). 
Residues 27 -  57 were originally reported as a zinc finger domain. Residues 311-360 form a 
glutamine rich region (underlined), while residues 194-234 (italicised) reportedly form a ubiquitin 
associated domain (or TS-N domain). Domains identified using the motif scan at http//hits isb- 
sib.ch/cgi-bin/PFSCAN. B) The putative GTPase activating domain is shown (dark grey). 
Reported zinc finger domain is also shown. The glutamine rich region is shown (crosshatched), 
and the ubiquitin associated domain (or TS-N domain) (light grey).
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5.2 Results
5.2.1 Gtslp interacts with Slalp and Ysc84p, as determined by yeast two
hybrid analysis
Previous large scale 2-hybrid screens have identified interactions between Gtslp, 
the cortical patch protein Ysc84p, and the cortical adaptor protein Slalp (Uetz et al, 2000). 
My aim was to confirm these interactions, and to further define the interacting regions in 
both Slalp and Ysc84p. 2-hybrid analysis is described in detail in sections 2.5.1 - 2.5.3 of 
the Materials and Methods. GTSl was initially cloned in-frame into the Gal4-binding 
domain plasmid (pGBDU-Cl). Correct integration of GTSl was confirmed by sequencing 
and a plasmid encoding an N-terminal Gal4-binding domain Gtsl fusion protein (Gal4- 
BD-Gtsl) generated. This plasmid was then transformed into yeast two-hybrid strain, 
pJ69-4a. Gal4-activation domain plasmid (pGAD-C2) constructs, encoding regions of both 
Ysc84p and Slalp fused N-terminally to the Gal4-activation domain, had previously been 
generated and are summarised in table 5-1. Plasmids encoding these N-terminal Gal4- 
activation domain fusions were then individually transformed into the yeast two-hybrid 
stain pJ69-4a. pJ69-4a strains containing plasmids encoding full-length, N-terminal Gal4- 
activation domain tagged Slalp and Ysc84p (KAY750 and KAY751, respectively) were 
also obtained commercially (Invitrogen). The 2-hybrid strain pJ69-4a, containing the Gal4- 
BD-Gtsl encoding plasmid was then sequentially mated with pJ69-4a strains containing 
plasmids encoding the N-terminal Gal4-activation domain Ysc84p and Slalp fusions, and 
also with the pJ69-4a strains encoding full length Ysc84p and Slalp fusions. Following 
mating, diploids containing both plasmid constructs were selectively grown on drop-out 
leucine and tryptophan synthetic media to ensure retention of both plasmids (figure 5-2A). 
Diploid strains were then assayed for interaction of the Gal4-BD-Gtsl fusion protein with 
N-terminal Gal4-activation domain fusions proteins; by growth of the strains on drop-out 
leucine, tryptophan and histidine synthetic media, to which adenine had been added (figure 
5-2B). Interaction between the two Gal4-domain fusion constructs brings the Gal4-binding 
and activation domains into close proximity, allowing expression of the HIS3 gene and 
subsequent growth on media lacking histidine. The addition of adenine to this selective 
media increased the stringency of this selection.
Figure 5-2B demonstrates the growth of diploid strains on drop-out leucine, 
tryptophan and histidine media containing adenine. Results confirm previous reports of a 
2-hybrid interaction between Gtslp and Ysc84p, with substantial growth of a diploid strain 
expressing Gal4-BD-Gtsl and Gal4-AD-Ysc84 seen. Additionally, analysis of the
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interaction of Gtslp with various Ysc84p fragments demonstrates the importance of the C- 
terminal SH3 domain of Ysc84p for interaction with Gtslp. A diploid strain expressing 
Gal4-BD-Gtsl and a Ysc84p construct which lacks the C-terminal SH3 domain (Gal4-AD- 
Ysc84-(-SH3)) did not grow on drop-out leucine, tryptophan and histidine media with 
adenine. Strong growth was however seen in diploids expressing Gal4-BD-Gtsl with 
Ysc84p constructs: Gal4-AD-Ysc84-(143-468), Gal4-AD-Ysc84-(181-468) and Gal4-AD- 
Ysc84-(229-468). These Ysc84p fragments decrease in size, with sequential removal of N- 
terminal residues. All fragments constructs however contained the C-terminal SH3 domain 
of Ysc84p. Data also confirms previous reports of a 2-hybrid interaction between Gtslp 
and Slalp, with strong growth of a diploid strain expressing Gal4-BD-Gtsl and Gal4-AD- 
Slal shown. Additionally, interaction between the Gtslp and a fragment of Slalp which 
encompasses the three N-terminal SH3 domains was assayed, by growth of a diploid strain 
expressing Gal4-BD-Gtsl and Gal4-AD-Slal-SH3#l-3. Slow growth of this diploid strain 
suggested that while this region of Slalp could mediate interaction with Gtslp, additional 
domains of Slalp may strengthen this interaction.
Plasmid Description
pKA388 Gal4-BD-Gtsl
pKA32B Gal4-AD-Slal-SH3#l-3
pKA251 Gal4-AD-Ysc84-(-SH3)
pKA241 Gal4-AD-Ysc84-(229-468)
pKA242 Gal4-AD-Ysc84-(I81-468)
pKA243 GaI4-AD-Ysc84-( 143-468)
pKA163 Gal4-AD empty activation domain (pGAD)
Table 5-1 2-hybrid constructs assayed
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A)
Sla1-SH3#1-3
Ysc84-(-SH3)
Ysc84
B)
Sla1
Sla1-SH3#1-3
Ysc84-(-SH3)
Ysc84
Ysc84-(229-468)
Ysc84-(181-468)
Ysc84-(143-468)
empty activation 
domain
Sla1-SH3#1-3
Ysc84-(229-468)
Ysc84-(181-468)
Ysc84-(143-468)
empty activation 
domain
Figure 5-2. G tslp interacts with Ysc84p and Slalp by 2-hybrid.
Diploid strains containing both the GaI4-BD-Gtsl encoding plasmid and fusion constructs 
detailed in table 5-1 and obtained commercially were grown on A) drop-out leucine and 
tryptophan synthetic media ensure retention o f both fusion construct plasmids, and B) drop-out 
leucine, tryptophan and histidine synthetic media containing adenine, to assay interaction o f the 
proteins o f interest.
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5.2.2 Gtslp interacts with the N-terminal SH3 domains of Slalp and the
SH3 domain of Ysc84p
Following confirmation of 2-hybrid interactions between Gtslp, Ysc84p and 
Slalp, and identification of domains able to mediate these interactions, the strength of 
these 2-hybrid interactions was investigated using the p-galactosidase assay (section 
2.5.3). Expression levels of the reporter gene, lacZ (which encodes p-galactosidase) can 
be measured by following the catalytic hydrolysis of the ONPG (o-nitrophenyl-8-D- 
galactopyranoside); a substrate cleaved by p-galactosidase to the bright yellow product, 
o-nitrophenol (ONP). The strength of this colour change is used to determine the 
strength of yeast 2-hybrid interactions in p-galactosidase units. P-galactosidase assays 
were performed in triplicate on the diploid strains previously described (section 5.2.2). 
Results of these assays are shown in figure 5-3.
The basal level of lacZ expression was determined using a strain containing the 
Gal4-BD-Gtsl plasmid (pKA388) and a control, empty Gal4-activation domain plasmid 
(pKA163). The basal level was determined as 1.69 ± 0.66 p-galactosidase units. A 
strong interaction between Gtslp and full length Slalp was also determined, following 
calculation of the strength of interaction in a diploid strain expressing Gal4-BD-Gtsl 
and Gal4-AD-Slal as 10.80 ± 0.96 P-galactosidase units. Deletion of the central and C- 
terminal domains of Slalp from residues 415 to 1244 however produced a substantial 
drop in this reading to a basal level of 1.99 ± 0.47 p-galactosidase units, suggesting the 
importance of the central and C-terminal domains of Slalp in mediating a strong 
interaction with Gtslp.
The interaction between Gtslp and full-length Ysc84p was recorded as 3.65 ± 
0.06 p-galactosidase units, substantially weaker than the interaction of Gtslp with full- 
length Slalp. This interaction was lost following deletion of the C-terminal SH3 domain 
of Ysc84p, and assays generated readings of 2.49 ± 0.34 p-galactosidase units, close to 
basal levels. Additionally, analysis of the interaction between G tslp and the shortest 
Ysc84p fragment Ysc84-(229-468), produced a decrease in reporter gene expression 
compared to that recorded for full-length Ysc84p, a reading of 3.14 ± 0.11 p- 
galactosidase units. Interactions between Ysc84p fragments, Ysc84-(181-468) and 
Ysc84-( 143-468) however showed an small increase in p-galactosidase expression 
when compared to the full length protein with levels of 4.02 ± 0.34 and 4.65 ± 0.70 p- 
galactosidase units respectively. These results confirm the importance of the SH3 
domain of Ysc84p for interaction with Gtslp. Analysis of Ysc84p fragments
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additionally suggests that the interaction mediated by the C-terminal domains of 
Ysc84p, may be strengthened by the inclusion of N-terminal domains.
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Figure 5-3. Testing the strength of interaction between G tslp, Ysc84p and Slalp by p- 
Galactosidase assay
P-galactosidase assays were performed on diploid strains containing both the Gal4-BD-Gtsl 
encoding plasmid and fusion constructs detailed in table 5-1 and obtained commercially. Results are 
shown graphically in P-galactosidase units.
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5.2.3 Gtslp localises to punctate structures at the plasma membrane,
independently of both Slalp and F-actin
Identification of an N-terminal region of Gtslp which shows homology to an Arf- 
GAP motifs, suggests a cytoplasmic localisation for Gtslp and regulation of members of 
the small GTPase ADP-ribosylation factor (Arf) family. Two hybrid interactions with the 
cortical patch protein Ysc84p and the adaptor protein Slalp; a protein which localises to 
both punctuate patches at the cell cortex and to the nucleus, also suggest that G tslp may be 
found in the cytoplasm. In order to identify the cellular localisation of Gtslp, a green 
fluorescent protein (GFP) tagged Gtslp construct was obtained (Research Genetics) in a 
wild-type background (KAY725). GFP-tagged Gtslp was localised by microscopy and 
direct observation of GFP fluorescence following growth of the strain in YPAD media. 
Images obtained are shown in figure 5-4. Gtsl-GFP is seen to localise to punctuate patches 
at the cell cortex. These patches polarise during budding and accumulate in the newly 
developing bud. Polarisation of these patches suggests a possible co-localisation or 
overlapping localisation with cortical actin patches.
The yeast 2-hybrid interaction between Gtslp and Slalp, suggests Slalp may be 
involved in the recruitment of Gtslp to punctate patches at the cell cortex. To investigate 
the role of Slalp in the localisation of Gtslp, Gtsl-GFP was localised in a Aslal strain 
(KAY752). The localisation of Gtsl-GFP to punctuate patches at the cell cortex was 
unaffected in a Aslal strain (figure 5-5).
Given that slal deletion has been shown to produce yeast cells with a distinct actin 
phenotype of fewer and enlarged cortical actin patches, mislocalisation of Gtsl-GFP in a 
Aslal strain would be expected if the localisation of Gtslp was dependent on actin. In 
order to confirm that Gtslp localises independently of the actin cytoskeleton, localisation 
of Gtsl-GFP in a Latrunculin-A treated wild-type strain (KAY725) was performed (section 
2.7.6). Latrunculin-A treatment causes rapid depolymerisation of F-actin. Following 
Latrunculin-A treatment, this strain was examined for complete disruption of actin 
structures by rhodamine phalloidin staining (Ayscough et al, 1997). The localisation of 
Gtsl-GFP in this strain is shown in figure 5-6. Gtsl-GFP was seen to localise to punctuate 
structures at the cell cortex, demonstrating that G tslp localises to these sites independently 
of F-actin. Polarisation of Gtsl-GFP in both Aslal cells and latrunculin-A treated cells was 
seen during budding, suggesting recruitment to sites of cell growth occurs independently of 
both F-actin and Slalp.
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Figure 5-4. GFP-Gtsl localises to punctuate patches at the cell cortex.
The strain KAY725 expresses an N-terminal GFP-tagged Gtsl construct. The GFP tagged 
protein was localised in this strain by direct fluorescence (upper panels). Nomarski images are 
shown in the lower panels.
Figure 5-5. GFP-Gtslp localisation is unaflected in a Sslal strain.
The Ssla l strain KAY752 expressed a genomically tagged N-terminal GFP-Gtsl construct. 
GFP-Gtsl was localised by direct fluorescence.
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Figure 5-6. GFP-Gtslp localises to punctuate patches at the cell cortex in Latrunculin-A 
treated cells. The strain KAY725 expresses a GFP-Gtsl construct. Latrunculin-A was added to 
the strain during log-phase growth 15 minutes. Complete disruption of the actin cytoskeleton 
was visualised by rhodamine phalloidin straining. GFP-Gtsl localisation was performed by 
direct fluorescence. Nomarski images are shown in the panels below.
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5.2.4 GTSl deletion indicates that the protein plays a role in endocytosis and
actin organisation
Given that G tslp interacts with the endocytic proteins Ysc84p and Slalp by yeast 
2-hybrid, and that Gtslp localises to punctuate structures at cortical sites which polarise 
during budding, data suggested a role for Gtslp in the regulation of endocytosis. The study 
of a gtsl deletion mutant was therefore undertaken in order to provide insight into the role 
of the G tslp at the cell cortex.
Haploid and diploid Agtsl strains (KAY709 and KAY710 respectively) were 
obtained (Invitrogen) and phenotypic analysis of these mutants performed, in conjunction 
with their respective parental wild-type strains (KAY 446 and KAY 480). Agtsl strains 
demonstrated a mild defect in the organisation of the actin cytoskeleton as determined by 
rhodamine phalloidin staining (section 2.7.3). Polarisation of actin towards a new bud site 
was seen to occur before completion of cytokinesis in 10% of the cells examined (figure 5- 
7), demonstrating that gtsl deletion has only a subtle effect on actin organisation. This 
budding defect may however be linked to the reported acceleration of budding and 
associated reduction in cell size following disruption of gtsl (Mitsui et al, 1994). 
Additionally, Nomarski images (figure 5-8) suggested an elongation of cells in the diploid 
Agtsl strain during budding and cytokinesis. Lucifer yellow uptake assays identified a 
reduction in uptake of the dye in Agtsl strains, demonstrating defects in fluid phase 
endocytosis (figure 5-8). Uptake was reduced by approximately 60% in 70% of Agtsl 
haploid cells examined and decreased by approximately 50% in 85% of Agtsl diploid cells 
examined, as determined qualitatively. Additionally, a decrease in the uptake of the 
lipophilic styryl dye FM4-64 ((N-triethylammoniumpropyl)-4-(p- 
diethylaminophenylhexatrienyl) pyridinium dibromide) in both Agtsl haploid and diploid 
strains suggested further endocytic defects, characterised by a decrease in internalisation of 
the cell membrane (figure 5-7). An approximately 80% decrease in FM4-64 uptake was 
identified in 62% of Agtsl haploid cells and 71% of Agtsl diploid cells examined, as 
determined qualitatively. The methods for assaying both lucifer yellow and FM4-64 uptake 
are described in sections 2.7.4 and 2.7.5 respectively.
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A) AGTS1 haploid wild-type haploid
B ) AGTS1 haploid 
L
AGTS1 diploid wild-type diploid
wild-type haploid
AGTS1 diploid wild-type diploid
Figure 5-7. Deletion of GTS! causes a mild actin defect and defects in the endocytic 
internalisation of membranes. A) Rhodamine phalloidin staining was performed on a haploid 
/strain (KAY 709), diploid tSgtsl deletion strain (KAY 710), and parental wild-type 
haploid (KAY446) and diploid (KAY480) strains. Accumulation o f actin at a new bud site was 
seen to occur early, before cytokinesis had concluded in the diploid GTSI deletion strain 
(arrow). B) FM4-64 uptake assays were also performed on the haploid Sg tsl deletion strain, 
diploid /deletion strain, and parental wild-type haploid and diploid strains. 10 pM bars are 
shown.
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AGTSl haploid wild-type haploid
r r r r
f
AGTSl diploid wild-type diploid
/  AGTSI haploid wild-type diploid
AGTSl diploid wild-type diploid
Figure5-8. Deletion of G TSI causes defects in fluid phase endocytosis. A) Nomarski images of 
haploid Agtsl strain (KAY709), diploid Agtsl strain (KAY710), and parental wild-type haploid 
(KAY446) and diploid (KAY480) strains. B) Lucifer yellow uptake assays were also performed on 
these strains.
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5.3 Discussion
Data presented in this chapter confirms that the initial identification of Gtslp 
as a nuclear transcription factor was incorrect. Cellular analysis has demonstrated that 
G tslp localises to the cell cortex in punctate patches and has a role in the regulation of 
actin and endocytic uptake. Consistent with previous reports (Uetz et al, 2000), we 
also find that G tslp interacts with Slalp and Ysc84p by yeast 2-hybrid. Our yeast 2- 
hybrid and p-galactosidase assays additionally demonstrate that the C-terminal SH3 
domain of Ysc84p is important for mediating the interaction with Gtslp, and that the 
N-terminal domains of Slalp mediate interaction with Gtslp.
A previous yeast 2-hybrid screen has also demonstrated interactions between 
Gtslp and Rvsl67p, Panlp, Slalp and Ysc84p (Uetz et al, 2000). Given that Panlp, 
Slalp and Ysc84p localised to endocytic sites (Dewar et al, 2002; Kaksonen et al,
2003), yeast 2- hybrid interactions with these proteins suggested that Gtslp may also 
localise to endocytic sites or have a role in the regulation of actin. In this study, I have 
confirmed the interaction of Gtslp with the cortical patch proteins Ysc84p and Slalp 
by yeast 2-hybrid analysis and determined the regions mediating these interactions to 
be located in the N-terminal domains of Slalp and the C-terminal SH3 domain of 
Ysc84p (sections 5.2.1 and 5.2.2). The interaction of the N-terminal domain of Slalp 
with Gtslp was however substantially weaker than that seen with full-length Slalp, as 
determined by p-galactosidase assay. This suggests that additional domains may 
strengthen the interaction mediated by the N-terminal domains of Slalp. These 
interactions must however be confirmed biochemically.
Significant progress has also been made in the characterisation of the cellular 
role of Gtslp. G tslp was localised to punctuate structures at the cell cortex which 
polarised to sites of cell growth during budding (section 5.2.3). This localisation and 
potential in vivo interactions with Slalp and Ysc84p, suggested a role for Gtslp in the 
regulation of endocytosis. Localisation of the protein to cortical sites was however 
shown to occur independently of both Slalp and F-actin; two integral endocytic 
components required for endocytic uptake (section 5.2.3). Localisation of Gtslp to the 
cell cortex therefore occurs via an as yet undefined mechanism. Potentially however, 
localisation may be mediated through interaction with Panlp or Rvsl67p as suggested 
by 2-hybrid analysis (Uetz et al, 2000) or by interaction with additional membrane
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associated or endocytic proteins. Consistent with a role in the regulation of 
endocytosis, deletion of gtsl in both haploid and diploid strains generated defects in 
fluid phase endocytosis and mild actin defects. Uptake of the lipophilic dye FM4-64 
was also aberrant in /S^gtsl strains, indicating an inhibitory effect on later endocytic 
events and internalisation of the cell membrane (section 5.2.4).
Biochemical analysis must be performed to confirm interaction between 
Gtslp, Ysc84p and Slalp, initial data however suggests that G tslp may link Slalp 
and Ysc84p at the cell cortex and may also regulate proteins of the Arf family. 
Regulation of Gtslp has been investigated in a study by Yaguchi and colleagues. Two 
forms of Gtslp were identified by SDS-page gel electrophoresis and the slower 
migrating form of Gtslp lost upon treatment with protein phosphatase (Yaguchi et al,
2000). This data identifies a phosphorylated form of Gtslp and suggests that Gtslp 
may be regulated by phosphorylation.
One potential mechanism for Gtslp recruitment and interaction with endocytic 
components is via Arf3p. The ADP-ribosylation factors (Arfs) are a family of small 
ubiquitously expressed Ras-like GTPases that are central to many vesicular transport 
processes. Like other GTPases, these proteins cycle between the active, GTP-bound 
form and the inactive GDP-bound form, and require accessory factors to mediate the 
conversion between GTP and GDP bound states. Arf guanine-nucleotide exchange 
factors (GEFs) catalyse the exchange of GDP for GTP, while Arf GTPase activating 
factors (GAPs) induced hydrolysis of GTP to GDP (for review see Randazzo et al,
2004). The identification of an Arf-GAP domain in Gtslp suggests the ability of 
G tslp to induce hydrolysis of GTP-bound ADP-ribosylation factors (Arfs). Arf3p has 
been shown to localise primarily to the cell periphery in S. cerevisiae, exhibiting a 
punctate fluorescence at the cell periphery and an evenly distributed cytoplasmic 
staining which polarises towards sites of cell growth during budding (Huang et al,
2003). Arf Ip and ArfZp are primarily Golgi localised. The mammalian homologue of 
Arf3p is Arf6. Arf6 retains a high level of sequence conservation, showing 60% 
identity at the amino acid level. Arf6 localises to the plasma membrane and has been 
implicated in early endocytic events (Millar et al, 1999; Altschulter et al, 1999; for 
review see Donaldson, 2003). Recent data from our lab has disproved initial findings 
that Arf3p is not linked to endocytosis (Huang et al, 2003). LsbSp interacts with 
Slalp, which regulates both actin structures and endocytic components at the plasma 
membrane (Dewar et al, 2002; Costa et al, 2005). By demonstrating a biochemical
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interaction between Arf3p and Lsb5p, a link between Arf3p and endocytic uptake has 
been shown (Costa et al, 2005). Endocytosis is however unaffected in arf3 mutant 
cells (Huang et al, 2003). The mammalian Arf3p homologue, Arf6 activates PIP5- 
kinase in vivo, which generates phosphatidylinositol 4,5-bisphosphate (PIP2) a key 
phosphoinositide at the cell cortex which is involved in membrane trafficking and 
actin regulation (Yin and Janmey, 2003). Arf3p was therefore proposed to regulate 
actin in a similar mechanism, however recent studies suggest that Arf3p does not 
directly regulate actin but instead has a role in polarisation and bud site selection 
(Huang et al, 2003). Intriguingly, the mild actin defect demonstrated in our 
Ag^f7diploid strain also suggests role for Gtslp in bud development (section 5.2.4). 
Disruption of the GTSl has previously been shown to accelerate budding (Mitsui et 
al, 1994).
The presence of an Arf-GAP domain in Gtslp and the localisation of both 
Gtslp and Arf3p at the cell periphery suggest G tslp may inactivate Arf3p. The active 
form of Arf3p and other Arf proteins have been shown to be membrane associated 
(Gaschet and Hsu, 1999; Huang et al, 2003), while the GDP bound form remains 
primarily cytoplasmic. The action of Gtslp may therefore inactivate and release Arf3p 
from the plasma membrane. However, while Gtslp has homology to the Arf GAP 
domain, previous analysis has demonstrated that Gtslp lacks the ability to rescue 
growth of an arf 1-3 mutant at 3T C  when overexpressed on a high-copy number 
plasmid. Overexpression of other known Arf-GAPs: SATl, GCSl, GL03, and 
YIL044C/SAT2 have been shown to compensate for the loss of Arf function associated 
with arf 1-3  (Zhang et al, 1998). This questions the ability of G tslp to act as an Arf- 
GAP. The potential Arf-GAP activity of Gtslp therefore should be examined in future 
work.
Data presented in this chapter has enabled us to propose several potential 
G tslp interactions which may occur in vivo (figure 5-9). We propose that Gtslp 
interacts with Slalp and Ysc84p at the cell cortex, as suggested by yeast 2-hybrid 
analysis (sections 5.2.1 and 5.2.2). Additionally, homology to an Arf-GAP domain 
suggests Gtslp may regulate Arf proteins, and specifically Arf3p which localises 
predominantly to the plasma membrane in yeast. Arf3p, through homology to 
mammalian Arf6 is proposed to interact with adaptor proteins and coat proteins at 
plasma membrane (Austin et al, 2002). While Arf6 is not involved in recruitment of 
GGAs to the trans-golgi network (TGN), it does however appear to recruit GGAl to
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putative early endosomes (Takatsu et al, 2002), suggesting that Arf6 may be involved 
in the recruitment of specific proteins to compartments other than the TGN. 
Interestingly, Arf3p has recently been shown to interact with Lsb5p at the cell cortex; 
a protein which shows significant similarity to the GGA proteins (Costa et al, 2005). 
Yeast Ggalp and Gga2p proteins interact with Arflp and Arf2p but not Arf3p 
(Zhdanina et al, 2001; Huang et al, 2003)). Recruitment of Lsb5p to the cell cortex is 
dependent on Arf3p and in turn, Lsb5p binds to Slalp (Costa et al, 2005). Through 
homology to the GGA proteins therefore, Lsb5p may be recruited to the plasma 
membrane by Arf3p in its GTP bound form, potentially stabilising Arf3p, as 
stabilisation of Arflp by several GGAs has been demonstrated, possibly by direct 
competition with Arf-GAP proteins for a binding site (Puertollano et al, 2001). The 
action of Arf3p in the GTP bound form additionally may be regulated by the 
recruitment of Gtslp which potentially promotes hydrolysis of GTP through its Arf- 
GAP domain.
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Plasma membrane
sb5|
Slalp
Ysc84d
G tS lD
Endocytic
components
Actin regulation at 
endocytic sites
Figure 5-9. Proposed G tslp interactions at the cell cortex. Gtslp may regulate ArfBp 
at the plasma membrane via its Arf-GAP domain. In addition, 2-hybrid interactions 
suggest Gtslp interacts with both Ysc84p and Slalp in vivo. Slalp has been previously 
shown to interact with Lsb5p which interacts with Arf3p. Known roles are linked by block 
arrows, while proposed interactions are demonstrated with dashed arrows.
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6 THESIS SUMMARY AND FUTURE DIRECTIONS
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6.1 Thesis Summary
The filamentous structure assumed by polymerised cytoplasmic actin is utilised 
in the cell by the organisation of such filaments into a diverse array of structures. These 
structures include both actin cables and patches in S. cerevisiae, and filopodial and 
lamellipodial structures in motile mammalian cells. To achieve this organisation, actin 
regulating proteins regulate filaments on an individual scale, while also co-ordinating 
the integration of filaments into complex filamentous networks. Elucidation of the 
mechanisms controlling the dynamic rearrangements of the actin network is therefore a 
significant challenge to researchers. The activity and function of many specific actin 
regulating proteins have however been the focus of a multitude of studies which are 
enabling the wider picture of cellular actin control to become clear. The focus of my 
work was an investigation of specific proteins which were known to regulate, or were 
proposed to regulate actin in S. cerevisiae. By enabling further insights into the 
activities and regulation of such proteins, I hope to contribute to the overall 
understanding of actin dynamics in S. cerevisiae and in other organisms.
Slalp was previously known as a multifunctional cortical adaptor protein. In 
Chapter 3 however, I present data which details my investigation of nuclear Slalp. This 
analysis has allowed the proposal of a mechanism for the regulated nuclear translocation 
of Slalp. The aberrant nuclear localisation of two slal mutants, was shown to correlate 
with the loss of specific nuclear transport signals, suggesting specific regions of the 
protein which were important for mediating nuclear translocation of Slalp. Subsequent 
studies of nuclear transport receptor mutants also enabled the identification of an 
importin mutant which inhibited nuclear translocation of Slalp. Finally, the microarray 
analysis of a wild-type and a Aslal strain was detailed and the results considered. These 
microarray results may provide crucial clues which may enable the role of nuclear Slalp 
to be identified. Chapter 3 therefore defines the nuclear localisation of a protein 
previously known to localise only to the cellular cytoplasm. This work is the first 
detailed analysis of such a protein in S. cerevisiae.
A mechanism for the nucleai* translocation of phosphorylated Slalp has been 
proposed. The proposed recognition of phosphorylated Slalp by the importin Rsllp, is 
supported by the detection of Slal-myc in an rsll mutant strain. Slal-myc exhibits a 
higher molecular weight in this mutant strain than was seen our wild-type strain (figure 
3-12), suggesting that Slalp exists primarily in a modified, and potentially
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phosphorylated form when nuclear translocation by R sllp is blocked. It is proposed 
therefore that the nuclear translocation, and potentially the nuclear role of Slalp may be 
dependent on protein modification, similar to the role of Slalp in the 
Slalp/End3p/Panlp endocytic complex. Accumulation of a potentially phosphorylated 
form of Slalp upon inhibition of nuclear uptake by rsll mutation, also suggests that 
dephosphorylation of Slalp may occur in the nucleus. PPl is known to localise to the 
nucleus and has been reported to interact with Slalp by yeast 2-hybrid analysis. Nuclear 
PPl may therefore potentially dephosphorylate Slalp.
Microarray analysis of a wild-type and a Issla strain identified gene expression 
changes in a number of genes which encoded nuclear proteins. While this study failed to 
directly identify a role for nuclear Slalp, microarray data may be used to promote 
further investigations into nuclear Slalp. The identification of nuclear actin and 
suggestion that actin continues to play a structural role in the nucleus, implies a 
continuing requirement for the regulation and nucléation of actin polymers, and 
therefore potential conservation of the regulatory mechanisms of actin and Slalp 
activity at this location. Additionally however, the potential of Slalp to perform a 
transcriptional role in the nucleus should also be investigated.
The dynamic nature of the actin cytoskeleton is a consequence of the 
coordinated control of filament polymerisation, disassembly and nucléation. Ysc84p 
associates with cortical actin patches, which are composed of over 30 patch proteins and 
an integral branched, filamentous actin network (Pruyne and Bretscher 2000b, Young et 
al 2004). In Chapter 4, I demonstrate the interaction of Ysc84p with actin filaments in 
vitro. Additional analysis also reveals both the filament severing and capping activity of 
Ysc84p in vitro. Finally, by localising these activities to an amino-terminal region of 
Ysc84p, and demonstrating a loss of capping activity associated with the full length 
protein, a possible regulatory mechanism for Ysc84p was considered. This in vitro data 
suggests an exciting role for Ysc84p in the regulated control of branched actin filaments 
at cortical patches in S. cerevisiae. Actin patches are integral components of the 
endocytic machinery in S. cei'evisiae and I therefore proposed that the capping and 
severing activity of Ysc84p may be central to the co-ordinated control of actin 
regulation at the cell cortex. Ysc84p may influence actin dynamics both during the early 
stages of endocytic uptake, and during the generation of an actin based propulsive force, 
which is thought to be harnessed to enable the movement of endocytosed vesicles. 
Additionally, the localisation of the Ysc84p homologue, hSH3yl-l, to sites of dynamic 
actin remodelling, and demonstration of the ability of hSH3yl-l to partially functionally
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replace Ysc84p in S. cerevisiae, suggests that this Ysc84p homologue may also perform 
an important role in the regulation of actin in higher cells. The in vitro actin regulating 
abilities of hSH3yl-1 however remain to be examined.
The actin binding, severing and capping activities of the conserved N-terminal 
region of Ysc84p suggest a previously unidentified functional domain. This region of 
Ysc84p fails to show significant homology to known domains or motifs upon 
investigation, and Ysc84p itself does not show significant homology to known actin 
severing and capping proteins. Initial secondary structural predictions of Ysc84p 
however identify several regions of predicted alpha helical and beta sheet structures in 
the N-terminal region which in combination with actin binding, capping and severing 
activities, suggests an as yet uncharacterised conserved functional domain in Ysc84p. 
Ysc84p and its homologues may therefore constitute a new class of actin 
severing/capping proteins. Additionally it is also suggested by our analysis that Ysc84p 
may preferentially bind to phalloidin stabilised filaments. Binding of both full length 
and Ysc84p N-terminal fusions to unstabilised F-actin was demonstrated by F-actin 
sedimentation, however a lack of severing activity exhibited by GST-Ysc84 in the 
absence of phalloidin suggests that Ysc84p may require stabilisation of filaments in 
order to exhibit strong binding to F-actin. Phalloidin does not inhibit the hydrolysis of 
ATP-actin following incorporation into actin filaments, but has been shown to inhibit 
the release of the product of hydrolysis, inorganic phosphate from filaments. This effect 
may therefore stabilise the interaction of Ysc84p with F-actin and should therefore be 
investigated.
The generation of cellular phenotypes upon deletion of both YSC84 and LSB5 
suggests a partial overlap the function of these proteins. Endocytic and actin defects, a 
temperature dependent growth defect and slow growth phenotype, are seen in a 
Aysc84Alsb5 mutant; phenotypes which are not apparent in single deletions. EM studies 
of this double mutant also demonstrate vesicle accumulation and thickening of the cell 
wall, which suggest trafficking defects in this strain. The potentially involvement of 
Lsb5p in the regulation of actin through interaction with the Arp2/3 regulating protein, 
Lasl7p (Madania et al, 1999), recent studies which suggest that Lsb5p may regulate 
endocytic uptake and vesicle trafficking at the cell cortex, and the identification of the 
actin regulating abilities of Ysc84p, suggest Lsb5p and Ysc84p may both play roles in 
endocytic regulation, although a specific functional overlap has yet to be identified
Both Ysc84p and Slalp localise predominantly to the cell cortex, where they are 
proposed to transiently interact. This interaction may function as a recruiting or
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regulatory mechanism in the control of endocytic uptake at the cell cortex. An 
additional link between Ysc84p and Slalp may be Gtslp. In chapter 5 ,1 confirmed the 
previously reported interaction between Gtslp, and both Slalp and Ysc84p, as 
determined by yeast 2-hybrid analysis. I also identified domains in both Slalp and 
Ysc84p which were involved in mediating these interactions. These interactions suggest 
that Gtslp, Slalp and Ysc84p may interact in vivo at the cell cortex, potentially linking 
the inactivation of Arf3p with endocytosis, via the proposed Arf-GAP activity of Gtslp. 
The potential Arf regulating ability of Gtslp should therefore be investigated in 
subsequent studies. Gtslp may act in the recruitment of specific components to sites of 
Arf3p mediated vesicle formation or in the recruitment of components important for 
bud growth and development to specific sites.
The work which I have presented in chapters 3 - 5  provides further insights into 
the regulatory mechanisms controlling remodelling of the actin cytoskeleton in S. 
cerevisiae and higher organisms. While this study has concentrated specifically on the 
roles of Slalp, Ysc84p and Gtslp, information gathered during the course of this work 
can be regarded as pieces of a larger actin puzzle, the understanding of which will 
eventually enable a better understanding of cellular regulation. Knowledge gained from 
this study may also be extrapolated and applied to regulatory networks in other systems, 
which in many cases show a high degree of conservation. This thesis therefore provides 
a body of research which can be regarded as incomplete and which raises many further 
questions. With these questions in mind, I propose several experiments in section 6-2 to 
address some interesting possibilities which have arisen from my studies.
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6.2 Future Directions
6.2.1 Investigating the nuclear translocation of Slalp
Cellular and protein analysis suggests that Slalp cycles through the nucleus 
(chapter 3). By undertaking point-mutagenesis of potential signal sequences located 
between residues 118-511 and 507-1008 of Slalp, the identification of precise signal 
sequences which specified the nuclear translocation of the Slalp could be made. 
Additionally, Slalp point-mutants which were deficient in nuclear translocation may 
retain the functionality lost by domain deletion in the slal-A 188-511 and slal-AG2 
mutants. Such strains would potentially therefore identify cellular defects specific to the 
inhibition of Slalp nuclear translocation only. Successful inhibition of Slalp nuclear 
translocation would be detected by immunofluorescence of the tagged mutant protein, 
with cellular analysis undertaken in strains demonstrating Slalp mislocalisation.
6.2.2 Examining the regulatory mechanism of Slalp
A model for the phosphorylation dependent cycling of Slalp through the nucleus 
has been proposed. 2-Dimensional gel analysis of our slal-A 188-511 and slal-AG2 
mutant strains, followed by Slalp detection with Slalp specific antibodies, would 
provide insight into the modification and regulation of Slalp. Previously unpublished 
data from our lab has identified four modified forms of Slalp by 2-Dimensional gel 
analysis of the wild type strain (KAY 302) during log phase growth. The study of slal- 
A188-511 and slal-AG2 mutants by 2-Dimenstional gel analysis would identify 
modified forms of these Slalp mutants, and may suggest whether a specifically 
modified form of the protein predominates in these strains. Our model proposes the 
nuclear entry of a phosphorylated form of Slalp. Analysis of the slal-AG2 strain would 
therefore be of particular interest, as our model predicts that this mutant protein would 
be predominantly phosphorylated.
A previous screen has identified an interaction between Slalp and Glc7p, the 
catalytic subunit of protein phosphatase 1 (PPl) by yeast 2-hybrid analysis (Venturi et 
al, 2000). In order to further investigate the regulatory mechanisms of Slalp, 
confirmation of this interaction both by 2-hybrid and biochemical analysis could be 
undertaken, while additionally undertaking a study of Slalp localisation and 
modification in PPl mutant strains.
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6.2.3 Identifying Slalp protein-protein interactions
To further investigate the function and regulation of Slalp, GST pull-down 
assays should be used to identify proteins in crude yeast extracts which physically 
interact with Slalp. GST tagging, expression and purification of GST-Slalp would 
enable immobilisation of the purified fusion protein on glutathione sepharose beads. 
Subsequent incubation of both a control GST column and a column containing 
immobilised GST-Slalp with yeast extracts, followed by column washing, elution and 
SDS-page gel analysis of the eluted proteins, would identify protein bands which 
specifically bound to the GST-Slalp. Analysis of such bands could then be undertaken 
by mass spectrometry, following identification of known or potential binding partners 
by western blotting. The tandem affinity purification (TAP) tagging method may also be 
useful in purifying Slalp complexes under native conditions. Prior purification of Slalp 
has however proved difficult due to degradation of the protein.
6.2.4 Investigating the effect of Ysc84p on actin polymerisation
To further investigate the actin severing and capping activities of Ysc84p, the 
effect of Ysc84p on the kinetics of actin polymerisation should be measured by 
following the polymerisation of pyrene labelled actin, in both the presence and absence 
of untagged Ysc84p and Ysc84p fragments. The pyrene conjugated G-actin monomer is 
weakly fluorescent, but upon polymerisation fluorescence is substantially enhanced. 
The speed of polymerisation can therefore be followed by measuring the increase in 
fluorescence in a spectrofluorimeter (Cooper and Pollard 1982). From these studies the 
binding affinity and kinetic rate constants of Ysc84p and Ysc84p fragments could be 
determined. Additionally the actin severing activities of Ysc84p could be studied by 
following the time course of depolymerisation upon incubation with pre-formed actin 
filaments. Polymerised pyrene labelled actin filaments could also be incubated with 
various concentrations of free Ca^ "*", in the presence of Ysc84p, and the intensity of 
fluorescence recorded. This study would allow the depolymerising effects of Ysc84p to 
be compared to that of known actin severing and capping proteins, and the effects of 
calcium addition to be quantified.
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6.2.5 Investigating the in vivo function of Ysc84p and protein-protein 
interactions
Overexpression of hSH3yH in S. cerevisiae is known to affect the actin 
cytoskeletal network. Additionally, overexpression of capping protein (CP) in S. 
cerevisiae is known to generate cells which demonstrate a loss of heterogeneous 
morphology; with many showing abnormally thickened cell walls, loss of actin cables 
or an altered actin cytoskeleton, in addition to aberrant bud morphology (Amatruda et al 
1992), Overexpression studies of Ysc84p may therefore yield important information as 
to the effects of the protein in vivo. The ability of Ysc84p overexpression to rescue 
defects associated with capping protein deletion could also be tested, which may 
suggest a functional overlap between these two proteins. Genetic screens to identify 
suppressors of YSC84 overexpression phenotypes could additionally be performed, in 
order to identify proteins which may physically interact with Ysc84p.
The generation of antibodies specific to Ysc84p was a significant development 
which was not utilised fully in this study. Ysc84p has been shown to immunoprecipitate 
with Abplp, and to potentially interact with LaslTp and G tslp by two-hybrid analysis. 
Ysc84p specific antibodies could therefore be used to perform immunoprécipitation 
assays in which the proposed interactions between Ysc84p, LaslVp, and Gtslp could be 
confirmed biochemically.
6.2.6 Analysis of the Arf-GAP activity of Gtslp
In order to confirm the proposed Arf-GAP activity of Gtslp, subsequent analysis 
must be performed. The Arf-GAP activity of Gtslp could be assayed in total cell lysates 
as described by Randazzo and colleagues (Randazzo and Kahn, 1994). Cloning of 
G tslp to engineer a myc epitope at the C-terminus of the protein could be undertaken, 
and the fusion expressed in yeast cells on a high copy number plasmid. Total cell 
lysates from this strain and a control untransformed strain could then be assayed by 
immunoblotting with anti-myc antibodies to identify the tagged protein, and to ensure 
expression of the fusion protein at the coivect molecular weight. Arf-GAP activity 
would then be assayed by incubating total cell lysates with known concentrations of 
[^^P] GTP loaded, purified A rfl. Untransformed yeast would exhibit low background 
levels of GAP activity, from endogenous Arf-GAP proteins. However, in strains
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overexpressing Gtslp a marked increase in Arf-GAP activity would potentially be seen. 
Protein bound nucleotides are then trapped on nitrocellulose filters from which they are 
extracted. Analysis is then performed by chromatography to separate the nucleotides, 
from which [^^P]-containing nucleotides can be visualised and quantified using a 
phosphoimager.
6.2.7 Investigating protein-protein interactions and the localisation of
Gtslp
2-hybrid data indicates interactions between Gtslp and both Slalp and Ysc84p. 
Purification of tagged Gtslp would enable these proposed interactions to be confirmed 
biochemically. GST tagging, expression and purification of GST-Gtslp would enable 
immobilisation of the fusion protein on glutathione sepharose beads, and subsequent 
incubation with purified proteins of interests or with yeast extracts from strains 
expressing tagged proteins of interest, in order to confirm these interactions. The 
tandem affinity purification (TAP) tagging method may also be useful in purifying 
G tslp complexes under native conditions.
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